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6 Introduction 
This thesis focuses on the quality of life and the quality of primary care in 
osteoarthritis (OA) patients. Even though this affection of joints is a highly 
prevalent disease and its prevalence is increasing, little is known about this topic. 
Thus, the overall aim of this thesis was to describe and analyse various aspects of 
the quality of life in OA patients and the primary care they receive. In the first 
section of this thesis several measures of quality of life of patients with OA will be 
examined. In the second section, comorbidities and their influence on the quality of 
life and health service utilisation (HSU) are explored. In the final section, the 
currently provided primary care and approaches to its improvement will be studied.   
 
Osteoarthritis 
DEFINITION 
Osteoarthritis is the most common affection of joints worldwide.1 Interestingly, 
there is no consistent definition of osteoarthritis.2 It can be defined by either 
symptoms or pathology. In contrast to prior ideas, nowadays, OA is regarded not 
only as an affection of the cartilage or joint alone.3 The pathology involves the 
whole joint in a disease process that includes cartilage loss with concomitant 
changes in the bone underneath the cartilage, including marginal outgrowths 
(osteophytes) and bone sclerosis.4 Also the soft tissue is involved in this complex 
process, including synovium, ligaments and muscles. The synovium often shows 
modest inflammatory infiltrates, the ligaments are often lax, and the muscles are 
often of reduced strength: supporting a hypothesis which favours joint stability as 
important predictor of OA. It is still unclear whether OA is a single disease or a 
combination of many disorders with a similar final common pathway.  
The clinical definition takes into account the pathology, resulting in functional 
disability and pain occurring with joint use. But interestingly, in detail, the cause of 
the pain is unknown.5 It is regarded as a result of the complex interaction between 
the structures in and around the joint which are involved in the use of the joint.6  
 
Prevalence 
Regarding the prevalence, it is important to distinguish between the radiological 
prevalence and the prevalence of symptomatic OA.7-9 To develop radiological 
signs of degenerative affections of the joint seems almost unavoidable: in the 
general population over 50% of the women aged 80 or over have radiological 
signs of osteoarthritis.7,10 But fortunately X-ray findings do not hurt: the prevalence 
of symptomatic osteoarthritis is notably lower. Nevertheless, according to 
estimations of the WHO, about 9% of men and 18% of women suffer from 
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symptomatic OA.1 The prevalence of diagnosed OA in healthcare is lower than in 
the open population. Data from the Netherlands (based on the International 
Classification for Primary Care, ICPC) for instance showed a prevalence of hip OA 
of 3.8%, of knee OA of 5.6% and 4.0% on other joints, diagnosed in a primary care 
population.11
Interestingly, the prevalence patterns change with the age of the observed 
population: before the age of 50, the prevalence of OA in most joints is higher in 
men than in women.3 After the age of 50, women are more often affected, 
especially with OA to the knee, whereas men are more affected by OA to the hip. 
Since its prevalence and incidence is expected to rise in the upcoming years – at 
least in the industrialised countries – the World Health Organization (WHO) has 
declared this decade as “bone and joint” decade.12 Regarding the localisation of 
OA, the knee and the hip are the mostly affected joints.13
 
Risk factors   
Among risk factors for emergence and prognosis of OA influenceable and non-
influenceable factors have to be distinguished. Regarding non-influenceable risk 
factors, many studies have shown that genetic factors account for at least 50% of 
cases of OA in the hands and hips and a smaller percentage in the knees.14 The 
strongest non-influenceable risk factor is age.15 With increasing age the probability 
to develop radiological signs of degenerative changes in the joints increases.  
Especially for the knee, weight load and stability are the most important 
influenceable factors. Therefore, increased body weight represents the strongest 
predictor for developing OA.15,16 Strengthening the muscles, especially the 
musculus quadriceps femoris, increases the stability of the knee joint and lowers 
the risk of OA. This is not only effective in primary prevention, studies have also 
shown that strengthening muscles can reduce pain and increase functional ability 
in patients who suffer already from symptomatic OA. Unfortunately, many people 
are not very physically active.  
 
Quality of life in patients with osteoarthritis in primary care 
Few studies of the quality of life in OA patients have involved large samples of 
primary care patients or the general population. Some epidemiological studies 
included risk factors or other epidemiological aspects.8,10,20 Therefore, in the first 
section of this thesis the problems and needs of OA patients in primary care will be 
assessed and measures of their disease specific quality of life (QoL) will be 
9
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examined. Since it is also unclear how GPs estimate the QoL of their OA patients, 
we will assess this issue in a separate study. 
OA shows a strong association to the body weight, obesity respectively.21-23 But 
obesity is also an important risk factor for many other diseases, especially 
cardiovascular diseases.24 How comorbidities influence QoL in OA patients and 
health service utilisation (HSU) has only been marginally assessed so far. 
Furthermore, chronic diseases as OA often influence many dimensions of the QoL 
as for instance, affective aspects. Depressive disorders are often increased in 
patients with chronic diseases.25-27 Psychosocial aspects are important for the 
clinical management of the disease and also influence HSU substantially. Pain for 
example, one of the biggest burdens of OA, was strongly associated with 
depression.28,29 Depression has a detrimental effect on physical activity, which is 
important to strengthen muscles and keep patients mobile.28,30 Regarding all these 
aspects only little research is currently available, especially from large samples of 
primary care patients. Therefore, in section two of this thesis the prevalence of 
comorbidities and determinants of depression and pain and their association with 
obesity and HSU will be assessed. 
 
Chronic care model  
Due to the demographic trend in most industrialised countries, chronic diseases 
like arthritis, diabetes, hypertension and asthma are expected to increase 
tremendously in the upcoming years.31 They may represent the biggest challenge 
for the health care systems in the near future, not only from a medical but also 
from a societal perspective. Current care, also for the chronically ill is often 
dominated by reactive and event-driven approaches which will not succeed in 
delivering appropriate, patient-centred care. Ed Wagner and colleagues developed 
a Chronic Care Model (CCM).32,33 The CCM represents a broad conceptual 
framework that aims to overcome the increasing and well-documented gap 
between clinical research findings and real practice.34 It supports evidence-based 
proactive and planned care for chronic diseases instead of event-driven and 
unplanned activities. It specifies six broad dimensions: organisation of health care, 
clinical information systems, delivery system design, decision support, self-
management support and community resources. In this thesis, the chronic care 
model is used as a broad framework to examine approaches for the improvement 
of primary care for OA patients. Particularly, the thesis will explore which 
components of the model can be effectively implemented in German primary care 
– physician orientated medical care, delivered in small practices. 
10
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A recent review of the literature confirms that successful improvement strategies 
concerning chronic diseases are consistent with the concept and components of 
the CCM.35 The needs of chronically ills and consequently the requirements on 
health care providers are quite similar in many chronic diseases. Even the 
effective interventions applied in a proactive approach are similar to some other 
chronic diseases: for example, similar to hypertension or diabetes, a reduction in 
body weight has proven to improve pain and functional disability.22 Therefore, the 
CCM seems to be appropriate for various chronic diseases36 such as 
hypertension, diabetes37,38 and also arthritis. But some limitations of complex 
approaches as the CCM have to be acknowledged: the concept has been 
developed in large Health Maintenance Organization (HMOs) in the US, which 
provide a large variety of health care professionals. Primary care, especially in 
Germany, is very physician centred. Currently it seems not possible to provide 
care according to the CCM in primary care in Germany; even recent findings 
indicate that required changes in practices are small. Taking into account the lack 
of young GPs and the expected decrease in numbers of GPs providing primary 
care, delegating work will be indispensable in the care for chronically ills. As a 
consequence, primary care will most likely shift from a physician centred system to 
a team structure in care, even in Germany. In consequence, it seems interesting to 
assess – compared to a conventional, physician centred approach - a team 
approach. In section three of this thesis a qualitative approach on this issue, as 
well as the realisation of a team approach in a large cluster randomised-controlled 
trial, is presented.  
 
Aims and objectives 
The central aims of this thesis were  
1. to assess the quality of life of patients with osteoarthritis in general practice and 
to validate appropriate instruments (chapters 1 to 3). 
2. to reveal the impact of concomitant complaints and conditions on QoL and 
health service utilisation (chapters 4 to 7). 
3. to assess the care provided, reveal possible improvements and to evaluate their 
impact in a randomised controlled trial (chapters 8 to 11). 
11
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Table 1 gives an overview of the specific objectives and the associated chapters 
addressed in the three main sections of this thesis: 
Aim of the section Objective of the specific chapter 
1. To assess problems and needs of OA patients 
in a qualitative study 
2. Validation of the short and long form of the 
Arthritis Impact Measurement Scale (AIMS)
I. To assess the quality of life of patients 
with osteoarthritis in general practice and 
to validate appropriate instruments  
3. To assess determinants of GPs estimation of 
patients’ QoL 
4. To assess prevalence and determinants of 
depression
5. The influence of depression on quality of life 
and HSU 
6. The determinants of pain in OA patients 
II. To reveal the impact of concomitant 
conditions, on QoL and health service 
utilisation  
7. The effect of obesity on QoL and HSU 
9. Congruency of provided care with the Chronic 
Care Model 
8. Association of patient satisfaction and disease 
specific quality of life 
10. Involvement of the practice nurse in the 
treatment of OA patients 
III. To assess the provided care and to 
evaluate a case management approach 
11. The effect of case-management provided by 
practice nurses 
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Abstract 
Background: Osteoarthritis (OA) is highly prevalent and has a substantial impact 
on the quality of life as well as on healthcare costs. The general practitioner (GP) 
is often the first care provider for patients with this chronic disease. The aim of this 
study was to identify health care needs of patients with OA and to reveal possible 
obstacles for improvements in primary care management of OA patients. 
Methods: We performed semi-structured interviews with a stratified sample of 20 
patients, 20 GPs and 20 practice nurses. 
Results: Diagnosing OA posed no major problem, but during the course of OA, 
GPs found it difficult to distinguish between complaints resulting from the affection 
of the joints and complaints related to a concomitant depression. Patients felt to be 
well informed about the degenerative nature of the disease and possible side 
effects of medications, but they lacked information on individual consequences of 
the disease. Therefore, the most important concerns of many patients were pain 
and fear of disability which they felt were only marginally addressed by GPs. 
Regarding pain treatment, physicians and patients had an ambivalent attitude 
towards NSAIDs and opiates. Therefore, pain treatment was not performed 
according to prevailing guidelines. GPs felt frustrated about the impact of 
counselling regarding lifestyle changes but on the other hand admitted to have no 
systematic approach to it. Patients stated to be aware of the impact of lifestyle on 
OA but lacked detailed information, e.g., on how to exercise. Several suggestions 
were made concerning improvement. 
Conclusion: GPs should focus more on disability and pain and on giving 
information about treatment since these topics are inadequately addressed. 
Advanced approaches are needed to increase GPs impact on patients' lifestyle. 
Being aware of the problem of labelling patients as chronically ill a more proactive, 
patient-centred care is needed. 
8
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Background 
About 10% of men and 18% of women aged 60 years and over suffer from 
symptomatic osteoarthritis (OA)1. Due to increasing life-expectancy as well as 
constant increase in the average body mass index, which constitutes a principal 
risk factor for OA 2, the incidence of OA is expected to rise in years to come3. OA 
causes high direct costs (0.7 % to 1.2 % of the gross national product), and also 
high indirect costs as a consequence of morbidity and disability and represents 
one of the diseases with the highest economic impact 4-7. 
The main care provider for many patients with OA is the GP8,9. To improve quality 
of care for osteoarthritis patients, evidence-based guidelines and a quality 
indicator set exist in most countries; however, this is not the case in Germany 10,11. 
It has been suggested that conservative management of OA is difficult for 
physicians and patients, but little is known about the actual management of OA in 
primary care in Germany. Moreover, there is only limited information on the 
perspectives of different groups involved in the treatment of OA12. For instance, 
practice nurses play an increasing role in providing care in many health care 
systems, but their perspective is often ignored13,14. Insight into patients', 
physicians' and practice nurses' views on management of OA is needed to identify 
problems concerning quality of care and possibilities for improvement. The aim of 
our study was to reveal patients' needs, assess their wishes for improvement and 
to identify obstacles that handicap improvements. In order to implement such 
improvements, it is important to not only assess the views of patients but also 
those of doctors and practice nurses. The interview guideline was created 
according to our hypothesis that patients lack information on the disease, 
medication and possible approaches and wish for more consultation time. The 
results of this study should help create interventions for the primary care setting to 
be evaluated in a subsequent intervention study. 
 
Methods 
A qualitative interview study with general practitioners (GPs), practice nurses and 
patients with OA was performed according to the guidance for qualitative 
research15. A heterogeneous sample of 20 GPs, 20 practice nurses and 20 
patients was stratified by gender and urbanisation level16. The GPs had to have a 
minimum of 5 years experience; the assistants were required to have a minimum 
of 10 years professional experience. The patients were selected at random from 
the GPs' computer files by searching for patients with the ICD -code M16.0–16.9 
(coxarthrosis) and M17.0–17.5 (gonarthrosis). During their practice visit they were 
9
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asked by the GP if they wanted to participate in an interview. All patients but one 
agreed to participate. The study protocol (named as "PraxArt-barriers-study") has 
been approved by the ethics committee of the University of Heidelberg; approval 
number 019/2004. 
 
Interviews 
After a detailed study of the literature on evidence-based, non-surgical treatment 
options for OA and regarding patient perspectives in chronic diseases, we 
compiled a semi-structured interview guide with open-ended questions. 
All interview guidelines were as similar as possible to allow comparisons across 
groups and followed the normal course of a consultation: diagnostic routines, 
information giving, prescribing, advice on lifestyle change and referral. Due to the 
small number of non-surgical evidence-based treatment options we were 
especially interested what importance evidence-based treatments have. In 
addition, we focused on the attitudes of patients, doctors and assistants towards a 
larger involvement of the practice nurse in the care of patients suffering from OA. 
 
Procedures 
The interviews were conducted during 2004. The GPs and practice nurses were 
interviewed in their respective practices; the patients were interviewed at home by 
trained interviewers. During the interview, the interviewer ensured that every 
aspect was explained sufficiently and in detail so that there would be no questions 
or misunderstandings later on. 
 
Analysis 
The conversations were recorded digitally, transcribed literally and analysed by 
four different researchers with ATLAS.ti-Software17. An initial categorising system 
was established based on the interview guidelines. In order to achieve maximum 
objectivity, all interviews were read by four researchers and categorised 
independently. The categorising system was consequently modified; 
subcategories were added after agreement had been reached among all four 
researchers. Numerous free categories were developed from the text, discussed 
and adjusted in an iterative process so that they were as similar as possible in all 
three interviewed groups, as the objective was to emphasise the different 
perspectives of the groups regarding individual subject complexes. The codes 
were clearly defined and linked with representative examples from the original text. 
 
20
 Problems and needs of osteoarthritis patients 19 
Results 
The mean age of our patients was 56, with a range from 40 to 78 years as can be 
seen in table 1. The educational level was relatively high. Working experience 
ranged from 8–19 years with a mean of 11.3 years among GPs and from 13–35 
years (mean: 21.7) among practice nurses. Some items yielded very limited 
responses among practice nurses; therefore their statements were only mentioned 
if they provided an important contribution to a specific aspect. 
 
Table 1. Baseline characteristics of the study sample 
 
 N 
(female) 
Age (mean) Years of working experience 
(mean)  
Education level * 
(mean) 
Interview time 
(minutes) 
practice nurses 20 (20) 29-56 (41.3) 13-35 (21.7)  25 (21-34) 
GPs 20 (4) 33- 57 (43.5) 8-19 (11.3)  45 (41-60) 
patients 20 (12) 40-78 (56.2)  3.3 43 (41-55) 
* (1= no school; 5=university degree) 
 
Tables 2, 3, 4 display the categorical system with subcategories. The numbers in 
brackets display how many participants responded to the respective category. 
 
Diagnotic aspects – proceedings 
The interviewed GPs stated that in most cases diagnosing OA poses no major 
problem to them. The diagnosis is frequently based on an extensive anamnesis 
and an accurate examination. The interviewed GPs stated that if they are unsure 
whether the pain is caused by the joint or periarticular structures, an X-ray is 
performed to confirm OA. During the course of OA, the situation is more difficult: it 
sometimes represents a challenge for GPs to distinguish between complaints 
resulting from the joint affection and complaints which are mainly related to 
depressed mood. Satisfaction among patients regarding the diagnostic procedure 
was high: most patients in our study sample stated that the GP took enough time 
in diagnosing and that the examination was extensive and accurate. 
When asked about how and to what extent GPs inform patients about the disease, 
some GPs stated that they try to assess the patients' need for information and 
their capability to understand, but also what they assume the patient can handle. 
Overall, patients were considered to be well informed due to their utilisation of 
countless other sources of information such as print media and TV. 
This assumption was confirmed by many patient statements. Regarding the cause 
and the pathomorphology, patients felt well informed. Most of them were aware of 
the degenerative nature of the disease. There was no apparent lack or request for 
more information on this topic. But in terms of the prognosis, patients were very 
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insecure. Pain and becoming disabled were the main fears of patients, and most of 
them stated that they were insecure to what extent the pain could increase and if 
they would still be able to walk at some point in the future. Many patients argued 
that physicians were mainly focused on explaining the pathology of the disease 
and the treatment options such as new surgical methods but less focused on their 
main fears. Especially older patients seemed to have problems mentioning these 
concerns. In conclusion, there was no quantitative lack of information, but a 
qualitative one, as the following two statements reflect: 
 
"The majority of patients nowadays open the envelope (of the specialist) 
themselves. They know exactly what is written down there. There is 
communication on the same level between doctor and patient." (GP 10, 
male, aged 37) 
"I know that OA is a one-way-street. That's not the problem. Life is a 
one-way-street too. But in OA I don't really know what's at the end." 
(Patient 17, male, aged 71) 
 
Diagnotic aspects – problems 
Asked about problems in the diagnostic process, most of the interviewed GPs 
were aware that like many other diseases of the musculoskeletal apparatus, OA 
only shows little correlation between what is pathomorphologically visible – e.g. on 
a radiographic image – and subjective complaints. Therefore, many GPs stated 
that they found it difficult to assess to what extent complaints originate from 
arthritis and what part of the complaints are due to concomitant depressive 
symptoms. This was particularly the case when there was insufficient radiographic 
evidence and the physical examination gave no sign for an acute inflammation of 
the joint. Depression was also recognised as an important barrier to motivate 
patients to take physical exercise. Concrete instruments such as well known 
questionnaires for instance the HAMDS18 or the PHQ-919 etc. were not used to 
reveal depression. 
One GP stated: 
 
"And there is always a depressive component. The relation between 
depression and arthritis pain and physical sensation is an important one. 
And exactly those people with depression cannot change anything about 
it, because they really suffer from depression and are not capable of 
changing their lives or doing something about their lives; they fall deeper 
2
 Problems and needs of osteoarthritis patients 21 
and deeper into this vicious circle of disease and pain, and nobody can 
help them." (GP 5, male, aged 47) 
 
According to GPs' statements, and confirmed by most patients of our sample, 
nearly every patient was sooner or later referred to an orthopaedic surgeon in 
order to confirm the diagnosis by taking an X-ray. 
 
"He was more interested in taking pictures of my knee than in examining 
it". (Patient 19, female, aged 68 on an orthopaedic specialist) 
 
Table 2.  Main categories regarding diagnostic aspects 
 
General Practitioners Patients Practice Nurses 
Proceedingsa (19)b:  
Making an extensive anamnesis c  (19) 
Making an extensive examination (18) 
Informing patients about cause and 
course of disease (17) 
Referring patients to orthopeadic (8)  
Referring to radiologist (6) 
Problems  
- diagnosing OA (12): 
Poor correlation between x-rays and 
complaints (8) 
Concomitant depression (5) 
Others (3) 
 - regarding specialist (6) 
Focusing on performing x-rays (5) 
Missing information about performed 
examinations/ recommendations (5) 
Felt pressure to refer to specialist (3) 
Satisfaction (20): 
Satisfied with diagnostic 
proceedings (15) 
Needs/problems regarding GPs 
(13) 
Missing information about 
diagnosis and its course/impact 
on individuals life (12) 
Lacking time (2) 
 
Needs/problems regarding 
specialists (15)    
Lacking time (14) 
Missing information about 
diagnosis and its course/impact 
on individuals life (8) 
Focussing on performing 
examinations (5) 
Recommendation of expensive  
treatments (4) 
Involvement (20): 
Current involvement in  
- diagnostic proceedings (2) 
- treatment (1) 
No involvement in diagnostic  
proceedings (17) 
Wish of being more involved (11) 
No wish of being more involved 
(9)  
 
Barriers against involvement 
(20) 
Lacking knowledge about disease 
(13) / treatment (17) 
Lacking time due to - 
administrative overload (11) 
- other reasons (3) 
 
a Words in italic are main categories; 
b number of participants referring to the respective category (multiple mentions possible) 
c subcategories (not all subcategories are displayed). 
 
Patients regarded specialists as an additional source of information, but most of 
them mentioned that the GP took definitely more time for the anamnesis and was 
often more accurate than the specialist. Many patients stated orthopaedics would 
be mainly interested in the use of machines then in talking to them. GPs also had 
an ambivalent attitude towards these referrals. On the one hand they did not 
recognise superiority in knowledge and treatment options of a conservative 
treatment by an orthopaedic surgeon. On the other hand they used the 
orthopaedic surgeon from time to time to escape from the psychological burden 
induced by the patient and the absence of treatment options. In addition they felt a 
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lot of pressure by patients to refer them to the specialist, especially in the case of 
younger and well-educated patients. But some stated that they sometimes felt 
abused by patients as well as by specialists, because the patients pushed them to 
be referred and the specialist did not take the time to explain what they had 
examined or the X-rays he had taken. Therefore, GPs often ignored the patients' 
repeated requests for referrals to an orthopaedic specialist. 
Interestingly, lack of time could not be revealed: most GPs stated to take as much 
time as possible and patients did not regard time limitation as a main problem or at 
least showed understanding for the limitation in the face of overcrowded waiting 
rooms. 
 
Treatment aspects – pharmacological treatment 
Regarding treatment aspects, pharmacological treatment was the topic on which 
the most statements were recognised, indicating the importance of this topic for all 
groups. Facing decreasing financial resources and increasing restrictions by most 
health insurances, many GPs stated that treatments like massages, physiotherapy 
and manual therapy were prescribed less frequently. Some GPs complained that 
in consequence OA treatment has been reduced to mainly prescribing pain 
medication.  
Asked about adherence to guidelines, which recommend Paracetamol as first 
choice of pharmacological treatment20-22, GPs stated that Paracetamol was not 
accepted as a real pain reliever because it is known to most patients as 
medication for "headache" and available without prescription. GPs also argued 
that most patients have already taken this drug on their own by the time they visit 
their physician. 
Consequently, Paracetamol was prescribed less by the interviewed GPs, and for 
all of them NSAIDs represented the main pillar in their pharmacological therapy of 
OA. But after the withdrawal of most COX-2-inhibitors, patients as well as doctors 
felt very uncertain what to consider as an appropriate pharmacological treatment. 
Interestingly enough, patients and GPs have a similar ambivalent attitude towards 
analgesics. Patients appreciated the alleviation of pain, but at the same time they 
instinctively rejected these drugs without an apparent rational explanation. For 
instance, Diclofenac's stomachirritating potential is such a well-known fact that 
positive aspects of the drug are being ignored. No patient stated that he would 
take pain relievers in advance; they normally wait until they cannot take the pain 
any longer. GPs felt that due to the package inserts patients mainly focused on 
side effects; and therefore these leaflets were regarded as a barrier for optimal 
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treatment compliance. GPs' main aim was to ensure that the patient actually took 
the prescribed drugs. Therefore, they had mostly developed individual strategies 
that consisted of a balancing act of explanations for anticipated objections 
regarding treatment, legal requirements and belittlement. 
Asked about the meaning of package inserts, most of the patients stated that 
information on side effects was not that important to them, because they were 
aware that many of the side effects mentioned on the package insert never 
occurred. On the other hand they generally read the package inserts. Most 
patients of our sample stated that they mostly trusted the information given by their 
GP. But it seemed that the package inserts alerted them for possible side effects. 
In conclusion patients as well as doctors are more focused on side effects then on 
positive effects such as the anti-inflammatory potential of NSAIDs. 
The following statement displays the strategy of one GP in dealing with side 
effects: 
 
"Well, my personal opinion is, if you give the patients two or three side 
effects, they are happy, otherwise they have all of them since they are 
printed on the package insert. For that reason, I limit myself to two or 
three that I mention. Sometimes, when you mention it and say,"oh you 
could get that, but not really, only a few get that", I always attach a 
negative example, "but I think you are quite fit and healthy, so that you 
will not get it", then they don't get it. (GP 3, male, aged 51) 
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Table 3. Main categories regarding treatment aspects 
 
General Practitioners Patients Practice Nurses 
Applied (non-surgical) treatments (20): 
Prescribing Pain relievers (19) 
Prescribing physiotherapy/ massages (3) 
Counselling (19) 
- to reduce weight (19) 
- to exercise (15) 
- others (2) 
Problems (20): 
General (14): 
- Increasing restrictions regarding 
prescription of physiotherapy, etc. (14) 
- Lack of time (3) 
Regarding pharmacological treatment (20):
- Package leaflets decrease adherence 
(14) 
- Insecurity with pharmacological 
treatment/guidelines (12)   
- Little acceptance of opiats (6)  
- Interaction with specialist (5) 
Regarding lifestyle: 
- Motivating the patient to exercise or 
reduce weight (17) 
- Concomittant depression (6)  
Needs/Expectations (20): 
Improvement of symptoms  
- pain (14) 
- physical activity (8) 
Pointing out possible treatments 
(5) 
Conversation about the 
problems (2) 
Referral (2) 
Problems (20): 
Regarding medication (20): 
- (Fear of) side effects (16) 
- Lacking pain relief (12) 
Regarding counselling (15): 
- reasons laying in individual 
behaviour (14) 
- no precise advices to reduce 
weight/exercise (8) 
- lacking information about 
supportive offers (6) 
 
 
Knowledge (20): 
Knowledge about treatment 
(18) 
No knowledge about treatment 
(2) 
 
Involvement (20): 
Involvement in treatment (2) 
No involvement in treatment 
(18) 
Wish of being more involved 
(14) 
No wish of being more 
involved (5) 
 
Regarding opiates, similar barriers could be revealed from the doctors' as well as 
from the patients' perspectives: GPs stated that many patients would reject these 
"heavy drugs" (GP 6) and it seemed that even GPs regarded use of these drugs 
as overtreatment in OA. Furthermore, most physicians stated not to prescribe 
them as they are poorly tolerated and cause nausea. Opiates were often 
recognised by patients as medication for people in very poor condition such as, 
e.g., cancer patients and therefore rejected. None of the patients received a 
structured pain treatment plan or systematic advice to cope with pain. The 
following statement of a patient (female, 76) reflects a quite typical statement: 
 
"But I am careful; if I can take the pain then I won't take a pill because 
they are not really good for you. Only if there is no other way, then I will 
take one and that has to be enough....I really only take a pill when I am 
in terrible pain, otherwise I am against drugs." (Patient 4, female, aged 
71) 
 
Treatment aspects – advice giving and counselling 
This topic received the second most statements from GPs and patients. Nearly all 
interviewed GPs emphasised that they repeatedly addressed behaviour 
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interventions that can slow down the progress of OA, including weight loss and the 
strengthening of musculature. However, most of them admitted that they did not 
focus on increasing patients' motivation for behavioural change, but just gave 
general recommendations. The success rate in motivating patients was considered 
too low by the GPs, and the majority appeared distinctly resignated regarding their 
impact on patients' lifestyle. Many GPs also mentioned that there was a vicious 
circle: due to pain when exercising, people move less and eat more due to 
accompanying frustration and sometimes depression. When asked about the 
reasons why it is so hard to communicate these secondary preventive measures to 
patients, most GPs answered as GP 17 (male, aged 54): 
 
"Osteoarthritis is ultimately only a symptom of a huge lifestyle problem a 
complete change in lifestyle is required.... and this is impossible for 
osteoarthritis patients who are mostly elderly people... nobody is willing 
to change his/her lifestyle due to osteoarthritis, the disease has to be a 
lot worse than this. People have basically learned to live with it. " 
 
The patients in our sample confirmed GPs' statements regarding lifestyle 
interventions. The majority indicated that their GP had tried to motivate them 
repeatedly and had explained the general effects of lack of exercise and 
overweight. The following statement displays this quite impressively: 
 
"He really talked to me again and again, once he even asked if I wanted 
to eat myself into a wheelchair. And if I don't do it then it is my fault. The 
spirit is willing, but the flesh is weak." (Patient 9, female, aged 68) 
 
According to patients' statements, concrete types of exercise or other possibilities 
were not mentioned, directions were mostly quite vague. Asked about reasons for 
failure regarding their own physical activity, the patients mentioned pain, lack of 
knowledge regarding respective offers, lack of mobility and a lack of motivation. 
Indeed, most of the interviewed GPs stated that they did not inform patients about 
self-help groups or about offers on community level for instance. Reasons for this 
were a lack of information and frustration about the impact of this information: the 
GPs who had experience in giving this information complained that a lot of patients 
always find excuses not to participate in these services such as the distance from 
their homes to the location, etc. Contrary to these statements, patients welcomed 
basic information on self-help groups, but they were often unsure about possible 
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benefits and also expressed their reservations, in particular regarding availability 
or location in the rural environment. Receiving just a short, vague hint without a 
clear advice or motivation was regarded as insufficient. 
 
Suggestions concerning improvement of care 
The interviewed GPs were convinced that a gate keeper role for GPs as in many 
other health care systems could reduce patients' pressure to refer to orthopaedics 
and decrease performed X-rays. Some GPs mentioned that better communication 
with specialists could increase efficacy of treatment, but no specific suggestions 
how to achieve this were made. Many GPs stated that the payment system has to 
be changed in order to upgrade conservative treatments and conversations with 
the patient. Due to the insecurity regarding NSAIDS, some GPs also desired 
evidence-based pharmacological recommendations. Interestingly, patients could 
define their needs of care, but ideas for improvement were quite vague such as 
better communication, etc. 
For most GPs an involvement of practice nurses -which is currently only marginally 
the case in Germany- is imaginable in the area of lifestyle counselling and advice 
giving. Involvement in the diagnostic process was refused. Main barriers 
mentioned were lack of professional knowledge and lack of time due to 
administrative overload.  
Moreover, all GPs stated that interventions performed by practice nurses have to 
be reinsured sufficiently. Interestingly, practice nurses' opinions were quite similar 
to GPs' statements: they mentioned lack of knowledge due to professional 
education which is mainly focused on administrative issues. Especially younger 
practice nurses desired more involvement. They regarded this as an upgrade of 
their profession. Some of the nurses declared that they would like to offer links to 
self-help groups or sport groups if this information would be available in the 
practice. 
To receive information and advice from practices nurses – by printed information 
or lectures – was acceptable for most patients. But some of them indicated – as 
some GPs did – that they fear a worsening of the trustful doctor-patient- 
relationship if the nurse is involved in too many proceedings. However, missing 
information about offers, e.g., in the community caused statements as the 
following one: 
"There is a "Nordic walking group" in town...I know that some of our 
patients participate, but I really don't know to whom I should send the 
patients to." (Practice nurse 7, aged 29) 
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Table 4. Suggestions concerning improvement of care 
 
General Practitioners Patients Practice Nurses 
Ideas how to improve treatment 
(19): 
Gate keeper role for GP (14) 
Financial reward for 
communication/more time for 
conversation (11) 
Evidence based pharmacological 
recommendations (5) 
Improved cooperation with 
orthopaedics (5) 
Integrating the patients’ social system 
(e.g. family) into treatment (2) 
More openly address psychological 
complaints of the patients (1) 
Team approach (20): 
Imaginable (18) 
Not imaginable (2) 
Possible tasks for practice nurses 
(20): 
Information about offers on the 
community level/self help groups (11) 
Providing additional written information 
(8) 
Relaxation techniques (2) 
Whishes concerning GP (16): 
Transparency concerning normal 
course of disease (11) 
Using less medical terms (3) 
GP should more openly address 
psychological complaints, direct 
questions about mood (3) 
More time (1)  
Team approach (20): 
Imaginable (13) 
Not imaginable (7) 
Possible tasks for practice 
nurses in the context of a team 
approach (10): 
Informing the patient about 
additional (non-pharmacological) 
approaches (9) 
Informing about offers on the 
community level, sport groups, self 
help groups (7) 
Asking for side effects (5) 
Asking patient about his mood (4)  
Talking to the patient 
sympathetically (3) 
Team approach (20): 
Imaginable (15) 
Not imaginable (5) 
Possible tasks for practice 
nurses in the context of a 
team approach (15): 
Talking to the patient (9) 
Counselling in groups (2) 
Asking patient about reason for 
consultation (2) 
Calling the patient in regular 
intervals and ask about pain, 
side effect of medications  (2) 
Motivating the  patient to use 
self-help groups and social 
contacts (2) 
Organising self-help groups (2) 
Exchanging information about 
the patient with the GP (2) 
 
 
Discussion 
In addressing different areas of OA treatment our study provides several important 
findings: the main finding is that although patients with osteoarthritis report on pain 
and disability as a primary concern, they do not feel that these topics are 
adequately addressed by their GP or specialty physician. Former studies also 
revealed a strong desire of OA patients for more information, but it remained 
unclear what kind of information was mainly required23. The qualitative approach 
of this study helped to specify the patient’s needs, which are clearly focused on the 
individual perspectives regarding pain and mobility rather than on information 
about the pathology of the disease. 
Regarding diagnosis and handling of OA, statements of GPs are concordant with 
previous studies showing that GPs have developed individual approaches to the 
management of OA. They perceived no major problems in diagnosing OA but had 
24,25 difficulties in assessing concomitant depression. Possible implications for 
practice could be to provide easy-to-use and less time consuming screening tools 
for depression such as, e.g., the PHQ-9. Moreover, most GPs seem to be aware 
that OA in primary care is mainly a syndrome and that X-rays contribute less to the 
management but may label the patient as chronically ill. As Bedson et al. 
discussed, this approach may be inadequate in primary care26. But many GPs felt 
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urged by patients to perform referrals, and consequently the wish for a gate keeper 
role – which was assumed to reduce this pressure – was frequently mentioned. 
In accordance with former research, NSAIDs represented the most important 
treatment for the interviewed GPs, but also an important source of uncertainty on 
both sides. Furthermore, ineffective pain treatment is still an important problem on 
both sides27-29. 
Since Paracetamol is known to be as effective as NSAIDs for mild and moderate 
OA but associated with fewer side effects than NSAIDs, our findings suggest that 
GPs' awareness about this fact needs to be increased. They should also 
communicate this to their patients. But also if NSAIDs or opiates are required, 
positive effects of NSAIDs and opiates and importance of pain control for physical 
ability instead of arguing about side effects could lead to a more appropriate pain 
treatment.  
GPs considered their impact on lifestyle of patients as low and were quite 
frustrated about behavioural interventions. Appropriate motivation strategies and 
lectures on adequate sport for patients could be possible interventions. Ideally, 
these educational activities are connected with a linkage to local patient groups 
and community offers. The practice nurse could provide advice to individual 
patients or groups of patients (similar to the already existing sessions with 
diabetes patients), provide follow-up by telephone to support behaviour change in 
patients and provide information on community support. All these options imply 
new roles of the practice nurse in Germany, so evaluations to test the feasibility 
and effectiveness of these roles are recommended. 
GPs desired a gate keeper role to decrease patients' pressure for extensive 
diagnostic procedures and referrals. Involvement of practice nurses were 
considered reasonable in advice giving and lifestyle counselling.  
Our study was probably the first to simultaneously examine the perspectives of 
primary care physicians, patients and practice nurses on the management of 
osteoarthritis simultaneously. We noticed that patients in our study were relatively 
old. Older people tend to be happier with the health care they receive30,31. On the 
other hand, our study sample was consistent with the real patient population 
suffering from osteoarthritis in primary care. Nevertheless, some limitations have 
to be considered. The aim of qualitative research is to generate ideas and 
hypotheses. Due to the methodological approach and the sample size, quantitative 
conclusions can not be drawn. It is also important to recognise that the statements 
reflect individual opinions, and that e.g. self-reported behaviour must not correctly 
reflect the real behaviour or does not reflect reality. For instance, if GPs report they 
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have no problem in distinguishing articular form periarticular pain this does not 
mean that they are correct in doing so. Additionally, the German system of care of 
people suffering from musculoskeletal disorders may be unique in the world due to 
the high amount of non-surgical orthopaedic physicians working in practices and 
representing some kind of midlevel structure between primary care and the 
orthopaedic surgeon located at hospitals. Problems arising from this situation, as 
for instance the high frequency of performed referrals and X-rays, cannot easily be 
transferred to different health care systems. 
 
Conclusion 
Osteoarthritis is a disease which will become increasingly visible in years to come. 
In search of practical and simple interventions on a primary care level this study 
resulted in a series of valuable suggestions about what patients require and how a 
practice team can respond: GPs should focus more on disability and pain and on 
giving information about treatment since these topics are often inadequately 
addressed. Advanced approaches are needed to increase GPs' impact on 
patients' lifestyle. Being aware of the problem of labelling patients as chronically ill, 
a more proactive, patient-centred care is needed. 
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Abstract 
Objective: To validate a translated and culturally adapted version of the Arthritis 
Impact Measurement Scale (AIMS) 2 in primary care patients with osteoarthritis 
(OA) of the hip and knee. 
Method: The AIMS2 was translated into German and culturally adapted. The 
questionnaire was then administered to 220 primary care patients with OA of the 
knee or hip. 209 questionnaires were returned and analysed. Test-retest reliability 
was tested in 50 randomly selected patients: of these 42 completed the 
questionnaire for a second time after two weeks. 
Results: Item-scale correlations were reasonably good as well as the 
discriminative power of separate scales. The assessment of internal consistency 
reliability also revealed satisfactory values; Cronbach's alpha was 0.77 or higher 
for all scales. The test-retest reliability, estimated in an intraclass correlation 
coefficient (ICC), exceeded 0.90, except the "social activities" scale (0.87). Since 
only patients with OA of the lower limb were enrolled, substantial floor effects 
occurred in the "arm function" (28.2%) and the "hand and finger function" scale 
(29.2%). The principal factor analysis confirmed the postulated three-factor 
structure with a physical, physiological and social dimension, explaining 48.5%, 
13.9% and 6.8% of the variation, respectively. External validity was assessed by 
calculating correlations to the Western Ontario and MacMaster (WOMAC) 
osteoarthritis questionnaire a pain visual analogue scale (VAS) and the Kellgren 
score as well as to disease duration. Spearman's "R" achieved satisfactory values 
for the corresponding WOMAC scales and the pain-VAS. Correlations with disease 
duration as well as with the radiological grading were low. 
Conclusion: The GERMAN-AIMS2 is a reliable and valid instrument to assess the 
quality of life (QoL) in primary care patients suffering from OA.  
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Background 
Osteoarthritis (OA) is the most common joint affection worldwide1. According to 
estimates of the World Health Organization (WHO), 190 million people worldwide 
are suffering from symptomatic OA. It is frequently associated with pain und 
functional impairment. In recent years, health-related quality of life (HRQL) has 
increasingly become an important outcome measure in clinical trials and 
treatment. The Arthritis Impact Measurement Scale (AIMS), developed by Meenan 
et al. in 1980 for rheumatoid arthritis, was one of the first self-administered 
questionnaires to assess functional status and HRQL2. In 1992 the AIMS2, a 
revised version of the original version of AIMS, was released. In many validation 
studies it has proven to be a practical, reliable and valid instrument in clinical 
research and also in clinical practice3-5. Today the AIMS2 is one of the most 
commonly used instruments to assess HRQL. With the AIMS2-SF, Guillemin et al. 
developed a less time consuming version6-8; but, nevertheless, the original long 
version, the AIMS2, remains the most important tool in assessing HRQL of arthritis 
patients. Mostly, the AIMS2 was used in a hospital setting, but results from clinical 
research cannot simply be transferred to a primary care setting. Furthermore, it 
can be assumed that acceptance of time-consuming tools may be lower than in a 
hospital setting. Additionally, assessment instruments cannot just be translated, 
since cultural differences do interfere with reliability and validity. Although about 
140 million people in the world speak German and it is one of the most frequent 
languages in Europe, a German version of the AIMS2 was not yet available. The 
aim of our study was to translate the AIMS2, assess cultural relevance by an 
expert panel and finally validate a culturally adapted version of the AIMS2 in 
primary care patients with OA of the knee or hip. 
 
Subjects and methods 
Recruitment of patients 
From April to July 2006, 220 patients were recruited consecutively in 20 primary 
care practices in Germany. The practices were randomly selected from the 75 
practices in the PraxArt project. This project aims to improve the quality of life 
(QoL) of patients with OA in primary care. It is financed by the German Ministry for 
Education and Research over a period of 6 years and will assess the effects of a 
multifaceted intervention in a large randomised controlled trial with over 2000 
patients. Inclusion criteria were at least 18 years of age, meeting the criteria of OA 
according to the American College of Rheumatology (ACR)9,10 and sufficient 
German language skills to understand and answer the questionnaire. Furthermore, 
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a diagnose-specific X-ray, performed within the 6 months prior to questionnaire 
completion, was required. To exclude patients with a doubtful OA diagnosis, a 
score according to Kellgren and Lawrence of at least 2 was required11. Patients 
were addressed in consecutive order. General practitioners (GPs) created a list 
with all addressed patients. This enabled linkage of the questionnaires with the 
medical file to compare nonrespondents with patients who returned the 
questionnaires. All patients gave their informed consent to the study, which was 
approved by the ethics committee of the University of Heidelberg. They were 
informed that the GP did not get knowledge about the answers and that the 
information from the medical file was given to the university anonymously. Patients 
received the AIMS2 together with a short information about the aim of the study. 
They were asked to personally complete the questionnaire. After 2 weeks, follow-
up questionnaires were sent by mail to a subset of 50 patients together with a note 
explaining that the follow-up was not meant to remember the initial replies, but to 
complete the questionnaire according to the present situation. 
 
Translation and cultural adaptation 
The translation process was performed according to the recommendations for the 
cross-cultural adaptation of HRQL measures12. In a first step, the AIMS2 was 
translated into German by three native German speakers. These three - slightly 
different - translations were discussed by an expert panel of three GPs, two 
orthopaedics and one rheumatologist, aiming at assessing the relevance as well 
as the acceptability of the items in Germany. The resulting final German version 
was translated back into English by a native English speaking colleague and 
compared with the English original to confirm that the meaning of the original 
version was met12. Slight adaptations were necessary for items 7 and 9, since the 
term "blocks" is no common expression of a distance in Germany. It was replaced 
by "a few hundred meters". Item 75, referring to the racial background had to be 
adapted as well. We changed the categories into "European", "Asian", and "other", 
since these were the only relevant ethnic groups. Regarding item 77, which refers 
to the school education, we categorised: less than 9 years ("kein Hauptschul-
abschluss"), 9 years ("Hauptschulabschluss"), high school degree ("Fach-/Abitur"), 
and university degree ("Fach-/Hochschulabschluss"). In Germany it is quite 
uncommon to ask for the income in surveys. Even though there is unlimited and 
free access to the German health care system, the utilisation of health care 
resources shows the same relationship to the social background as in other health 
care systems. Therefore, and to ease comparison in future research, we decided 
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to calculate the equivalents of income in Euros based on the US$ amount of the 
original AIMS2. A first draft of the translated AIMS2 was tested in 15 patients, 
without problems. 
 
Other measures 
In order to assess the external validity of the scales, additional data were retrieved: 
pain was assessed on a 100 mm visual analogue scale (VAS)13, all patients were 
asked to complete the validated German version of the Western Ontario and 
MacMaster (WOMAC) questionnaire14 containing five-point Likert scales similar to 
the AIMS2 questionnaire. As the AIMS2, these instruments asked the patient to 
report about the last 2 weeks prior to the assessment. The X-rays were scored by 
an orthopaedic according to the criteria of Kellgren and Lawrence11. 
 
Statistical analysis 
Data were entered in Microsoft Excel spreadsheets and analysed with the SPSS 
statistical package (version 14.0). When necessary, items were recoded and 
transformed from graduated 10-point scales, Likert scales of GER MAN-AIMS2 
and WOMAC and patient self-assessment so that results between 0 and 10 - with 
0 representing the best health status and 10 representing the worst - were yielded 
for all items. In case of missing values, the respective scale could not exactly be 
calculated and was therefore excluded from further analysis. Descriptive analysis 
included mean and standard deviation (SD). Since notable floor and ceiling effects 
would represent some limitation, we also calculated the percentage of participants 
achieving the lowest and highest possible score. 
To assess internal consistency reliability, we calculated Cronbach’s alpha to 
estimate if each item of a scale is appropriate to assess the underlying concept of 
its scale15,16. In accordance with comparable studies, values above 0.7 were 
considered as acceptable internal consistency; values above 0.9 were regarded as 
high internal consistency7,17. 
As an estimate of test-retest reliability, the intraclass correlation coefficient (ICC) 
was used. The ICC assesses the correlation of scales at two different measure 
points. It was calculated based on the 12 scales named as "areas of health, 
impacted by arthritis". A random sample of 50 patients from the initial sample of 
209 was asked to complete the questionnaire again 14 days later. In order to be 
eligible for retest, patients had to have no change in therapeutic regime, lifestyle or 
medication during those 14 days. This was confirmed by all of the 42 patients who 
returned their questionnaires after this period.  
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Scale internal validity was assessed by computing Pearson's r for the correlation 
of the items with the respective scales corrected for overlap to avoid the bias of 
self-correlation. A correlation of at least 0.4 for Pearson's r was assumed as the 
standard for supporting scale internal consistency7,17. Item-discriminant validity 
shows to what extent an item measures what it is not supposed to measure, the 
degree of discriminatory power. It was assessed by computing the correlation 
(Pearson's r) of each item with the other scales. In order to support high 
discriminatory power of scales, there should be no high correlation for item 
discriminance.  
Convergent validity was assessed using external and internal criteria. We 
calculated Spearman rank correlation "R" since different systems were compared 
and a linear relationship could not be assumed. To confirm convergent validity, we 
computed Spearman’s R for correlations between the GERMAN-AIMS2 scales 
and the scales of the previously validated WOMAC questionnaire, the pain-VAS as 
well as the Kellgren and Lawrence score. In this context, correlations between 
0.40 and 0.60 were regarded as good correlations and values above 0.6 as very 
high correlations18. P-values are provided in order to show levels of statistical 
significance. 
 
Construct validity 
To explore construct validity, we conducted a principal component factor analysis 
with varimax rotation analysis. This procedure reveals factors that explain variation 
of the specific scale. If the factor loading is in accordance with the hypothetic 
construct assumed to underline the specific scale, construct validity can be 
confirmed. The criterion for factor extraction was an eigenvalue >1.0. 
 
Results 
The GPs addressed 220 patients in total, 11 of them denied completing the 
questionnaire; the main reason given was time effort. Regarding age and disease 
duration, responders and nonrespondents did not differ significantly. Table 1 
displays the baseline characteristics of the 209 patients who returned the 
questionnaires. Men were overrepresented in the patient group with OA of the hip 
(43/72); in contrast, in the knee group nearly two-thirds (89/137) were women. 
Mean duration of disease was 7.9 (SD 6.8) years. 128 patients were at least 
working part-time; for the retired persons the "work" scale could not be calculated, 
which has to be considered in the upcoming analyses. 
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Table 1.  Baseline-characteristics of the 209 enrolled patients 
 
  Mean SD/% 
Age (years) 57.3 9.3 
Female 134 64.4% 
Duration of disease (years) 7.9 6.8 
Retired form work 138 66.0% 
Main manifestation of OA   
Hip  72 34.5%  
Knee 137 65.5% 
WOMAC   
Pain 12.9  4.7 
Stiffness 4.6 1.9 
 
Function 44.1 11.7 
VAS pain 51.8 19.4 
Kellgren score  2.62 0.85 
 
The descriptive statistics of the individual scales are displayed in table 2: mean, 
SD, percentage of people achieving the lowest scores (indicating best health) and 
patients achieving the highest scores (indicating worst health status).  
 
Table 2. Score distribution and response rates of the AIMS2  
 
 Response rate (%) Mean (0-10) SD Ceiling (%) Floor (%) 
Mobility level  92 3.8 2.3 0.9 0 
Walking and bending  93 4.3 2.4 0 0 
Hand and finger function  91 0.9 2.3 0 29.2 
Arm function  92 1.4 2.7 0 28.2 
Self care  97 1.6 2.2 0 0 
Household tasks  92 1.7 2.4 0 0 
Social activities  99 4.9 2.0 0 0 
Support from family and friends  100 2.4 2.7 0 0 
Arthritis pain  97 5.5 2.7 0 0 
Work*  93 2.8 2.3 0 0 
Level of tension  92 4.9 1.7 0 0 
Mood  94 4.3 1.5 0 0 
* The percentage refers to a number of 128 patients who were not retired. 
 
Notable floor effects occurred in the scales addressing limitations to the upper 
limb, "arm function" (29.2%) and "hand and finger function" (28.2%), indicating 
nearly one third of the patients had no notable limitation of the upper limb. This 
finding is mainly due to the study sample that consisted of patients with OA of the 
hip or knee. Notable ceiling or floor effects did not occur in any other scale. The 
response rate indicates in how many of the received questionnaires all items of the 
specific scale were completely answered. As can be seen, the response rate was 
over 90% in all scales. Interestingly, the highest values were achieved in the 
scales referring to the social situation. 
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Assessing scale internal validity and reliability 
Table 3 shows the statistical calculations of scale internal validity and reliability of 
the AIMS2. Regarding the scale internal consistency, the computed correlations of 
single items with the referring scale indicated high scale internal validity while 
surpassing the demanded minimum threshold of 0.40. Regarding the 
discriminatory power, Pearson’s r for correlations between the items of a scale and 
the other scales was less than 0.4, except for some overlaps between "walking 
and bending" and "mobility level" and "level of tension" and "mood", as well as 
between "support from family and friends" and "social activities". Altogether, the 
values indicated high discriminatory power of scales and little redundancy.  
The lowest values for Cronbach's alpha were achieved in the social activities and 
work scale, but all scales surpassed 0.7, most of them surpassed 0.8. This 
confirms high internal consistency of the scales. As an estimate for test-retest 
reliability, the ICC was calculated. The ICC was equal or surpassed 0.9 for all 
scales, except the social activities scale that achieved an ICC of 0.87. 
 
Table 3. Parameter of scale internal validity and reliability 
 
 Item-scale correlation
Item-discriminant 
validity 
Reliability 
(Cronbach’s alpha) 
Test-retest-
correlation (ICC)
Mobility level  0.63-0.91 0.05-0.45 0.81 0.95 
Walking and bending  0.53-0.92 0.04-0.61 0.77 0.94 
Hand and finger function  0.69-0.91 0.11-0.32 0.82 0.92 
Arm function  0.54-0.95 0.13-0.34 0.79 0.90 
Self care  0.51-0.90 0.08-0.35 0.88 0.92 
Household tasks  0.63-0.92 0.04-0.38 0.83 0.94 
Social activities  0.53-0.93 0.04-0.55 0.73 0.87 
Support from family and friends  0.68-0.94 0.12-0.55 0.83 0.92 
Arthritis pain  0.65-0.89 0.04-0.40 0.80 0.94 
Work  0.53-0.92 0.09-0.38 0.75 0.93 
Level of tension  0.58-0.91 0.08-0.38 0.79 0.90 
Mood  0.57-0.93 0.11-0.32 0.77 0.92 
 
Table 4 displays the results of the varimax rotation analysis for the different scales 
of the AIMS2. Three latent factors could be extracted. The factors "physical", 
"psychological", and "social" explained 48.5%, 13.9% and 6.8% of the cumulated 
variation, respectively. Together these three factors explained 69.2% of the 
variance of the questionnaire. We also calculated the factor loadings for every 
single item. Even though some single items loaded notably (>0.5) on two factors, 
for instance. some of the items referring to the "arthritis pain" scale also loaded on 
the psychosocial factor: the scales into which the specific items were grouped are 
clearly distinguished, as the high loadings of the scales indicated. 
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Table 4. Principal components factor analysis with varimax rotation analysis (eigenvalue > 1)  
 
 Physical Psychological Social 
Explaining % of variance 48.5 13.9 6.8 
Mobility level  0.74   
Walking and bending  0.68   
Hand and finger function  0.62   
Arm function  0.61   
Self care  0.75   
Household tasks  0.77   
Social activities   0.58  
Support from family and friends   0.57  
Arthritis pain    0.69 
Work  0.57   
Level of tension   0.77  
Mood   0.69  
Factor loadings > 0.50 are reported. 
 
Assessing external validity 
The correlations between AIMS2 scores and the data that were collected for 
estimating external validity are shown in table 5. We computed Spearman’s 
coefficient R for rank correlations since different systems without linear relationship 
were compared. The highest correlations of the GERMAN-AIMS2 were found 
between the "arthritis pain" scale and both the pain-VAS (R=0.63) and the 
WOMAC scale for pain (R=0.61). The WOMAC questionnaire addresses only the 
lower limb; therefore notable correlations could only be expected with the AIMS2 
scales that also addressed the lower limb. This was confirmed with the values for 
the correlations of WOMAC stiffness and function and the AIMS2 scales "mobility 
level", "walking and bending" that surpassed an R of 0.4. 
 
Table 5.  Convergent validity results: correlations between AIMS2-SF scales and external 
assessments (Spearman rank coefficient R)  
 
WOMAC  
Pain Stiffness Function 
Disease 
duration 
Kellgren-
score 
VAS 
"pain" 
Mobility level  0.43** 0.18 0.42** 0.15 0.29 0.41* 
Walking and bending  0.44** 0.19 0.44** 0.23 0.37* 0.43** 
Hand and finger function  0.15 0.14 0.19 0.04 0.11 0.09 
Arm function  0.25 0.08 0.32 0.2 0.14 0.19 
Self care  0.17 0.02 0.13 0.9 0.15 0.11 
Household tasks  0.34* -0.01 0.30 0.12 0.14 0.22 
Social activities  0.08 0.05 0.80 0.13 0.09 0.02 
Support from family and friends  0.05 0.23* 0.39 0.02 -0.05 0.04 
Arthritis pain  0.61 0.24* 0.35 0.19 0.20 0.63** 
Work  0.33 0.09 0.23 0.07 0.11 0.39* 
Level of tension  0.12 0.10 0.17 0.08 0.03 0.07 
Mood  0.25* 0.12 0.32 0.09 0.09 0.09 
Level of statistical significance: ** < 0.01; * < 0.05 
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Interestingly the correlation of the WOMAC function scale and "household tasks" 
was also significant with an R of 0.34. In accordance with prior studies, the 
correlations between AIMS2 and the radiological Kellgren and Lawrence scores 
were low, achieving the highest value in the "walking and bending" scale (R=0.37). 
No other correlations with the Kellgren score were significant. Interestingly, 
correlations between the duration of the disease and all scales were low and did 
not achieve any significance. 
 
Discussion 
QoL has become an important outcome measure in clinical trials as well as in 
clinical practice. The internationally well-known AIMS2 is one of the most important 
assessment instruments for QoL of patients suffering from rheumatoid arthritis as 
well as OA. So far, this instrument was not available in German. As our validation 
study proved, validity and reliability of the culturally adapted German version is 
quite similar to the original version of the AIMS2. 
If assessment instruments are provided in a different cultural setting, adaptations 
are indispensable to increase acceptability and to reduce missing data. As our 
study showed, the slight changes that were made according to the suggestions of 
the expert panel resulted in high acceptance. The fact that nearly all patients 
returned the questionnaire was most likely caused by the fact that they were 
directly addressed by their GP. The response rates regarding the different scales 
were quite similar to the ones reported by Arkela-Kautiainen et al. who validated 
the Finnish AIMS2 among patients with rheumatoid arthritis in a hospital setting19. 
The authors of the Turkish validation study even reported that all of the 141 
enrolled patients answered the AIMS2 completely20. Nevertheless, our results 
suggest that the AIMS is applicable in a primary care setting where response rates 
are often lower than in a hospital setting. 
Substantial ceiling affects occurred only in the dimensions reflecting affection of 
the upper limb. This finding may not represent a notable limitation since this finding 
is most probably due to the study sample that consisted of patients suffering from 
OA of the lower limb. The measures to assess the discriminative power and the 
scale internal consistency by computing the correlations of the scales with the 
other scales were satisfactory and higher than in the short version21. 
Regarding reliability, Cronbach’s alpha achieved very satisfactory results. The 
values for ICC in order to assess test-retest reliability indicated good 
reproducibility. The lowest ICC value was found in the scales dominated by 
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psychosocial factors. This effect already occurred in the validation of the short 
form as well as in validation studies in other languages8,17. 
Regarding the correlations of the GERMAN-AIMS2 scales with corresponding 
scales from the German WOMAC and the pain-VAS, it has to be acknowledged 
that we only included patients with OA of the lower limb. But the fact that high 
correlations between the pain-VAS and the corresponding AIMS2 scales as well 
as to the scales that were affected by OA could be observed, confirmed the 
underlying construct of the ‘‘arthritis pain’’ scale of the AIMS2. Prior studies have 
shown that the correlation between structural damages, reflected in X-rays, and 
patients’ complaints is weak22. This was confirmed by the weak association found 
between the Kellgren grading and the AIMS scales, a finding that also occurred in 
other validation studies of the AIMS220. 
The principal factor analysis revealed three latent factors that can be determined 
as "physical", "psychological" and "social". Altogether they explain 69.2% of the 
variance of the entire questionnaire and indicate high construct validity. Similar 
findings were made in prior validation studies5,17.  
Some weaknesses of the validation study have to be considered. First of all, we 
were not able to assess sensitivity change, but this will be the aim of future 
research. The results regarding the upper limb confirmed the convergent validity of 
the AIMS2 since our patients had no affection of the upper limb. Due to the low 
values achieved in the respective scales, we cannot conclude anything about 
performance of these scales in relation to external criteria. Nevertheless, this study 
represents a structured and carefully conducted approach to validate the AIMS2 in 
a large sample of OA patients in primary care. 
The WHO has proclaimed the current decade to be the "bone and joint decade" 
since the prevalence of OA is expected to rise tremendously in upcoming years1. 
OA is the most frequent affection of joint worldwide and associated with substantial 
impact on patients' QoL. Since researchers as well as clinicians focus more and 
more on QoL, the need for easy-to-use and valid assessment instruments is 
obvious. Worldwide established instruments as the AIMS2 enable comparisons 
between different populations as well as assessing the influence of different health 
care systems. 
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Conclusion 
The German version of the well-established AIMS2 has reasonably good scale 
internal validity, reliability and external validity. Even though it is more 
comprehensive than the short form, response rates were high and did not indicate 
reduced acceptance among patients. We conclude that with the GERMAN-AIMS2 
we provide a well-suited instrument for QoL assessment in patients suffering from 
OA of the knee or hip in a primary care setting. 
6
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Abstract 
Objectives. The aim of the study was to examine the validity of a translated and 
culturally adapted version of the Arthritis Impact Measurement Scales 2, Short 
Form (AIMS2-SF), in patients suffering from osteoarthritis (OA) in primary care. 
Methods. A structured procedure was used for the translation and cultural 
adaptation of the AIMS2-SF into German. The questionnaire was administered to 
220 primary care patients with OA of the knee or hip. Test–retest reliability was 
tested in 35 randomly selected patients, who received the questionnaire a second 
time after 1 week. The physical scale of the original AIMS2-SF was divided into an 
‘upper body limitations’ scale and a ‘lower body limitations’ scale. 
Results. With values ranging from 0.52 to 0.97 for Pearson’s r, item-scale 
correlations were reasonably good. The discriminative power of separate scales 
was also good, reflected in low values for correlation between different scales, 
indicating little redundancy. Only two items (13 and 15) referring to the symptom 
scale showed item-scale correlation of r=0.72 and r=0.67, respectively with the 
lower body limitation scale. The assessment of internal consistency reliability also 
revealed satisfactory values: Cronbach’s α was ≥ 0.83 for all scales, except for the 
social interaction scale (0.66). The test–retest reliability, estimated as the 
intraclass correlation coefficient (ICC), exceeded 0.85 except for the affect scale 
(0.72). Substantial floor effects occurred in the upper limb scale (33.8%). Principal 
factor analysis confirmed the postulated three-factor structure with physical, 
physiological and social dimensions, explaining 49.8, 14.1 and 6.4% of the 
variation, respectively. The assessment of external validity revealed satisfactory 
correlations with the corresponding WOMAC (Western Ontario and McMaster 
Universities Arthrosis Index) scales. As expected, correlations with radiological 
grading were moderate to low. The correlation with the physician’s assessment 
was high in the scales that were dominated by physical factors, but rather low in 
the areas of health, which were found to be dominated by psychological or social 
factors. 
Conclusion. The German AIMS2-SF is a reliable and valid instrument to assess 
the quality of life in primary care patients suffering from OA. When addressing the 
different impacts of OA, the physical scale should be divided into an upper body 
scale and a lower body scale. The floor and ceiling effects revealed are in 
accordance with the disease characteristics of the study sample and do not limit 
the significance of the questionnaire.  
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Health-related quality of life is an important outcome measure in many clinical 
areas, including osteoarthritis (OA) of the knee or hip. Validated measuring 
instruments are needed to assess functional status and health-related quality of 
life in research and clinical practice. The AIMS questionnaire, originally developed 
by Meenan et al. in 1980 for rheumatoid arthritis, and the HAQ (Health 
Assessment Questionnaire) of James Fries were the first self-administered arthritis 
questionnaires1,2. Several validation studies confirmed that AIMS is a practical, 
reliable and valid instrument for health-related quality of life. In 1992 the AIMS2, a 
revised version of the original, long version of AIMS, was released and validated in 
many countries3–5. A short version of the AIMS2, the AIMS2-SF, was developed by 
Guillemin et al. and reduced to 26 items in order to reduce time and effort and to 
increase acceptance among patients in clinical trials. It was validated in France, 
Norway and the Netherlands for RA and in the USA for patients with OA6–8. In 
several comparison studies, performed by Guillemin, Haarvardsholm and Taal, it 
proved to be just as reliable and valid as the long version, but without achieving 
perfect agreement6,8,9. In covering the five components of physical, affect, 
symptom, social interaction and role, the AIMS2-SF is more comprehensive than 
the frequently used instruments WOMAC (Western Ontario and McMaster 
Universities Arthrosis Index)10 and the Lequesne index11. This comprehensiveness 
makes AIMS particularly useful for studies and interventions that use a multimodal 
rather than a pharmacologically oriented approach, such as self-management 
education12–14. So far, a German version of the AIMS2-SF has not been available. 
The aim of our study was to examine the validity of a translated and culturally 
adapted version of the AIMS-SF2 in primary care patients with OA of the knee or 
hip. 
 
Subjects and methods 
Recruitment of patients 
Between April and July 2004, 220 patients were recruited in 21 primary care 
practices in Germany. The University of Heidelberg has 210 associated teaching 
practices; the practices were randomly selected from a list of these practices. 
Inclusion criteria were: to be over 18 years of age; meeting criteria for OA 
according to the American College of Rheumatology15,16 and sufficient German 
language skills to understand and answer the questionnaire. In addition, the 
availability of a diagnosis-specific radiograph, not older than 6 months at the date 
of questionnaire completion, was required. Patients were recruited in two regions 
with completely different dialects. All eligible patients gave their informed consent 
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to the study, which was approved by the ethics committee of the University of 
Heidelberg. Patients were handed a questionnaire together with a small amount of 
information about the aim of the study and were asked to complete the 
questionnaire personally. After 1 week, follow-up questionnaires were handed to a 
subset of 35 patients together with an explanatory note, saying that the follow-up 
was not meant to remember the initial replies (but complete the questionnaire 
according to the current situation). Only two patients of the 222 initially approached 
refused to complete the questionnaire: this because of the time and/or effort 
needed. 
 
Translation and cultural adaptation  
The German version of AIMS2-SF was translated and retranslated according to 
guidelines for cultural adaptation in order to address content validity17. Slight 
adaptations were necessary for item 7 (‘Did you have problems either walking 
several blocks or climbing a few flights of stairs?’. The expression ‘blocks’ is not 
commonly understood in German as a measure for distance and was replaced by 
‘a few hundred metres’. Item 49 contains the expression ‘bothered by nervousness 
or your nerves’, which sparked intense discussion among the translators because 
there are various potential translations in German. The case was settled for a 
more understandable translation capturing the original idea of the item rather than 
the more direct translation. 
The draft translation was piloted with 15 patients. In accordance with Taal et al., 
we replaced item 33 of the original AIMS2, ‘How often did you go to a meeting of a 
church, club, team or other group?’, with item 31, ‘How often did you visit friends or 
relatives at their homes?’, because this is to be expected to increase the internal 
consistency of the social interaction component8,18. On the other hand we did not 
follow the Bland-Altman approach, unlike Taal and Havaardsholm, who replaced 
item 42 of the original AIMS version, ‘How often did your pain make it difficult for 
you to sleep?’, with item 38, ‘How would you describe the arthritis pain you usually 
had’ 9,18. Like Ren and colleagues7, who validated the AIMS2-SF in the USA 
among patients with OA, we divided the German AIMS2-SF component ‘physical’ 
into the two components ‘upper body limitation’ and ‘lower body limitation’. Ren et 
al. discussed some possible limitations due to ceiling and floor effects, especially 
in patients suffering from OA to the knee or hip. As they did, we included item 1 
(drive a car or use public transport), item 11 (need help to get dressed) and item 
12 (need help to get out of bed) in the lower body limitation scale. We also 
followed their approach in including item 24 of the AIMS2-SF, ‘family and friends 
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sensitive to personal needs’, and item 19, ‘enjoy the things you do’, in the affect 
scale and not in the social interaction scale. Contrary to Ren et al., and in 
agreement with some previous validation studies, we did not exclude the role 
component, even if this scale is usually only answered by half of the participants 
addressing only those who are still involved in the working process. 
 
Other measures 
In order to assess the external validity of the scales, additional data were retrieved. 
The patient’s general practitioner (GP) was asked to evaluate the severity of 
arthritis based on available radiographs, the patient’s history and clinical 
examination based on the classification criteria of the American College of 
Rheumatology15,16. The GP’s evaluation was scored on a 0–10 scale, 10 
representing no limitation of quality of life by arthritis and 0 representing massive 
limitation of quality of life. All patients were also given the validated German 
version of the WOMAC questionnaire19, containing five-point Likert scales similar 
to the German AIMS2-SF questionnaire. For inclusion in the study, an X-ray of the 
affected joint, not older than 6 months, was required. The X-rays were scored 
according to the criteria of Kellgren and Lawrence20: grade 0=normal; grade 
4=massive alterations with complete collapse of the joint space. 
 
Statistical analysis 
Data were entered in Microsoft Excel spreadsheets and analysed with the SPSS 
statistical package (version 11.0). When necessary, items were (according to the 
recommendations of Meenan et al.1,3) recoded and transformed from graduated 
10-point scales, Likert scales of the German AIMS2-SF and WOMAC and patient 
self-assessments, so that results for all items lay between 0 and 10: 0 representing 
the best and 10 the worst health status. Descriptive analysis included mean and 
standard deviation, and in order to assess floor and ceiling effects the percentage 
of participants achieving the lowest and highest possible score was calculated. 
 
INTERNAL CONSISTENCY RELIABILITY. As an indicator of internal consistency reliability, 
we calculated Cronbach’s α to estimate whether each item of a scale is 
appropriate for assessing the underlying concept of its scale21,22. Achievable 
values for Cronbach’s α range from 0, signifying no internal consistency, to 1, 
signifying identical results. We considered high internal consistency to be 
represented by values of 0.50–0.70 for group comparisons and by values of over 
0.90 for individual patients’ results. 
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TEST–RETEST RELIABILITY. We used the intraclass correlation coefficient (ICC) as an 
estimate of test–retest reliability. In order to assess the test–retest reliability of the 
individual scales, we computed the ICC based on Ren et al.’s six-component 
model of the AIMS2-SF: upper body limitation; lower body limitation; affect; 
symptom; social interaction; and role. A random sample of 35 patients from the 
initial sample of 220 was asked to complete the questionnaire again after 7 days. 
All of the 35 patients selected for the retest returned their questionnaires. In order 
to be eligible for retest, patients had to have no change in therapeutic regimen, 
lifestyle or medication during these 7 days. 
 
SCALE INTERNAL VALIDITY. Scale internal validity was assessed by computing the 
correlation (Pearson’s r) of the items with the respective scale corrected for 
overlap to avoid bias from selfcorrelation. A correlation of at least 0.4 was 
assumed as the standard for supporting scale internal consistency7,23. 
Itemdiscriminant validity shows the extent to which an item measures what it is not 
supposed to measure: the degree of discriminatory power. It was assessed by 
computing the correlation (Pearson’s r) of the items with the other scales. Cut-off 
values have not been defined, but in order to support the high discriminatory 
power of scales there should not be a high correlation for item discriminance. 
 
CONVERGENT VALIDITY. Convergent validity was assessed using external and internal 
criteria. In using external criteria to estimate convergent validity different systems 
are usually compared and a linear relationship cannot be assumed. Therefore, 
Spearman rank correlation tests are most commonly used, e.g. in the validation 
studies of Stucki et al. (WOMAC)19, Roos et al. (WOMAC)24, Ludwig et al. 
(Lequesne) 25 and Salaffi et al. (AIMS)23. This study challenged the hypothesis that 
AIMS2-SF scales correlate with corresponding scales of the previously validated 
WOMAC questionnaire. In addition, the correlations of the AIMS2-SF with the 
Kellgren score and the physician assessment were estimated by computing the 
Spearman rank test. As Roos et al. have discussed in this context24, correlations 
usually range between 0.2 and 0.6: correlations between 0.40 and 0.60 are 
regarded as good correlations and values above 0.6 as very high correlations. P-
values are provided in order to show levels of statistical significance.  
In addition to external criteria, convergent validity was also assessed by analysing 
demographic subgroups by age, gender and level of education. A low level of 
education was defined as education only as far as secondary school. Education 
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more advanced than this was considered a high level of education. To compare 
the different groups we used Student’s t-test for independent samples. 
 
CONSTRUCT VALIDITY. To explore construct validity we conducted a principal 
components factor analysis with varimax rotation analysis. The criterion for factor 
extraction was an eigenvalue >1.0. 
 
Results 
Table 1 displays the baseline characteristics of the study sample. Women were 
slightly under-represented in the patient group with coxarthritis. This is in line with 
the epidemiology of arthritis, which shows that women suffer more from 
gonarthritis and men more from coxarthritis. Mean duration of disease was 11.3 yr 
among women and 8.8 yr among men. For subgroup analysis, data on school and 
professional education and present occupation were retrieved. 
 
Table 1.  Baseline-characteristics of patients 
 
Sex Main manifestation 
of OA 
N Kellgren 
(Mean) 
S.D. Duration 
Mean 
S.D. Age S.D. 
 Hip Knee        
w 37 60 97 2.85 0.96 11.34 6.29 43.76 23.58 
m 78 45 123 2.55 0.74 8.78 5.11 49.86 13.30 
Total 115 105 220 2.68 0.85 9.90 5.79 47.17 18.75 
 
Table 2 shows the descriptive statistics of the individual scales: mean, standard 
deviation, percentage of people achieving the lowest scores (indicating best 
health) and patients achieving the highest scores (indicating worst health status). 
As expected in a sample of patients suffering from OA of the knee or hip, the mean 
score on the lower body limitation scale was 3.37, clearly higher than the mean 
score on the upper body limitation scale (2.32). The difference in means (Student’s 
t-test) was statistically significant (P<0.01). Substantial floor effects occurred in the 
upper body limitation scale, indicating that one-third (33.8%) of the patients had no 
limitation of the upper limb. Ceiling effects, representing the patients achieving the 
highest possible score and indicating the worst health status, were below 2.5%, 
except for the component lower limb function (3.9%). Substantial floor effects 
occurred in our study sample in the component upper body limitation (33.8%) and 
moderate floor effects in the role scale. 
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Table 2.  Descriptive statistics and score distributions for GERMAN-AIMS2-SF 
 
 N Mean (Range 0-10) Median S.D. Ceiling, % Floor, %
Upper body limitation 219 2.32 2.02 1.71 0.0 33.8 
Lower body limitation 216 3.37 2.75 2.06 3.9 0.0 
Symptom 220 3.32 2.49 2.74 1.8 1.8 
Affect 219 4.27 4.10 1.29 2.4 0.0 
Social Interaction 218 5.11 5.01 1.94 2.3 0.1 
Role 109 2.05 3.79 3.04 0.9 8.3 
 
Assessing scale internal validity and reliability 
Table 3 shows the statistical calculations of scale internal validity and reliability of 
the German AIMS-SF. Regarding the internal consistency scale, the correlations of 
single items with the referring scale ranged from 0.56 to 0.98, representing 
excellent consistency for the scales upper limb function, lower limb function, 
symptom and affect. Interestingly, the item-scale correlation achieved the highest 
values in the role scale. All scales achieved values above the minimum demanded 
threshold of 0.40; and therefore all values indicated high scale internal validity. 
 
Table 3.  Parameter of scale internal validity and reliability 
 
 Item-scale-
correlation  
Item-discriminant 
validity 
Reliability 
(Cronbach’s alpha) 
Test-retest 
correlation (ICC) 
Upper body limitation 0.67-0.92 0.04-0.48 0.89 0.97 
Lower body limitation 0.56-0.97 0.04-0.65 0.83 0.93 
Symptom 0.69-0.94 0.13-0.72 0.83 0.95 
Affect 0.58-0.98 0.13-0.35 0.82 0.72 
Social Interaction 0.52-0.90 0.06-0.64 0.66 0.77 
Role 0.80-0.95 0.05-0.07 0.89 0.85 
 
Regarding discriminatory power, Pearson’s r for correlations between the items of 
a scale and the other scales were less than 0.48, except in a few cases. Item 13, 
‘How often did you have severe pain from your OA?’, and item 15, ‘How often did 
your pain make it difficult for you to sleep?’, of the symptom scale achieved a 
correlation of 0.72 and 0.67, respectively, with the ‘lower body function’ scale. Item 
21, ‘How often did you meet with friends or relatives’, showed a correlation of 
r¼0.64 with the affect scale. Overall, the values achieved indicate high 
discriminatory power of the scales and little redundancy. 
Computing Cronbach’s α values revealed excellent values: all scales achieved 
values equal to or above 0.82, except for the social scale (0.66). In meeting and 
exceeding the recommended range of 0.5–0.7, the results indicated high internal 
consistency of the scales. 
Generally high values for test–retest reliability were found for all scales except for 
the affect scale, for which the ICC was only 0.72, and the social interaction scale 
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(ICC 0.77). With values above 0.81, the areas dominated by physical factors and 
the role scale showed slightly higher test–retest reliability. 
Table 4 shows the results of the varimax rotation analysis with the three latent 
factors that could be extracted. The factor ‘physical’ explained 49.8% of the 
cumulated variation, the factor ‘psychological’ 14.1% and the factor ‘social’ 6.4%. 
The high loading of these three factors in certain items confirms that the 
dimensions are clearly distinguished. All items referring to the symptom 
component (item 13, severe arthritis pain; item 14, morning stiffness >1 h; and 
item 15, pain influencing sleep) are loaded on two factors, physical as well as 
psychological, reflecting the complex nature of these areas of health. 
 
Table 4.  Principal components factor analysis with varimax-rotation-analysis (eigenvalue > 1)  
 
 physical psychological social 
Explaining % of variance 49.8 14.1 6.4 
Usage of car or public transportation 0.56   
Staying in bed most of the day 0.57 0.47  
Trouble during vigorous activities 0.51   
Trouble walking a few hundred meters /climbing 0.43   
Unable to walk without assistance 0.46   
Pencil writing 0.92   
Button a shirt 0.91   
Turn a key  0.90   
Comb or brush hair 0.70   
Reach something above the head 0.69   
Need help to get dressed 0.26 0.30  
Need help to get out of bed 0.39   
Severe arthritis pain 0.31 0.81  
Morning stiffness > 1 hour 0.37 0.75  
Pain influencing sleep 0.38 0.70  
Felt tense  0.48  
Bothered by nerves  0.50  
In low or very low spirits  0.64  
Enjoying things  0.58  
Feeling to be a burden for others  0.30  
Get together with friends   0.84 
Phoning close friends or relatives   0.78 
Visiting friends or relatives   0.65 
Family or friends sensitive to your needs   0.77 
Factor loadings > 0.30 are reported 
 
Assessing external validity 
Table 5 shows the correlations between German AIMS2-SF scores and the data 
that were collected to estimate external validity. To compare different systems 
without linear relationship, we computed Spearman’s rank correlation coefficient p. 
The highest correlation of the German AIMS2-SF was found between the symptom 
scale and the WOMAC scale for pain (p=0.83). The WOMAC questionnaire 
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addresses only the knee and hip; therefore correlations of the German AIMS2-SF 
lower limb function scale with the WOMAC scales ranging from 0.52 to 0.78 are 
higher than for the upper limb function scale, where Spearman’s p ranges from 
0.28 to 0.47. In accordance with previous studies, the correlations between the 
German AIMS2-SF and the radiological Kellgren and Lawrence scores were low, 
achieving the highest values in the symptom scale (p=0.42) and the lower body 
limitation scale (p=0.36). 
Correlations between AIMS2-SF and the physician’s assessment ranged from low 
values for the role and social interaction scales (p=0.17 and p=0.23, respectively) 
to good values for the lower body limitation scale (p=0.55) and the symptom scale 
(p=0.60). 
 
Table 5.  Convergent validity results: Correlations between AIMS2-SF scales and external 
assessments (Spearman rank coefficient R)  
 
WOMAC Kellgren-Score Physician assessmentAIMS-Scale 
Function  Stiffness Pain Global   
Upper body limitation 0.28** 0.36** 0.47** 0.32 ** 0.27** 0.42** 
Lower body limitation 0.54** 0.52** 0.78** 0.46 ** 0.36** 0.55** 
Symptom 0.52** 0.56** 0.83** 0.57 ** 0.42** 0.60** 
Affect 0.36** 0.45** 0.58** 0.41** 0.25 0.35** 
Social Interaction 0.29** 0.28** 0.41** 0.29** 0.12 0.23** 
Role -0.21* -0.12 -0.17 0.21* 0.21* 0.17 
Level of statistical significance: ** < 0.01;  * < 0.05 
 
Relationship with demographic subgroups 
The use of demographic and socioeconomic subgroups is an additional approach 
to the assessment of convergent validity. Table 6 displays the results of these 
analyses. The differences were assessed with Student’s t-test for independent 
samples. Women obtained significantly higher average scores in the physical and 
symptom scales, indicating worse health status and more burden due to OA. 
Women also had higher average scores for social interactions (5.69) and affect 
(4.81), with a statistically significant difference in the variance of the means 
(P<0.05 and P<0.01, respectively). This is in line with previous studies from Salaffi 
et al. and may be due to the fact that female study participants, on average, 
suffered longer from arthritis than male participants (11.3 vs 8.8 yr)23. 
As expected, the scores for the patients aged over 65 yr indicated a greater effect 
of OA in all scales, especially in the scales referring to physical aspects and pain. 
Similar differences could be found between the participants with a low vs high 
educational level. A higher educational level is associated with lesser burden from 
reduced physical capacity and pain, as represented in the symptom scale. 
8
 Evaluation and cultural adaptation of a German version of the AIMS2-SF 55 
Table 6.  Mean scores for demographic subgroups - Students t-test 
 
 Sex Age Education 
 Female  Male P < 65 > 65 P Low  High P 
N 97 123  159 60  125 95  
Upper body limitation 3.62 2.55 0.61 2.31 4.11 ** 3.50 2.03 ** 
Lower body limitation 4.37 2.62 ** 2.63 5.45 ** 4.12 2.39 ** 
Symptom 4.69 3.09 ** 2.50 5.98 ** 4.49 1.88 ** 
Affect 4.81 3.83 * 4.01 4.95 0.47 4.55 3.90 0.64 
Social interaction 5.69 4.64 ** 4.82 5.88 0.43 5.44 4.66 0.71 
Role 3.11 
(n=35) 
2.72 
(n=74) 
0.55 - - - 3.33 
(n=46) 
2.61 
(n=63) 
0.07 
Level of statistical significance: ** < 0.01;  * < 0.05 
 
Discussion 
In research and practice, valid measurement instruments are needed to assess 
quality of life in patients with OA of the knee or hip. The internationally well-known 
AIMS2-SF was not yet available in German. Therefore, we translated the 
instrument into German and tested it in a sample of primary care patients. Our 
findings showed that the instrument had reasonably good scale internal validity, 
reliability and external validity in the primary setting. It is easy to use for patients 
and it covers most important areas of quality of life that are influenced by 
degenerative joint processes. We conclude that the German AIMS2-SF is well 
suited for quality of life assessment in patients suffering from OA of the knee or hip 
in a primary care setting. 
The results of the assessment of scale internal validity, internal consistency and 
item-discriminant validity indicated that the German AIMS2-SF questionnaire 
appears to measure what it is supposed to measure and that its items are 
selective and non-redundant. 
Cronbach’s α showed very satisfactory results and by following the approach of 
Ren et al. in including item 19 (which asked the patients whether they enjoyed the 
things they did) in the affect scale, even the value for the social scale reached 
0.66: results quite similar to those of the validation study of Ren (0.67) and much 
better than in the study of Guillemin et al. (0.32) 6,7. The ICC values (assessing 
test–retest reliability) indicated good reproducibility. 
The lowest ICC value was found for the affect scale and the social interaction 
scale: an area that largely depends on external factors, such as telephone calls 
and visits from friends and family. These scales have performed similarly in 
validation studies in other languages8,23. 
Correlations of the German AIMS2-SF scales with corresponding scales from the 
already validated German WOMAC were very satisfactory. In achieving quite 
different values for the upper body limitation and lower body limitation scales, the 
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correlations with the WOMAC questionnaire substantiate the approach of Ren et 
al.7 in dividing the physical scale into scales addressing upper and lower limb 
functioning. Ren et al.7 (using a different coding, 0 representing worst and 10 
representing best health status) found substantial ceiling effects in their validation 
study among patients with OA. They discussed possible limitations of the AIMS2-
SF in applying it to patients with OA of the lower limb section. In our inclusion of 
patients suffering from OA to knee or hip we found no substantial ceiling effects in 
the lower limb scale but quite large floor effects in the upper limb section. Our 
results are in line with the findings of Taal et al.8, who reported moderate floor 
effects (1.6) and no ceiling effects (0.0) in the physical scale, and Salaffi et al.26, 
who also found only moderate ceiling (0.6–4.1) effects in the scales representing 
lower limb function but substantial floor effects (43.9–67.1) in the scales 
representing upper limb function. Like Salaffi et al., we regard the disease 
characteristics of the study sample as responsible for these results. To summarise, 
we did not find any possible limitations due to ceiling or floor effects of the German 
AIMS2-SF in patients suffering from OA of the knee or hip. 
As expected, and supported by clinical experience, the correlation between the 
AIMS2-SF and radiological scores were low to moderate in the symptom and lower 
body limitation scales19,27,28. It is known that self-reported functional ability 
assessed by instruments such as the AIMS reflects physical impairment due to the 
arthritic joint disease quite well29. Therefore, it is not surprising that the correlation 
was high between physician assessment and physical aspects of the AIMS. The 
fact that the correlation was much lower for items reflecting social interaction may 
indicate that these areas are outside the scope of physicians’ assessment of their 
patients’ quality of life, even for GPs who are well acquainted with their patients, as 
was the case in this study. Therefore, these results reflect the potential benefit of 
AIMS in OA-related quality of life assessment in primary care.  
As in previous validation studies, the principal factor analysis indicated high 
construct validity by revealing three latent factors: physical, psychological and 
social; these explained 70.4% of the variance of the entire questionnaire5,23. 
Comparison of demographic subgroups consistently showed plausible results: 
impairment increased with age28. In line with previous studies, educational level 
affected quality of life. Salaffi et al.26 also found higher levels of education to be 
related to higher quality of life in the validation study of the Italian AIMS 
questionnaire. Therefore, the results for the demographic subgroups substantiate 
the convergent validity of the German AIMS2-SF.  
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Especially due to demographic trends, the incidence and prevalence of OA are 
increasing in most western industrialised nations. They cause a substantial burden 
of disease, as well as high direct and indirect costs. OA has a massive impact on 
patients’ quality of life, which poses a challenge to reliable and valid measurement 
instruments for the assessment of potential interventions. The well-established 
WOMAC and Lequesne questionnaires can be used to assess medical and 
surgical interventions in OA. In addition to these two instruments, the AIMS2-SF 
questionnaire also addresses aspects of life that are less directly related to joint 
diseases. The AIMS2-SF is therefore suitable for use in the evaluation of 
multimodal interventions, such as self-management programmes30. Results from 
hospital-based studies cannot easily be generalised to primary care. The present 
validation study underlines that the German culturally adapted AIMS2 short 
version promises to have these qualities. The instrument could be used in different 
German regions with distinct dialects. As in previous studies, willingness to 
participate was high among OA patients. This was reflected by high response 
rates, both in the test and the retest, and in the low rate of unanswered items. 
The results presented are particularly interesting because results of hospital- or 
treatment centre-based studies cannot easily be transferred to a primary care 
setting. The results of this validation study indicate that the German AIMS2-SF is a 
valid and reliable instrument for assessing the quality of life of patients with OA, 
and it provides us with an important instrument to assess the effects of complex 
interventions in primary care.  
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Abstract 
Background: Chronic diseases like osteoarthritis (OA) substantially affect 
different dimensions of quality of life (QoL). The aim of the study was to reveal 
possible factors which mainly influence general practitioners’ (GPs’) assessment of 
patients' QoL. 
Methods: 220 primary care patients with OA of the knee or the hip treated by their 
general practitioner for at least one year were included. All GPs were asked to 
assess patients' QoL based on the patients' history, actual examination and 
existing X-rays by means of a visual analog scale (VAS scale), resulting in values 
ranging from 0 to 10. Patients were asked to complete the McMaster Universities 
Osteoarthritis Index (WOMAC) and the Arthritis Impact Measurement Scale2 Short 
Form (AIMS2-SF) questionnaire. 
Results: Significant correlations were revealed between "GP assessment" and the 
AIMS2-SF scales "physical" (rho = 0.495) and "symptom" (rho = 0.598) as well as 
to the "pain" scale of the WOMAC (rho = 0.557). A multivariate ordinal regression 
analysis revealed only the AIMS2-SF "symptom" scale (coefficient beta = 0.2588; 
p = 0.0267) and the X-ray grading according to Kellgren and Lawrence as 
significant influence variables (beta = 0.6395; p = 0.0004). 
Conclusion: The results of the present study suggest that physicians' assessment 
of patients' QoL is mainly dominated by physical factors, namely pain and severity 
of x-ray findings. Our results suggest that socioeconomic and psychosocial factors, 
which are known to have substantial impact on QoL, are underestimated or 
missed. Moreover, the overestimation of X-ray findings, which are known to be 
less correlated to QoL, may cause over-treatment while important and promising 
targets to increase patients' QoL are missed. 
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Background 
About 10% of men and 18% of women 60 year and older suffer from symptomatic 
osteoarthritis (OA)1. Among people aged 75 or older it is the third most common 
reason to visit a primary care physician2. Due to an increasing life-expectancy as 
well as a constant increase in the body mass index (BMI), which constitutes a 
principal risk factor for OA3, the incidence of OA is expected to rise in upcoming 
years4. 
Usually, the general practitioner (GP) is not only the first care provider but also 
sees the patient regularly during the course of disease5. Moreover, the GP is the 
physician who is most familiar with the social background of the patients. These 
socio-economic and psychosocial factors contribute substantially to the quality of 
life (QoL) of patients6-8. It is known that the treatment plans of GPs and specialists 
are quite similar, but also that there is a broad range of possible approaches to the 
disease by GPs2,5,9. However, previous findings indicate that GPs as well as 
specialists seem to have a perspective that is dominated by physical aspects of 
OA. Psychosocial aspects and their influence on QoL seem to be 
underestimated10. Moreover, it is known that radiographic changes and subjective 
complaints show very poor correlation; therefore it could be assumed that their 
contribution to physicians’ assessment of patients QoL may be limited. However, 
the extent to which psychosocial and radiological findings influence GPs 
assessment remains unclear. Interestingly, QoL is coming more and more into the 
focus of health care professionals and represents an increasingly important 
outcome parameter in many clinical trials11. Different questionnaires have been 
developed and validated to assess the impact of joint diseases on QoL. Assessing 
QoL in patients suffering from OA the most frequently used instruments are the 
McMaster Universities Osteoarthritis Index (WOMAC)12,13, the Arthritis Impact 
Measurement Scale (AIMS)14,15 and the Lequesne-Index16. 
WOMAC and Lequesne-Index both focus on physical effects of arthritis on mobility 
and physical activity and are limited to the lower limbs (hip and knee). The AIMS 
questionnaire originally developed by Meenan et al. in 1980 for rheumatoid arthritis 
is a more comprehensive tool, which includes in 78 items the five dimensions 
physical, affect, symptom, social interaction and role14. In 1997, Guillemin et al. 
developed a shorter version, the AIMS2-SF, containing 26 items, to reduce time 
effort and to increase acceptance among patients. In several validation studies the 
AIMS2-SF, which has recently become available in a German version 20, has 
proven to be a reliable and valid instrument to asses QoL of patients with 
rheumatoid arthritis and OA 17-19. Due to its comprehensiveness the AIMS2-SF 
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gives insight into different dimensions of QoL in OA. 
The aim of our study was to examine which dimensions of QoL of osteoarthritis 
patients are considered by GPs. To reveal factors influencing GPs' picture of 
patients QoL we estimated relationship to different assessment tools, AIMS2-SF, 
WOMAC and X-ray. 
 
Methods 
Recruitment of patients 
The study was approved by the ethics committee of the University of Heidelberg. 
From April to July 2004, 222 patients were approached in 21 primary care 
practices. Inclusion criteria for patients were: aged over 18, meeting the criteria of 
OA according to the America College of Rheumatology (ACR) [21,22] and 
sufficient German language skills to understand and answer the questionnaire. All 
patients had to be treated by the physician for at least one year. Additionally, the 
availability of a diagnose-specific radiograph, not older than six months at the date 
of questionnaire completion, was required. In all participating practices the patients 
were identified by ICD-10 codes in patient files and put on a list in alphabetical 
order. Patients from this list were contacted in consecutive order of appearance in 
the practice and informed about the option to participate in the survey. After giving 
their written informed consent they received the questionnaire and an envelope. 
The enveloped questionnaires were returned in a sealed box at the practices. 
Neither the GP nor the practice team had any possibility to see patients' answers. 
Two of the addressed patients refused to complete the questionnaires due to time 
effort, so that 220 patients could finally be included. Enrolled patients received the 
validated German version of the WOMAC and AIMS2-SF questionnaire, each 
containing 5 point-Likert scales. In addition, patients received short written 
information about the aim of the study and were asked to personally complete the 
questionnaire without any assistance. For subgroup analysis data on school and 
professional education and present occupation were retrieved. 
The patient's GP was asked to evaluate the severity of arthritis based on available 
radiographs, the patient's history and clinical examination based on classification 
criteria of the American College of Rheumatology. The GP's evaluation was 
scored on a visual analogue scale. The scale was organized in that manner that 
the results achieved ordinal values with 10 representing no limitation of QoL by 
arthritis to 0 with massive limitation of QoL. The X-rays were scored according to 
the criteria of Kellgren and Lawrence13, Grade 0 = normal and Grade 4=massive 
alterations with close to complete reduction of the joint space. If only one joint was 
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affected, the score for this joint was used. If different joints were affected, patients' 
highest radiological score was used. 
 
Statistical analysis 
Data were analysed with the SPSS statistical package (version 12.0). In a 
standardisation process, the items of AIMS and WOMAC were recoded and 
transformed, so that results between 0 and 10 were yielded for all items with 10 
representing the best health status and 0 representing the worst. This 
standardisation process was performed according to the recommendations of 
Guillemin (AIMS2-SF) and Bellamy (WOMAC), respectively. The radiological 
grading according to Kellgren and Lawrence was not adjusted. Descriptive 
analysis included mean and standard deviation separated for the mainly affected 
joint (hip or knee). In order to assess floor and ceiling effects the percentages of 
participants achieving the lowest and highest possible score were calculated. 
Group comparisons were adjusted for sex and age and, in case of ANOVA, post 
hoc corrections according to Bonferoni were performed to avoid effects caused by 
multiple testing. 
As a first estimation of factors influencing GPs' assessment of patients' QoL, we 
computed correlations of sociodemographic variables, AIMS2-SF, WOMAC and 
Kellgren-score with the GP score. The correlations of the individual scales with the 
overall scores were computed via Spearman rang correlation. P-values are 
provided in order to show levels of statistical significance. 
In order to identify factors independently associated with GP ratings of patient 
quality of life, we additionally performed a polytomous ordinal logistic regression 
analysis23. The purpose of this procedure is to model the dependence of an ordinal 
categorical response variable (here: GP ratings of patient quality of life) on a set of 
discrete and/or continuous variables (here: age, gender, education, physical, 
affect, symptoms, social interaction, function, stiffness, pain, Kellgren score). 
 
Subgroup analysis 
Finally, subgroup analyses were performed by age, gender and level of education. 
A low level of education was defined by secondary school. More advanced 
degrees were considered as higher education. For the subgroup analysis the 
Student-t-Test for independent samples was used. 
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Results 
Table 1 reflects the baseline characteristics of the study sample, separated by 
gender. Main manifestation of OA in women was knee (60), while only 37 suffered 
mainly from OA of the hip. 78 men suffered mainly from OA of the hip, while in 45 
cases men were mainly affected at the knee. This is in line with arthritis 
epidemiology showing that women suffer more from gonarthritis and men more 
from coxarthritis. Mean duration of disease among women was 11.3 years and 8.8 
years among men. This difference was significant as well as the difference in age: 
men were older (49.8 vs. 43.7 years; p < 0.01). 
 
Table 1.  Baseline-characteristics of patients separated by sex 
 
Sex Mainly  
affected joint 
N Kellgren 
(Mean) 
S.D. Duration 
Mean 
S.D. Age S.D. 
 Hip Knee        
w 37 60 97 2.85* 0.96 11.34** 6.29 43.76** 23.58 
m 78 45 123 2.55* 0.74 8.78** 5.11 49.86** 13.30 
Total 115 105 220 2.68 0.85 9.90 5.79 47.17 18.75 
Level of significance (t-test for group comparison):*p<0.05;**p<0.01) 
 
Table 2 shows the distribution of the Kellgren and Lawrence score according to the 
affected joint. ANOVA adjusted for age and gender with post hoc Bonferoni 
correction revealed no significant differences in Kellgren scores between patients 
suffering from osteoarthritis of hip or knee. Figure 1 shows the distribution of the 
GP scores in percentages. 
 
Table 2.  Kellgren Score distribution according to joint 
 
Kellgren-Score 
 1 2 3 4  
Hip 8 31 56 20 115  
Knee 11 38 39 17 105 
Total 19 69 95 37 220 
*Adjusted ANOVAs (gender, age) revealed no significant differences  
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In table 3 the characteristics of the study sample are separated by the affected 
joint. Differences were assessed by adjusted ANOVA: Patients suffering from OA 
to the knee had a significantly higher BMI (27.9 vs. 26.3; p < 0.05; adjusted for sex 
and age), and suffered longer from the joint affection (11.2 vs. 9.3 years; p < 0.01; 
adjusted for sex and age). Regarding age, the hip and the knee group did not 
differ (ANOVA adjusted for sex). 
 
Table 3.  Descriptive statistics and score distributions for the different assessments according to 
affected joint  
 
 Affected joint  Range N Mean SD 
Hip 38-89 115 56.53 12.39 Age 
Knee 25-83 105 58.54 12.02 
Hip 20.3-39.7 115 26.35 3.49 BMI* 
Knee 19.6-41.1 105 27.95 4.82 
Hip 1-23 115 9.39 4.56 Duration of OA**  
Knee 1-24 105 11.27 5.91 
Level of significance: *p<0.05; **p<0.01  
 
Table 4 displays the descriptive statistics of the different assessments separated 
by the affected joint. As can be seen, the GP score as well as the Kellgren score 
did not differ significantly from each other. Regarding the AIMS2-SF, significant 
differences did occur in the scale "physical", in which a mean of 3.95 for the knee 
group indicated more limitation regarding physical aspects. The "symptom" scale 
indicated more impact due to pain in the knee group (p=0.03). "Affect", "social" 
and "role" did not differ significantly. In accordance to this finding the WOMAC 
"pain" scale revealed significantly (p=0.01) higher results for the knee group (5.93 
vs. 5.21). 
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"Stiffness" also differed significant between knee and hip patients (5.48 vs. 4.96; 
p=0.08). 
 
Table 4.  Descriptive statistics and score distributions for the different assessments 
 
Assessment range  joint N Mean SD p 
Hip 115 3.97 2.36 GP score 0-10  
 Knee 105 4.23 2.48 
0.43 
Hip 115 2.77 0.82 Kellgren-Score 1-4  
 Knee 105 2.59 0.89 
0.13 
Hip 114 3.61 1.57 physical 
Knee 101 3.92 1.64 
0.15 
Hip 115 4.20 1.32 affect 
Knee 104 4.34 1.25 
0.40 
Hip 115 3.05 2.70 symptom 
Knee 105 3.88 2.95 
0.03 
Hip 114 5.04 2.00 social 
Knee 104 5.18 1.87 
0.58 
Hip 63 8.33 2.69 
AIMS2-SF 0-10 
role 
Knee 46 7.41 3.41 
0.12 
Hip 114 5.21 1.99 Pain 
Knee 103 5.93 2.07 
0.01 
Hip 115 4.96 1.97 Stiffness 
Knee 105 5.48 2.43 
0.08 
Hip 115 5.59 2.30 Function 
Knee 105 5.98 2.50 
0.23 
Hip 115 5.25 2.08 
WOMAC 0-10 
Overall 
Knee 105 5.75 2.36 
0.10 
 
Figure 2 displays the GP score distribution in relation to the Kellgren score 
separated by hip and knee. As can be seen, the median of GP scores increases 
with the Kellgren score. Interestingly, in the hip and in the knee group the GP 
score achieved the widest range when patients were rated with a Kellgren score of 
two or four. 
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Table 5 displays statistically significant correlations for the GP assessment and the 
scale "physical" (rho=0.495) and "symptom" (rho=0.598) of the AIMS-
questionnaire and good correlations (rho=0.557) with the "pain" dimension of the 
WOMAC. The radiological grading according to Kellgren and Lawrence correlates 
quite well with the "symptom" dimension of the AIMS. All other correlations tended 
to be low, reaching the lowest values for the scales social and role of the AIMS2-
SF. 
 
Table 5. Correlations (Spearman rho) of GP score and x-ray findings with AIMS2-SF and WOMAC 
 
AIMS2-SF WOMAC  
Physical Affect Symptom Social Role (n=109) Function  Stiffness Pain  
GP-Score 0.495** 0.370** 0.598** 0.161* -0.165 0.358** 0.373** 0.557** 
Kellgren-Score 0.328** 0.320** 0.419** 0.107 -0.214 0.227 0.302 0.303 
Level of significance: *p<0.05; **p<0.01  
 
Table 6 displays score distributions in demographic subgroups. Age was positively 
correlated with the impact of OA on QoL, reflected by higher scores in all 
instruments in the group aged over 60, despite the "affect" and "social" scale of the 
AIMS2-SF. Patients with lower educational level achieved higher values in most 
scores. Women obtained higher values in most scores except for the "role" scale 
of AIMS2-SF. 111 patients were already retired from work; therefore numbers for 
the "role" scale were smaller.  
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Table 6. Mean scores for demographic subgroups 
 
 Sex Age Education 
 Male  Female P < 60 >=60 P High  Low P 
N 123 97  83 137  125 95  
Pain 4.92 6.41 ** 4.65 7.11 ** 4.62 6.31 ** 
Function 6.44 5.26 ** 5.13 6.84 ** 4.91 6.43 ** 
Stiffness 5.59 6.01 ** 4.65 6.12 ** 4.36 5.86 ** 
WOMAC 
 
Global 4.90 6.23 ** 8.86 6.52 ** 4.65 6.12 ** 
GPs assessment 3.43 4.94 ** 3.36 5.30 ** 3.06 4.88 ** 
x- ray 2.55 2.85  2.58 2.84 ** 2.45 2.86 ** 
Physical 3.25 4.43 ** 3.20 4.74 ** 3,09 4.26 ** 
Affect 3.83 4.81 ** 3.95 4.79 ** 3.90 4.55 ** 
Symptom 2.32 4.57 ** 2.16 5.22 ** 1.83 4.44 ** 
Social 4.08 5.02 ** 4.05 5.23 ** 4.16 8.28 * 
AIMS 
 
 
Role 1.74 
(n=74) 
2.72 
(n=35) 
 2.06 
(n=97) 
1.98 
(n=12) 
** 5.25 
(n=63) 
2.31 
(n=46)
 
Level of significance: *p<0.05; **p<0.01 
 
Table 7 displays the results of the polytomous ordinal regression analysis that 
mirrors the dependence of the GP score on age, gender, education, on the AIMS2-
SF scales "physical", "affect", "symptoms", "social" and on the WOMAC scales 
"function", "stiffness", "pain" as well as on the radiological grading according to 
Kellgren and Lawrence. Interestingly, in contrast to our bivariate comparisons, only 
"symptoms" and "Kellgren score" emerged as significant influence variables: 
 
SYMPTOMS
^β = 0.2588, 95% CI [0.03, 0.49], p = 0.0267 
KELLGREN
^β  = 0.6395, 95% CI [0.29, 0.99], p = 0.0004 
 
whereby j  represent the regression coefficient estimations according to the 
maximum likelihood method
^β
24 for the underlying regression model. Obviously, the 
impact of "Kellgren score" appears to be stronger and is more significant in 
comparison to "symptoms". 
 
Conclusion 
Physicians' assessment of patients' QoL is mainly influenced by two factors, pain 
and radiological findings. The results of the present study suggest that other 
factors, which are known to have an important influence on QoL of patients 
suffering from osteoarthritis such as socio-economic and psychosocial factors, are 
not sufficiently considered by the GPs. 
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Table 7.  Results of logistic regression analysis 
 
 Variable ^β  P 95% CI 
age  0.0555 0.6611 [-0.19, 0.30] 
sex -0.0720 0.3530 [-0.22, 0.08] 
Socio-demographic factors 
education -0.0693 0.6552 [-0.37, 0.24] 
physical -0.0272 0.8343 [-0.28, 0.23] 
affect  0.0521 0.7276 [-0.24, 0.34] 
symptoms  0.2588 0.0267 [ 0.03, 0.49] 
AIMS2-SF  
social -0.0107 0.9060 [-0.19, 0.17] 
function  0.1235 0.2928 [-0.11, 0.35] 
stiffness -0.0526 0.6726 [-0.30, 0.19] 
WOMAC  
pain  0.1389 0.3545 [-0.16, 0.43] 
X-ray  Kellgren-Score  0.6395 0.0004 [ 0.29, 0.99] 
 
Strength and weaknesses of the study 
To our knowledge, this is the first study exploring physicians' assessment of 
patients' QoL by estimating factors that may influence GPs. Some limitations have 
to be mentioned. In Germany more X-rays are taken in the care of patients with 
OA in comparison to other countries25. Therefore, influence of X-ray findings on 
GPs may be higher than in other countries. Assessing the socio-economic status 
of patients by asking for the annual income is very uncommon in Germany, so the 
educational level was used instead. 
Without a doubt OA has an important impact on patients' QoL. This was revealed 
by multiple primary care based studies26,27. There is also strong evidence that QoL 
of patients suffering from chronic diseases is influenced by multiple individual 
factors as for instance support from family, the social situation, affect and 
mood7,8,28-32. 
Moreover, previous studies indicated that even physical disability cannot only be 
explained by structural changes in the joint6,29. Neither the assessment of 
correlations nor the logistic regression analysis could identify socioeconomic or 
psychosocial factors to have important influence on the GPs' assessment. This 
may indicate that these factors are beyond the scope of physicians, even if the 
GP, who is more familiar with the patient and his individual situation than all other 
physicians, is estimating patients' QoL. This is in accordance with findings of 
previous studies which, for instance, revealed that psychological factors as well as 
concomitant depressions are often missed by physicians treating OA10. In ignoring 
these factors, GPs could also miss the possibility to involve additional important 
caregivers or persons out of patients' social context such as a spouse or other 
family members and friends33. 
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Our study suggests that instead of considering these important factors, GPs’ 
assessment of QoL is more focused on evident structural changes as documented 
in radiographs. Though it has been known for a long time that radiological findings 
show only poor correlation to pain and patients’ QoL, physicians' estimations are 
still strongly influenced by radiographs. Ignoring psychosocial influence factors 
may cause a lack of treatment and on the other hand considering factors which are 
less related to patients' QoL –such as radiological findings– may lead to 
inadequate treatment. The implications for practice are obvious: our results 
suggest that physicians should consider physiological and social factors more 
intensely when treating patients suffering from OA. They should be aware that 
these factors contribute substantially to patients' QoL and may represent an 
important target for non-surgical and non-pharmacological interventions. 
Moreover, GPs should avoid overestimation of X-ray findings and treat patients not 
pictures. 
6
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Abstract 
Objective: Although there is a strong relationship between depression, chronic 
pain and physical activity, there are few findings regarding the prevalence and 
predictors of depression in patients with osteoarthritis (OA). The goal of the 
present study was to assess the prevalence and severity of depression in a large 
sample of patients with OA and to reveal predictors of depression. 
Methods: Patients were approached consecutively in 75 general practices. Of 
1,250 distributed questionnaires, 1,021 were returned and analysed. Besides 
sociodemographic data, medication and comorbidities, depression, and arthritis 
were assessed using the Patient Health Questionnaire (PHQ-9) and the Arthritis 
Impact Measurement Scale. A stepwise multiple linear regression analysis with the 
PHQ-9 score as the dependent variable was performed. 
Results: On the PHQ-9, 19.76% of men and 19.16% of women achieved a score 
of ≥15, indicating at least a moderately severe depression. Significant gender 
differences could not be revealed. The strongest predictor for depression severity 
was perceived pain (ß=0.243, P < 0.001) and little social contact (ß=0.218, P < 
0.001). Further predictors were physical limitation of the lower body (ß=0.157, P < 
0.001) and upper body (ß=0.163, P < 0.001), age (ß=0.168, P < 0.001), and body 
mass index (ß=0.080, P=0.020). 
Conclusion: These findings suggest an increased prevalence of depression 
among patients with OA and emphasise the need for recognition and appropriate 
treatment. Most of the revealed predictors are influenceable and should be 
potential targets in a comprehensive treatment of OA to interrupt the vicious circle 
of pain, physical limitation and depression. 
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Introduction 
Osteoarthritis (OA) is highly prevalent in the older population and is associated 
with a substantial impact on patients’ quality of life1. The most frequent symptoms 
are chronic pain and physical limitation. Therefore, arthritis represents the most 
commonly reported physical source of chronic pain in the elderly2. Depression is 
also highly prevalent in the elderly and a common comorbidity of many chronic 
diseases3. The impact on OA, for example, is great because depression has a 
substantial impact on the two main symptoms of OA: pain and disability. 
Regarding pain, previous studies have shown that individuals with depression are 
more likely to report chronic pain and that more than half of patients with chronic 
pain experience depression4,5. In patients with OA, depression was found to be 
associated with increased pain sensitivity and less effective coping with the 
illness6. Consequently, several attempts have been made to assess the 
relationship of pain and depression and to explain the psychopathologic process of 
chronic pain. Dieppe and Lohmander stated that “the association and 
pathogenesis of pain are in as much need of investigation as joint damage”7. A 
recent meta-analysis pointed out that depression probably is the consequence and 
not a disposing factor for pain in patients with arthritis8. Regarding functional 
impairment, which represents the second major burden of OA, the causality of the 
association between physical limitation and depression is also still unclear. Similar 
as in pain and depression, the relationship seems to be in some way bidirectional9. 
Because it is quite obvious that depression can aggravate the main symptoms of 
arthritis, many studies have been aimed at revealing risk factors for depression 
among patients with arthritis. Sociodemographic and psychosocial factors were 
found to play an important role, but their contribution is not yet clarified7,10,11. 
Moreover, many studies aimed to explain the relationship failed to control for 
important covariates such as sociodemographic factors, disease duration, 
comorbidities, level of disability, or social support, which may have an important 
impact on depression12–14. In consequence, the variability of the so far reported 
data may mainly be due to the measures used and to the controlled factors. 
Nevertheless, the association between arthritis and depression mediated through 
pain and functional limitation represents important information for developing 
clinical and public health interventions, which could interrupt the vicious circle of 
depression, pain, and functional limitation. Treatment of depression can improve 
health status and functional ability15, and screening and appropriate interventions 
can help prevent subsequent health burdens and related health care costs16. 
Therefore, it is important to identify patients with OA at high risk for depression so 
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that these patients may be targeted for depression screening and treatment. 
Knowledge about risk factors or predictors of depression can ease identification of 
these patients. Consequently, the goal of this study was to assess the prevalence 
and risk factors of depression in a large sample of patients with OA in a primary 
care setting. 
 
Patients and methods 
The data used for this study were obtained from the baseline assessment of the 
PraxArt project17, which aims to improve the quality of life of patients with OA. The 
project is financed by the German Ministry for Education and Research over a 
period of 6 years, starting in 2003. A randomly created sample of 75 general 
practitioners in the areas of Baden-Wuerttemberg and Bavaria was enrolled and 
recruited the patients. The data for this baseline assessment were collected 
between March and May 2005 and can be considered a representative reflection 
of the present situation of patients with OA in primary care in Germany with regard 
to health status and received care. 
 
Patient inclusion criteria. To be eligible for inclusion, patients had to be at least 18 
years of age and diagnosed with OA of the hip or knee according to the criteria of 
the American College of Rheumatology18,19. The patients were asked by the 
general practitioner (GP) to participate in the study if OA represented the main (or 
at least one) reason for the current encounter. In each of the participating 75 
practices, 15 patients fulfilling the criteria were recruited consecutively so that a 
total of 1,250 sets of questionnaires were delivered to patients. GPs created a list 
of all recruited patients. After giving their written informed consent, patients 
received the questionnaires and a stamped envelope. They were informed that 
neither the GP nor the practice team had any possibility of finding out their 
answers. Inclusion of patients did not start until there was a written and 
unrestricted positive vote of the ethics committee of the University of Heidelberg, 
which was received in March 2005 (approval number 021/2005). 
 
Data collection. Each patient’s set of questionnaires was linked with an 
identification number to the participant’s list, so that data provided by the patients 
could be checked by comparing them with the patients’ files. If differences 
between patients’ answers and the medical file occurred, the data from the file 
were used. This procedure was performed to assess reliability of answers later in 
the PraxArt project. Nonrespondents were identified by comparing the GP’s list of 
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recruited patients with received questionnaires. Sociodemographic data (sex, age, 
ethnicity, educational level, working situation, family situation) were collected. 
Educational level was defined as follows: ≤1 represented elementary school, 2 
represented high school, and ≥3 represented a college degree. Regarding 
comorbidities, the following comorbid conditions were surveyed: high blood 
pressure (HBP; >140/90 mm Hg), diabetes, chronic heart failure, coronary vessel 
disease (CVD), elevated cholesterol level (total cholesterol >200 mg/dl), ulcer or 
stomach disease, asthma/chronic obstructive pulmonary disease, renal 
insufficiency, cancer (prior), and stroke (prior). 
Depression was measured using the depression module of the German form of the 
Patient Health Questionnaire (PHQ-9)20,21. The PHQ-9 is a completely self-
administered questionnaire that enables screening for depression and assessment 
of depression severity. For each of the 9 depressive symptoms, according to the 
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition22, patients 
indicated whether, during the previous 2 weeks, the symptoms had bothered them 
“not at all,” “several days,” “more than half the days,” or “nearly every day,” yielding 
a score of 0–3. The PHQ-9 severity score thus ranges from 0 to 27. The internal 
reliability of the PHQ-9 severity measure is excellent with a Cronbach’s alpha 
between 0.86 and 0.89 23,24. Following the recommendation of Kroenke and 
colleagues23, we classified patients’ level of depression as mild, moderate, 
moderately severe, and severe if they scored between 5 and 9, 10 and 14, 15 and 
19, and 20 and 27, respectively. Additionally, to compare the rate of depression 
symptoms with that of other studies, we collapsed the categories into moderate, 
moderately severe, and severe depression (i.e., PHQ-9 score ≥10) 25,26. Secondly, 
we used a stricter cut-off score (PHQ-9 score ≥15), because this score usually 
signifies the presence of major depression23.  
The impact of OA on patients’ health was assessed by the German Arthritis Impact 
Measurement Scales Short Form (AIMS2-SF), which provides a comprehensive 
assessment of patients’ health status including the dimensions: physical limitation, 
symptom (reflecting perceived pain), social (reflecting social contacts), affect 
(reflecting mood), and work (reflecting the ability to work). The AIMS2-SF has 
recently been validated in German using a sample of patients with OA and has 
proven to be comparable with the original version regarding reliability and 
validity27,28. As suggested in the German validation study, we divided the physical 
limitation scale of the AIMS2-SF into upper body limitation and lower body 
limitation. 
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Statistical analysis. The data were analysed with the SPSS program, version 12.0 
(SPSS, Chicago, IL). Because the prevalence of depression differs between men 
and women in the general population, the results of descriptive statistics were 
separated by sex29. Group comparisons between sexes were made using 
Students’ t-test for continuous variables and Fisher’s exact test for nominal 
variables. Analyses of covariance (ANCOVAs), which were adjusted for covariates 
such as age, disease duration, and number of comorbidities if applicable, were 
used to compare multiple variables between sexes . Scatter plots were performed, 
where applicable, to confirm linear relationship. Prior to regression analysis, 
univariate correlations were calculated. Correlations between sociodemographic or 
clinical variables and PHQ-9 scores were assessed by computing Spearman’s rho 
or, if linear relationship was confirmed, Pearson’s correlation coefficient.  
To determine predictors of depression severity, a multiple linear regression 
analysis was performed with the PHQ-9 score as the dependent variable. Factors 
were only entered in the regression models if they showed significant correlation 
(P < 0.01) in the univariate correlation analysis. Multicollinearity could be assumed 
at least for some of the factors, so that a stepwise multivariate regression analysis 
may have resulted in an artificially high linear regression coefficient R2 due to 
forced entry in the model of highly correlated factors. Therefore, we used a 
hierarchical stepwise technique with 2 blocks of variables. The sociodemographic 
variables were entered in the first block and the disease characteristics were 
entered in the second block. In a subsequent backward elimination process in 
every step, the variable with the lowest beta was excluded, if no significance was 
achieved (P > 0.01). This approach has already been chosen by other authors and 
can be regarded, in a statistical sense, as a conservative approach to assessing 
predictors30,31. 
 
Results 
Of the 1,311 patients recruited by the GPs, 1,250 agreed to fill out the set of 
questionnaires; 1,021 sets were returned to the university. At least 11 sets were 
returned per practice. The main reason given for not participating was time effort. 
Missing data mainly occurred within the same questionnaires, resulting in 271 
questionnaires with missing data. In 123 cases, the data could be completed from 
the patient’s file. The PHQ-9 scores could be calculated in 1,012 cases. A 
comparison of the 1,021 respondents and the nonrespondents revealed no 
significant differences regarding sociodemographic variables (age, sex), disease 
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characteristics (duration of disease), number of comorbidities, and prescribed 
medication. 
Various characteristics of the study sample are displayed in table 1. Of the 1,021 
included patients, 347 (34.0%) were men and 674 (66.0%) were women. In 
comparison with women, significantly more men were married or lived with a 
partner. The t-test for group comparison revealed a significant difference in the 
(formal) educational level. Differences in body mass index (BMI), age, number of 
comorbidities and disease duration were not significant between sexes. Regarding 
ethnicity, >92% of both sexes were white. Regarding pain treatment, the most 
frequently prescribed medications were nonselective cyclooxygenase inhibitors 
such as diclofenac. Of both sexes <9% received antidepressants. Regarding 
comorbidities, more than half of the included patients had HBP, men significantly 
more frequently than women.  
 
Table 1.  Characteristics of the study sample (n=1021) 
 
Gender  
Male (n=347/34.0%) Female (n=674/66.0%)  
 
mean SD mean SD p 
Age 65.16 14.75 66.64 15.33 0.166 
Duration of OA (years) 14.80 16.18 13.13 11.09 0.098 
Body mass index (BMI; kg/m²)  28.39 4.26 28.12 5.16 0.277 
No. of comorbidities (0-10) 2.20 1.81 2.24 1.65 0.741 
Educational Level (1-3)  2.61 1.11 2.38 0.83 0.001 
GP contacts in the last 6 months 4.08 6.29 5.61 8.26 0.002 
Radiographs of joint in the last 6 months 0.78 4.15 0.98 4.15 0.121 
 Total % Total %  
Married/Living in partnership 278 80.1  376 55.8  0.001 
Retired 233  67.1 482  71.5  0.788 
Medication      
Acetaminophen 2 0.6 8 1.2 0.056 
COX 2-inhibitors 8 2.3 18 2.7 0.236 
Nonselective COX- inhibitors 120 34.6 276 41.0 0.059 
Opioids 22 6.3 46 6.8 0.429 
Other pain relievers 7 2.0 14 2.1 0.514 
Antidepressants 31 8.9 48 7.1 0.141 
Comorbidities      
High blood pressure 181 52.1 384 56.9 0.001 
Elevated cholesterol 124 35.7 245 36.3 0.059 
Diabetes 57 16.4 120 17.8 0.068 
Chronic heart failure 63 18.1 131 19.4 0.099 
Coronary vessel disease 62 17.8 70 10.3 0.009 
Ulcer/gastritis 77 22.1 146 21.6 0.341 
Asthma/COPD 34 9.8 64 9.5 0.278 
Renal insufficiency 23 6.6 33 4.9 0.085 
Cancer 21 6.1 16 2.4 0.008 
Stroke 16 4.6 30 4.4 0.367 
(p-values by means of t-test, Fishers exact test respectively for nominal data ) 
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Among comorbidities that may have an impact on patients’ physical activity, 
cardiovascular diseases were the most frequent: heart insufficiency (18.1% of men 
and 19.4% of women) and CVD (17.8% of men and 10.3% of women) were much 
more common than stroke (4.6% men and 4.4% in women). 
Regarding the PHQ-9, 344 men (98.9%) and 668 women (99.1%) answered all 9 
items. The categories of depression severity according to the PHQ-9 are displayed 
in table 2 with the categories none (score 1–4), mild (score 5–9), moderate (score 
10–14), moderately severe (score 15–19) and severe (score 20–27). As can be 
seen, 100 men (29.1%) and 233 women (34.9%) were classified as not depressed. 
With a score of ≥10, 181 women (27.1%) and 107 men (31.1%) were depressed. 
Using a cut-off score of 15, a total of 196 (19.4%) patients, namely, 68 men 
(19.8%) and 128 women (19.2%) were classified as depressed.  
 
Table 2. Scores and grading of the severity index of depression (PHQ-9)* 
 
PHQ-9 scoring Total (n=1012) Male (n=344) Female (n=668) P#
Total score, mean (SD) 15.73 (4.7) 15.33 (4.8) 15.95 (4.6)  
None 1-4  333 (32.9) 100 (29.1) 233 (34.9) 0.11 
Mild 5-9 391 (38.6) 137 (39.8) 254 (38.0) 0.06 
Moderate 10-14 92 (9.1) 39 (11.3) 53 (7.9) 0.04 
Moderately severe 15-19 151 (14.9) 52 (15.1) 99 (14.8) 0.23 
Severe 20-27 45 (4.4) 16 (4.7) 29 (4.3) 0.34 
*  Values are the number (percentage) unless otherwise indicated. 
#  Analysis of covariance (adjusted for age, disease duration and number of comorbidities) 
 
Because the prevalence of depression differs in the normal population15 and in 
some severe diseases16, we computed group comparisons for each severity 
category. Adjusted ANCOVAs (age, disease duration, number of comorbidities) 
revealed no significant differences (P > 0.05) between men and women in the 
categories moderate, moderately severe and severe. Consequently we abandoned 
the idea of assessing predictors separately for each sex. A comparison of PHQ-9 
scores of patients receiving antidepressants with patients receiving no medication 
revealed no significant differences, even after adjusting ANCOVAs for age and 
disease duration for both sexes. 
Prior to the regression analysis, bivariate correlations between the PHQ-9 score 
reflecting the severity of depression, sociodemographic variables and disease 
characteristics were performed (table 3). Pearson’s correlation coefficient was 
determined if a linear relationship could be confirmed: otherwise, Spearman’s rho 
was calculated. Interestingly, a linear relationship could be confirmed for all of the 
AIMS2-SF scales, as well as for disease duration, age, number of comorbidities 
and BMI. Apart from the marital status, all variables showed significant correlations 
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with the PHQ-9 score, but correlation size was notable only for the AIMS2-SF 
affect scale (r=0.678, P < 0.001); the symptom scale, representing patients’ 
perceived pain (r=0.442, P < 0.001); and the lower body limitation scale (r= 0.436, 
P < 0.001). 
 
Table 3.  Correlations of patients’ demographic and clinical variables to severity index of 
depression (PHQ-9 score: n=1012) 
 
 Mean SD Pearson’s r Spearman’s rho P (two-sided) 
Female sex    0.076 0.027 
Being married    -0.046 0.191 
Education 2.45 0.94  -.0097 0.005 
Disease Duration 13.69 13.04 0.097  0.006 
Lower body* 2.78 1.98 0.436  <0.001 
Upper body* 1.49 2.26 0.326  <0.001 
Symptom* 4.90 2.20 0.442  <0.001 
Affect* 2.93 1.36 0.678  <0.001 
Social* 4.67 1.83 0.354  <0.001 
Work* 2.65 2.45 0.225  0.002 
Age 66.17 15.16 -0.147  <0.001 
BMI 28.21 4.88 0.133  <0.001 
Amount of comorbidities 2.22 1.71 0.154  <0.001 
* representing AIMS2-SF scales 
 
All variables that showed a significant correlation were entered into the multiple 
regression analysis with the severity index of depression (PHQ-9 score) as the 
dependent variable (table 4): sex, educational level and age were entered in the 
first block, which contained the sociodemographic variables. Of these, only age 
(ß=0.168, P < 0.001) remained in the final model as a significantly contributing 
determinant. Interestingly, the algebraic sign for the factor age was negative, 
indicating that older age predicted lower PHQ-9 scores in our study sample. The 
second block of the hierarchical regression analysis contained the disease 
characteristics. Of these, the symptom scale, reflecting patients’ perceived pain, 
remained as the strongest predictor with a beta of 0.243 (P < 0.001). Also, having 
few social contacts resulted in higher scores in the AIMS2-SF social scale, 
remained a predictor (ß=0.218, P < 0.001), as did physical limitation of the lower 
body (ß=0.157, P < 0.001) and of the upper body (ß=0.163, P < 0.001). The beta 
of 0.080 for BMI (P=0.020) indicated that this variable was only a weak predictor. 
The adjusted R2 of the final model was 0.338, indicating that the revealed 
predictors leave a notable amount of variation of the dependent variable, the PHQ-
9 score, unexplained. 
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Table 4. Predictors of severity index of depression assessed by a stepwise multiple regression 
model 
 
Dependent: PHQ-9 score  β SE T p
Included  
Age -0.168 0.010 -4.935 <0.001
Lower body* 0.157 0.107 3.569 <0.001
Upper body* 0.163 0.083 4.240 <0.001
 
 
 
Symptom* 0.243 0.095 5.820 <0.001
 Social* 0.218 0.097 6.150 <0.001
 BMI 0.080 0.035 2.324 0.020
 (Constant)  1.259 7.578 <0.001
Excluded  
 Block 1   
Education -0.006 -0.189 0.850
Sex 0.012 0.345 0.730
 
 
 Married/partner -0.014 -0.418 0.676
 Block 2   
Disease duration -0.034 -1.004 0.316 
Sum of comorbidities  0.041 1.167 0.244
R²= 0.345; Adjusted R²= 0.338; F=51.815 ; p<0.001 
*representing AIMS2-SF scales 
 
Discussion 
Pain, few social contacts, and physical limitation were revealed as the most 
important predictors of a high score on the PHQ-9 depression severity instrument. 
Also, age and BMI contributed significantly to the prediction of PHQ-9 scores. 
Furthermore, our findings suggest that the point prevalence of depression 
symptoms among patients with OA in a primary care setting is increased 
compared with unselected primary care patients of the same age. Interestingly, 
gender differences in the prevalence of depression as found in the general 
population29 and revealed for instance among patients with diabetes32, did not 
occur in our study sample. 
Previous findings regarding the prevalence of depression among patients with 
arthritis mainly focused on patients with rheumatoid arthritis; there was no 
indication of increased prevalence rates among patients with OA if they were 
assessed30,33,34. Contrary to these findings, our data demonstrated that 29% of 
patients achieved a PHQ-9 score ≥10 and nearly 20% scored ≥15, indicating major 
depression. Moreover, the mean scores of the PHQ-9 were quite high, with a 
mean of >15. In comparison, in a study among 3,000 American primary care 
patients the mean was 5.0 for all patients, 15.1 for patients with a depressive 
disorder and 18.6 for patients with major depression19. A recent study revealed a 
point prevalence among primary care patients of 5.6% for major depression and 
5.2% for minor depression35. Our findings indicate a significant increase in the 
prevalence rate of depression in patients with OA compared with unselected 
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primary care samples. Prevalence rates of concomitant depression reported for 
other chronic diseases differ widely: Wiehe et al. revealed a point prevalence of 
12.4% among 1,174 men and women with high blood pressure36 and Odden et al. 
reported a rate of 17% in patients with chronic kidney disease26. Higher rates were 
reported for patients with chronic heart failure (28.6%)37, type 2 diabetes (32.9%)32 
and asthma (45%)38. But when comparing such prevalence rates, disease 
characteristics of included patients as well as the method of assessment of 
depression (self-reported or by physician interview) should be acknowledged 
because they contribute substantially to prevalence rates32.  
Regarding predictors of depression, pain represented the strongest predictor in our 
study. Physical limitation, pain and depression have frequently been found to be 
closely related to each other and many studies have attempted to reveal the 
causality4,39,40. One hypothesis is that one causes the other. Other hypotheses 
suggest a shared diathesis that increases the risk for individuals to be more 
susceptible to both. Newer studies in patients with chronic pain suggest the 
existence of independent neuronal networks for sensory and affective pain 
elements. These findings suggest that appropriate treatment of depression might 
increase patients’ mood but may not help reduce the pain felt 39. Regardless of 
these findings on a neuronal level, it appears that functional ability, depression and 
social support have a strong impact on an individuals’ capacity for occupational 
adaptation, which is essential for coping with pain41. Therefore, even if the causal 
linkage between depression and physical limitation remains unclear, our finding, 
that physical disability is a predictor for depression severity, is in accordance with 
multiple previous studies and most likely reflects a bidirectional relationship: 
although functional disability can lead to depression, depression has a detrimental 
effect on physical mobility42,43. 
The importance of the social background has already been mentioned above and 
its contribution to depression in the general population has been pointed out by 
many studies in the past30,44. Therefore, not surprisingly, it is also an important 
predictor among patients with OA, as revealed in this study. 
The finding that increased BMI represents a (comparably weak) predictor for 
higher PHQ-9 scores is new. None of the previous studies have assessed BMI as 
a contributing factor. Nevertheless, the result seems plausible, since an increased 
BMI represents a further element in the vicious circle of pain, depression and 
physical inactivity. It seems that increased BMI does not only increase the risk for 
OA but also the probability of depression. Regarding the lifetime prevalence of 
depression, which reaches a peak in the fourth and fifth decades as well as at the 
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mean age of our study sample, which was beyond that time frame: the finding that 
increased age is a predictor for lower PHQ-9 scores seems plausible45,46. 
Interestingly, neither the duration of OA nor the sum of comorbid conditions 
contributed to depression severity. Regarding comorbidities, some previous 
findings indicate that, for instance, heart diseases are risk factors for depression42. 
Nevertheless, we abandoned the idea of controlling the regression analysis for 
certain comorbidities because of two reasons. Firstly, the contribution of the 
assessed comorbidities is still unclear, even if there are some indications for 
certain diseases, such as heart disease. Secondly, it can be assumed that this 
contribution is mediated by physical limitation, as pointed out by Dunlop and 
colleagues42. Therefore, we supposed that the contribution of comorbidities is 
mostly reflected in the physical limitation dimension of the AIMS2-SF. 
Some further limitations and weaknesses of our study have to be noted. Firstly, 
even if there are many studies demonstrating that the PHQ-9 has proven to be a 
sensitive and specific instrument to reveal depression23,24, the final diagnosis 
needs to be confirmed by further exploration. This, however, was not the case in 
our study and would have been difficult to do because of the sample size. 
Secondly, as already mentioned, it can be assumed that the quantity as well as the 
quality of comorbidities influence depression. We were only able to control for the 
number of comorbidities. Finally, previous studies have demonstrated that a lower 
social status is associated with increased depression due to increased barriers to 
health care47. We did not ask participants about their income, because this is very 
uncommon in Germany and because low income does not necessarily represent 
an important barrier for access to the health care system in Germany.  
Despite the mentioned weaknesses, this study is the largest study up to now 
assessing depression in patients with OA in primary care with data collected in 
individual practices. Moreover, we controlled for more variables contributing to 
depression than any previous study. 
In conclusion, the impact of depression on patients with OA has been documented 
in many aspects: despite the impact on quality of life, depression has been 
revealed as a negative predictor of the outcome of surgical interventions48 and 
interventions aimed at physical activity49. As in the general population, depression 
influences consulting behaviour and increases health service utilisation45,50. In 
contrast, previous findings indicate that physicians overestimate structural 
changes in OA and underestimate the contribution of depression to pain 
perception, functional ability and quality of life51,52. Furthermore, previous studies 
have demonstrated that improved depression care can improve pain and 
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functional ability among patients with OA15. The impact of OA on a patient’s life is 
multifarious and should be treated appropriately. Our findings present some 
influenceable targets for a multifaceted treatment of OA, which may help increase 
patients’ quality of life. 
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Abstract  
To assess the impact of concomitant depression on quality of life (QoL) and health 
service utilisation of patients with osteoarthritis (OA). Data were collected from 75 
primary care practices in Germany. In total 1,250 patients were consecutively 
approached; 1,021 (81.7%) questionnaires were returned and analysed. Measures 
included sociodemographic data, the Arthritis Impact Measurement Scale (AIMS2-
SF) and the Patient Health Questionnaire (PHQ-9) to assess depression. A PHQ-9 
score of 15 or higher, was defined as reflecting depression. Patients with a 
depressive disorder achieved significantly (all P < 0.001) higher scores in all 
AIMS2-SF dimensions. They had more contact with general practitioners (P < 
0.01), orthopaedics (P < 0.01) and with providers of complementary alternative 
medicine offered, e.g., by healers. Concomitant depression aggravates the burden 
of OA significantly. This results in increased health service utilisation. Appropriate 
treatment of depression would appear not only to increase QoL but also to lower 
costs by decreasing health service utilisation. 
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Introduction 
Recent research has shown that the point prevalence of depression is increased 
among patients suffering from osteoarthritis (OA) to the hip or to the knee1. It could 
be proved that early recognition and treatment of concomitant depression 
increases quality of life (QoL) and reduces the burden of disease2.  
Furthermore, it is known that patients with depressive disorders are high utilisers 
of health services3. Most prior studies defined health service utilisation as, e.g., 
contact with general practitioners (GPs) or physicians overall and did not 
differentiate between different providers of medical care or different medical 
services, such as performed X-rays4. No prior study assessed providers of 
complementary alternative medicine (CAM), even though it is known that the use 
of CAM is quite common among patients with arthritis5. In all health care systems 
OA is associated with high indirect and direct costs6,7, and our hypothesis was that 
the health service utilisation (HSU) of OA patients with concomitant depression is 
significantly increased compared to controls of OA patients without a depressive 
disorder. It can be assumed that depression is not only directly linked to increased 
HSU but also mediates increased HSU by its substantial impact on all dimensions 
of QoL. Therefore, the aim of this study was not only to assess the impact of 
depression on the QoL of OA patients but also its impact on health service 
utilisation including the use of CAM. 
 
Materials and methods 
The data used for this study stem from the PraxArt project, which aims to improve 
the QoL of patients suffering from OA. The project is financed by the German 
Ministry for Education and Research over a period of 6 years and comprises data 
on patients with OA from 75 general practitioners in the areas of Baden-
Wuerttemberg and Bavaria. 
 
Patient inclusion criteria 
The study protocol was approved by the ethics committee of the University of 
Heidelberg previous to the start of the study in January 2005. Patients were not 
included unless there was a written and unrestricted positive vote from the ethics 
committee. To be eligible for inclusion, patients had to be adult and diagnosed with 
arthritis to the hip or knee according to the ACR criteria.8,9 All patients who visited 
their GP because of complaints related to OA were addressed consecutively in 
GPs’ practices. After giving their written informed consent they received the 
questionnaire and a stamped envelope with the postal address of the university. 
9
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The patients were asked to return this questionnaire to the university. They were 
informed that it was impossible neither for the GP nor the practice team to get 
knowledge of their answers. 
 
Data collection 
Each questionnaire was linked to the list of participants by an identification 
number; so data given by patients could be checked by comparing them with the 
patient’s file. Sociodemographic data (sex, age, educational level, working 
situation, family situation) were collected. Regarding comorbidities, the following 
conditions were collected: high blood pressure, diabetes, heart insufficiency, 
coronary heart disease, elevated cholesterol level (LDL > 200 mg/dl), ulcer or 
stomach disease, asthma/COPD, kidney disease, cancer and stroke. If differences 
between patients’ answers and the medical file occurred, the file data were used. 
In addition to the comorbidities, we asked the patients “Did you have any 
complaints or notice side effects you assume to be related to the prescriptions you 
are taking for your arthritis?” Depressive disorders were diagnosed using the 
depression module of the German Patient Health Questionnaire (PHQ-9).10 The 
PHQ-9 is a self-administered questionnaire that enables the diagnosis of major 
depression and minor depression according to DSM-IV.11 Moreover, the 
summarised scales score allows the assessment of the severity of depression. 
The PHQ-9 has proven to be a valid instrument for such assessments.12,13 In 
accordance with recommendations by Kroenke et al. a cut-off of 15 points was 
used to define depression. 
The impact of OA on patients’ QoL was assessed by the GERMAN-AIMS2-SF, 
which represents a reliable, valid and comprehensive tool. It provides a 
comprehensive assessment of QoL while comprising the dimensions physical 
limitation, symptom (reflecting perceived pain), social (reflecting social contacts), 
affect (reflecting mood) and work (reflecting the ability to work). It has recently 
been validated in the German language in a sample of OA patients.14 As 
suggested in this study, we differentiated between upper body limitation and lower 
body limitation on the physical limitation scale of the AIMS2-SF. 
To assess physical activity we used the short form of the International Physical 
Activity Questionnaire (IPAQ)15, developed by an international panel of experts 
(EUPASS) and validated across Europe. Physical activity-related energy 
expenditures (MET-min/week) were calculated using existing recommendations 
available at http://www.ipaq.ik.se. For vigorous physical activity, the total of 
minutes of activity per week were multiplied by the factor 8, for moderate physical 
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activity by the factor 4, and for walking by the factor 3.3. The sum of these three 
products is the MET-min/week.  
 
Statistical analysis 
The data were transferred into the SPSS program (version 12.0). All data were 
reported descriptively. Comparisons were made between genders by means of the 
Student’s t test or by ANOVAs, which were adjusted for covariates such as age or 
disease duration if applicable. Group comparisons between depressed and 
nondepressed OA patients were made by means of ANCOVA [adjusted for age, 
disease duration, body mass index (BMI)], using a cut-of of 15 on the PHQ-9 
score. A Bonferroni post hoc correction was performed to avoid bias of multiple 
testing where applicable. 
 
Results 
Characteristics of the study sample are displayed in table 1. Of the 1,021 included 
patients, 347 (34.0%) were male and 674 (66.0%) were female; 278 (80.1%) of 
men and 376 (55.8%) of women were married or lived with a partner. Since most 
patients had already retired from work (67.1% of men and 71.5% of women), the 
work scale of the AIMS2-SF was excluded from further analysis. Interestingly, 
differences in BMI, age, the number of comorbidities and disease duration 
achieved no significance between genders.  
 
Table 1.  Characteristics of the study sample (n=1021) 
 
Gender 
Male (347/34.0%) Female (674/66.0%) 
 mean SD mean SD 
Age 65.16 14.75 66.64 15.33 
Disease duration (years) 14.80 16.18 13.13 11.09 
Body mass index (BMI)  28.39 4.26 28.12 5.16 
No. of comorbid conditions (0-10) 2.20 1.81 2.24 1.65 
Educational Level (1-3) ** 2.61 1.11 2.38 0.83 
Married/Living in partnership 278 80.1 (%) 376 55.8(%) 
 **t-test: p<0.01 
 
Regarding the answer rates within questionnaires, 344 men (99.1%) and 668 
(99.1%) women completely answered all nine items of the PHQ-9. As can be seen 
in table 2, of these, 65 (18.9%) men achieved a score of 15 or higher. In women, 
131 (19.6%) reached or surpassed the score level, which is considered to indicate 
depression. The overall prevalence of depressive disorders according to the PHQ-
9 score and including both genders was 19.4%. Gender comparisons by means of 
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ANOVA (ANCOVA), adjusted for age and disease duration revealed no significant 
differences in PHQ-9 scores between the sexes. 
 
Table 2. PHQ-9 scores (severity index of depression) 
 
Fulfilling criteria for  Overall 
Gender N Mean SD Major Depression Minor Depression Depressive Disorder 
male 344 15.33 4.76 38 (11.0%) 27 (7.8 %) 65 (18.9% ) 
female 668 15.95 4.63 84 (12.6 %) 47 (7.1 %) 131 (19.,6%) 
Total   122 (12.0%) 74 (7.3%) 196 (19.4%) 
 
Table 3 shows a comparison of patients with and without PHQ-9 scores indicating 
depression. The first section of the table displays the sociodemographic 
characteristics of the study sample. Group comparisons of these characteristics 
were performed by means of a t test or Chi-square test.  
 
Table 3. Comparison of patients with and without PHQ-9 scores indicating depression 
 
PHQ-9 score  <15 (n=724)  >= 15 (n=288)  
  Mean  SD Mean  SD p 
Sociodemographics, disease characteristics and comorbidities a
Age 68.12 11.16 65.60 12.46 0.031 
Education level 2.48 0.946 2.31 0.882 0.035 
Physical activity (IPAQ) (MET-min/week) 2,545.3 1,872.5 2,001.1 1,871.3 <0.001 
Disease characteristics      
Duration of OA  13.18 12.991 16.20 13.050 0.007 
BMI 27.59 4.21 28.56 5.07 <0.001 
Number of comorbiditiesc 2.17 1.81 2.23 1.67 0.781 
Number of prescriptionsc  2.70 4.83 2.92 4.89 0.213 
Quality of life (AIMS2-SF dimensions) b     
Lower body 2.52 1.85 4.03 2.08 <0.001 
Upper body 1.26 2.07 2.68 2.81 <0.001 
Symptom  4.61 2.14 6.30 1.96 <0.001 
Affect  2.69 1.25 4.10 1.24 <0.001 
Social  4.49 1.80 5.54 1.73 <0.001 
Perceived side effects 1.87 4.268 4.09 6.617 <0.001 
Health service utilisation b     
Accupuncture 1.14 4.35 .57 1.76 0.111 
GP 4.67 7.35 7.10 8.87 <0.001 
Orthopeadics 1.59 3.10 2.90 5.23 <0.001 
Healer 0.11 0.97  1.15  6.16 <0.001 
Physiotherapy 6.59 12.29 7.30 9.96 0.496 
X-ray of joint  0.71 4.03 0.98 4.11 0.041 
a By means of t test/Chi-square test 
b By means of ANCOVA, adjusted for age and disease duration 
c Exclusive depression 
 
As can be seen, patients achieving a higher PHQ-9 score were significantly 
younger and less educated. Regarding OA, patients with a higher PHQ-9 score 
suffered from OA longer and had a higher BMI. Neither the differences regarding 
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comorbidities (exclusive depression and OA) nor the number of prescriptions for 
these comorbidities were significant. As a consequence of these findings, we 
adjusted ANOVAs for comparisons of QoL as well as health service utilisation for 
age, disease duration, educational level and BMI. Even after adjusting these 
factors, differences remained significant (P < 0.001 for all) for all dimensions of 
QoL, physical activity, contact with GPs, orthopaedics and healers. Differences 
regarding physiotherapy and acupuncture were not significant. A higher score was 
also associated with a positive answer to the question on more complaints about 
self-experienced side effects of OA treatment (P < 0.001). 
 
Discussion 
Our findings suggest that a concomitant depression in patients with OA has a 
substantial impact on their QoL. This effect remained even if data were controlled 
for important covariates that influence OA such as age, disease duration, 
educational level and BMI. Furthermore, these patients tend towards increased 
utilisation of the health care system, including visits to GPs and orthopaedics but 
also regarding the performance of X-rays.  
The fact that patients receiving a higher score on the PHQ-9 were younger is in 
accordance with life-prevalence of depression16. Prior research also shown that 
depression rates among patients with chronic diseases are often increased17–21 
and that depression frequently aggravates the burden of the chronic disease.22,23 
For instance, in rheumatoid arthritis, depression was found to be an independent 
risk factor for increased mortality24. This study group recently showed that 
depression rates seem to be increased in OA patients as well 1. Our findings 
confirmed that like most other chronic diseases, concomitant depression increases 
the disease burden of OA significantly. In our study sample, patients with a PHQ-9 
score equal to or above 15 were also found to be significantly less physically 
active than patients with a lower score. Our data cannot explain the causal linkage 
but reflect the bidirectional relationship between physical activity and depression.20 
However, this finding is of importance since moderate physical activity can 
decelerate the progress of OA and is an important target in the non-surgical 
treatment of OA.25 Since depression has been found to be a predictor for the 
success of interventions aiming at increasing physical activity26, our results 
emphasise the importance of the appropriate treatment of depression to increase 
the success of interventions aiming at increasing physical activity, including 
Arthritis Self Management Programs.27
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Prior research has shown that patients with depression tend towards an intensive 
use of the health service, including physician contacts as well as testing.3,4 
Regarding OA, prior research has found depression to be an important predictor of 
the outcome of surgical interventions28. Hopman-Rock and colleagues found the 
chronicity of pain to be the most important predictor for health service utilisation. 
The level of disability and radiological grading was of less importance for visits to 
GPs as well as specialists. Since depression is known to increase pain in OA 
patients2 our findings suggest that depression can work as a catalyser and 
increase HSU. Brandt et al.29, for instance, stated that in patients without 
radiological damage knee pain might be a manifestation of depression rather than 
of a joint disease. However, the economic burden of concomitant depression in OA 
mediated by increased HSU might be underestimated. Interestingly, HSU was 
focused on GPs, specialists and healers. Treatments such as physiotherapy, 
which require patients’ active participation were not used significantly and more 
often by patients with a high PHQ-9 score. 
 
Strengths and weaknesses 
Several limitations of the study should be mentioned. The assessment was cross-
sectional which includes some limitations regarding the association of factors per 
se. We could only assess associations between e.g. depression and QoL, and, of 
course, no causal conclusions could be drawn. Furthermore, some of the data 
regarding HSU were self-reported and could not be confirmed by data from 
patients’ files. The PHQ-9 is a self-administered questionnaire as well, but it has 
proven to be a sensitive and specific instrument to reveal depression in various 
studies.30 To our knowledge, the present study represents the largest assessment 
ever of the impact of depression on QoL and HSU. 
 
Conclusion 
The results emphasise the importance of the awareness of the impact of 
depression on QoL of patients with OA. Prior research has shown that the 
appropriate treatment of concomitant depression can reduce the burden of the 
disease2 and our data suggest that it would also reduce HSU and costs. Tools 
such as the PHQ-9, for instance, represent a valid, easy to use and non-time-
consuming instrument to assess depression. As prior research has shown, 
aggressive treatment can increase QoL of OA patients significantly. Our study 
suggests that this would not only decrease the burden of the disease but would 
also be a promising approach to decrease the high direct and indirect costs of OA. 
4
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Abstract 
Objective: To assess the association of obesity with quality of life, health service 
utilisation and physical activity in a large sample of primary care patients with 
osteoarthritis (OA). 
Methods: Data were retrieved from the PraxArt project, representing a cohort of 
1,021 primary care patients with OA. In 978 patients, height and weight were 
measured and the body mass index (BMI) was calculated. The AIMS2-SF was 
used to assess quality of life (QoL). Data about health service utilisation (HSU) 
were retrieved by means of patients’ medical files. Concomitant depression was 
assessed by means of the Patient Health Questionnaire (PHQ-9). Patients were 
grouped into normal weight, overweight and obese according to the definition of 
the WHO and compared by means of analysis of covariance (ANCOVA).  
Results: Obese and overweight persons achieved significantly higher scores on 
the AIMS2-SF lower body scale, the symptom, the affect and the work scale, 
indicating an increased burden by OA. The PHQ-9 score increased significantly 
over the three weight-groups, indicating a positive association of BMI and 
depression. With increasing BMI, the number of comorbidities increased and 
physical activity decreased significantly. After controlling for covariates, contacts 
with orthopaedics and performed X-rays remained significantly higher in obese 
patients but not contacts with general practitioners.  
Conclusion: The results display a strong association of QoL and BMI, resulting in 
increased use of the health care system. Thus, the study emphasises the need for 
appropriate approaches in primary care to break the vicious circle of overweight, 
depression, decreasing physical activity and decreasing QoL. 
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Background 
The relationship between osteoarthritis (OA) and body weight has been 
recognised for a long time.1,2 Body weight is the strongest influenceable predictor 
of OA. During walking, the body weight is transferred three to six times across the 
knee joint, showing the great influence body weight has for the risk of developing 
OA, especially in the knee. The Chingford study, for instance, showed that for 
every two units increase in body mass index, the odds ratio for developing 
radiographic knee OA increases by the factor 1.36.3 The Framingham study 
revealed a risk reduction of 50% for women to develop symptomatic OA if the body 
weight is reduced by about 5 kilograms.4 Furthermore, prior findings emphasise 
that not only the incidence of OA can be influenced, but also the progress of 
symptomatic OA can be reduced if body weight is reduced.5 Many prior studies 
focused on the association between obesity and OA in an epidemiological sense. 
If quality of life (QoL) was assessed, the studies focused on obese people in the 
general population.6 Patterns of OA due to obesity were also approached7, but 
interestingly less is known about the specific impact of obesity on OA patients 
regarding quality of life, especially in large samples of unselected primary care 
patients.  
This research deficit is astonishing especially with regard to economic aspects: 
direct and indirect costs of OA represent a tremendous burden on the health care 
systems.8 Prior research indicated that these costs could be reduced significantly 
by weight loss: Coggon et al. estimated that nearly a quarter of surgical 
interventions might be avoided if obese people reduced their body weight by at 
least 5 kg or to a normal BMI.9
Against this background, we assessed the hypotheses that the prevalence of 
obesity is increased among OA patients and that the disease specific QoL of 
obese OA patients is significantly reduced compared to OA patients with a normal 
BMI. Furthermore, we hypothesised that obese patients show an increased use of 
the health care system compared to control patients with OA and a normal BMI.  
 
Patients and methods  
The data are extracted from the baseline assessment of the PraxArt project, which 
is financed by the German Ministry for Education and Research over a period of 
six years and which aims to improve the quality of life of patients suffering from 
OA. Data were collected in a large cross-sectional survey including 75 
representative general practitioners (GPs) in the areas of Baden-Wuerttemberg 
and Bavaria, Germany. These GPs created a representative cohort of OA patients 
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to enable a long-time follow-up and the possibility to assess different aspects of 
QoL and received health care. Some of these analyses have been published 
elsewhere.10-12
 
Patient inclusion criteria  
To be eligible for inclusion, patients had to be adult and diagnosed with arthritis in 
the hip or knee according to the criteria of the American college of Rheumatology 
(ACR).13,14 In each of the 75 practices, all patients who visited their GP because of 
complaints related to OA were addressed consecutively until a maximum of 15 
patients per practice was reached. After giving their written informed consent, 
patients received the questionnaire and a return envelope with the postal address 
of the university. All patients were informed that neither the GP nor the practice 
team had any possibility to get knowledge of their answers.  
 
Data collection  
Within the project, GPs were asked to note down all patients who would be eligible 
on a list regardless of whether they agreed to participate or not. This was done in 
order to enable the comparison between responders and non-responders 
regarding sociodemographic characteristics later on. Each patient questionnaire 
was linked to the list with an identification number, so data assessed from patients 
could be checked by comparing them with the patients’ medical files. 
Sociodemographic data (gender, age, educational level, working situation, family 
situation) and the following comorbid conditions were retrieved by means of 
questionnaire: high blood pressure, diabetes, heart insufficiency, coronary vessel 
disease, elevated cholesterol level (defined as total cholesterol > 200 mg/dl), ulcer 
or stomach disease, asthma/COPD, renal insufficiency, cancer and stroke. 
Radiological severity of OA was graded according to the Kellgren and Lawrence 
score.15 The educational level was defined adapted to the German school system 
and according to the years of education: ≤ 7 years: 1; 8-10 years: 2; more then 10 
years: 3. Where applicable, patients’ answers were checked by comparing them 
with the patients’ files. If differences occurred, the data from the medical files were 
used. This procedure was performed to assess accuracy of patients’ self-reported 
data later on in the project. The same procedure was performed regarding 
information about health service utilisation, except for the information of 
complementary and alternative medicine; since these treatments normally do not 
require a prescription or are not a consequence of a referral, they are not recorded 
in the medical file. Depressive disorders were diagnosed using the depression 
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module of the German form of the Patient Health Questionnaire (PHQ-9).16 The 
PHQ-9 is a self-administered questionnaire that permits the diagnosis of major and 
minor depression according to DSM-IV.17 with a cut-off of 15 points to define 
depression according to the recommendations of Kroenke et al.18 Moreover, the 
summarised scale score allows assessing the severity of depression. The PHQ-9 
has proven to be a valid instrument for those assessments.19,20
The impact of OA on patients’ quality of life was assessed by the GERMAN-
AIMS2-SF, which represents a reliable, valid and comprehensive tool. It provides a 
comprehensive assessment of QoL while comprising the dimensions physical 
limitation (divided into upper and lower limb), symptom (reflecting perceived pain), 
social (reflecting social contacts), affect (reflecting mood) and work (reflecting the 
ability to work). It has recently been validated in German in a sample of OA 
patients.21 As suggested in this study, we separated the physical limitation scale of 
the AIMS2-SF in upper body limitation and lower body limitation to increase 
responsiveness. 
To assess physical activity (PA), we used the short form of the International 
Physical Activity Questionnaire (IPAQ).22 The IPAQ was developed by an 
international panel of experts (EUPASS), validated in nine European countries, 
including Germany, and has frequently been used to assess PA in different 
European countries.23 One measure of the volume of activity can be computed by 
weighting each type of activity with its energy requirements defined in Metabolic 
Equivalents (METs) to yield a score in MET-minutes, whereby METs are defined 
as multiples of the resting metabolic rate and a MET-minute is computed by 
multiplying the MET score of an activity by the minutes it is performed for. MET-
minute scores are equivalent to kilocalories for a 60 kilogram person. For vigorous 
physical activity, the total minutes per week were multiplied by factor 8, for 
moderate PA by factor 4, and for walking by factor 3.3. The sum of these three 
products is the MET-min/week. Inactivity is defined as a score below 150 
min/week. Individuals are sufficiently active if they perform (1) a minimum of three 
days of vigorous activity of at least 20 minutes per day, or (2) a minimum of five 
days with PA of moderate intensity or walking of a least 30 minutes per day, or (3) 
a minimum of five days of any combination of walking, moderate or vigorous PA 
accumulating to a total of at least 600 MET-min/week. Individuals are highly active 
if they perform vigorous PA on a minimum of three days accumulating to at least 
1,500 MET-min/week, or seven days of any combination of walking, moderate or 
vigorous PA accumulating to a total of at least 1,500 MET-min/week. Individuals 
who neither meet the criteria for inactivity nor sufficient or high activity are 
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insufficiently active. The PA-status (insufficiently active, sufficiently active, and 
highly active) was defined according to the IPAQ scoring protocol available at 
http://www.ipaq.ik.se. The categories are adjusted to recommendations of the 
centres for disease control (CDC) recommendations.23
Data were analysed with the SPSS program (version 14.0). The BMI was 
calculated on the basis of height and weight, measured after the consultation with 
the GP. The definitions of the certain groups “normal”, “overweight” and “obese” 
were based on the definition of the World Health Organization (WHO). The study 
protocol was approved by the ethics committee of the University of Heidelberg 
previous to the start of the study in January 2005. Inclusion of patients did not start 
unless there was a written and unrestricted positive vote of the ethics committee. 
This vote was received in March 2005 (approval number 021/2005).  
 
Statistical analysis 
All data are reported descriptively. Group comparisons between the three BMI 
groups regarding QoL, health service utilisation and physical activity were made by 
means of analysis of covariance (ANCOVAs). Adjustments were made for 
covariates such as age, disease duration, the radiological grading according to 
Kellgren and Lawrence and number of comorbidities where applicable. 
Dichotomous variables, as for instance comorbidities, were compared by means of 
Chi-square-test. 
 
Results 
Of the 1,250 questionnaires distributed, 1,021 (81.7%) were returned. In 978 
cases, body weight and height were measured by the GPs. 347 (34.0%) of the 
1,021 included patients were male and 674 (66.0%) were female. The comparison 
of patients who returned their questionnaire with the non-responders did not reveal 
significant differences regarding the following characteristics which could be 
retrieved form the medical file: sex, age, duration of OA and number of 
comorbidities as well as number of prescriptions. 278 (80.1%) men and 296 
(43.9%) women were married or lived with a partner. 233 (67.1%) men and 482 
(71.5%) women had completely retired from work. Most of the missing data 
referred to sociodemographic variables and could be completed by means of the 
patients’ medical files. Details about the study sample, separated by BMI, are 
shown in table 1. The displayed p-values are the result of group comparisons 
between the normal weight and the overweight group and between the overweight 
and the obese group. As can be seen, the groups did not differ regarding age and 
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duration of disease. Both the radiological grading according to Kellgren and the 
number of comorbidities increased significantly with an increasing BMI. The 
educational level decreased from normal weighted patients to obese patients.  
 
Table 1.  Baseline characteristics of study sample 
 
 BMI 
 ≤24.9 p* 25-29.9 p* ≥30 
 n  %  n  %  n  % 
Total (978) 251 25.7  402 41.1  325 33.1 
female  180 71.7  255 63.4  208 64.0 
 Mean  SD  Mean SD  Mean  SD 
Age (in years)  66.9 13.33 0.295 68.09 11.12 0.062 66.36 11.23 
Educational level  2.62 1.03 0.039 2.44 0.91 0.033 2.34 0.86 
Duration of OA (in years) 13.41 15.18 0.651 13.95 13.27 0.558 13.40 10.79 
Amount of comorbidities  1.69 1.283 <0.001 2.19 1.73 <0.001 2.72 1.86 
Kellgren score* 2.26 0.68 0.044 2.53 0.92 0.038 2.76 0.77 
* by means of ANCOVA, Chi-Square test respectively for comparison normal vs. overweight and 
overweight vs. obese 
 
Table 2 provides information about the association of patients’ comorbidities and 
the BMI. As can be seen, the prevalence of high blood pressure was significantly 
higher in the overweight group (compared to normal weight; p<0.001) and also 
significantly higher in the obese group than in the overweight group (p=0.002).  
 
Table 2.  Association of comorbidities with obesity (n) 
  
 BMI total 
 ≤24.9 p* 25-29.9 p* ≥30  978 (%) 
High blood pressure 95 <0.001 229 0.002 223 547 (55.9%)
Heart insufficiency 37 0.143 78 0.709 67 182 (18.6%)
Coronary vessel disease 15 <0.001 62 0.838 52 129 (13.2%)
Diabetes 15 <0.001 62 <0.001 93 170 (17.4%)
Cholesterol > 200 86 0.087 143 0.092 131 360 (36.8%)
COPD / Asthma 13 0.212 32 0.005 50 95 (9.7%)
Renal insufficiency 8 0.139 24 0.421 24 56 (5.7%)
(history of) Ulcer (stomach)  59 0.129 75 0.129 76 210 (21.5%)
(prior) Stroke/TIA/PRIND 6 0.083 23 0.076 12 41 (4.2%)
(history of) cancer  8 0.137 13 0.089 14 36 (3.5%)
* ANCOVA, adjusted for age for comparing normal vs. overweight and overweight vs. obese 
 
Similar findings could be revealed for the prevalence of diabetes. Regarding 
coronary vessel disease, only differences between the normal weighted patients 
and the other groups achieved significance but not when we compared overweight 
and obese patients. 21 men and 16 women reported about a history of cancer or 
current cancer disease, significant differences between the groups did not occur. 
 
13
110 Chapter 6 
Regarding OA specific QoL (table 3), differences between overweight and normal-
weight patients were not significant in any dimension, including the PHQ-9 score 
which was used to assess depression. Significant differences occurred in the lower 
body scale, the symptom scale, the affect scale and the PHQ-9 score when the 
BMI surpassed 29.9 m/kg² in comparison to the overweight as well as to the 
normal-weight group. The upper body scale did not differ between the three 
groups, a finding which is most likely due to the study sample that consisted only 
of patients with OA to the knee or hip. Also, there were no significant differences 
between all groups regarding scores of the social scale, which reflects social 
networks and support, and the work scale. However, it has to be acknowledged 
that the work scale was only applicable in 263 cases, since most of the patients 
were already retired. 
 
Table 3.  Impact of BMI on OA related quality of life  
 
 BMI 
  ≤24.9 P* 25-29.9 p* ≥30 
 Mean SD  SD  Mean   Mean SD 
AIMS2-SF scales         
Lower body 2.46 1.97 0.409 2.59 2.014 <0.001 3.31 1.89 
Upper body 1.47 2.35 0.637 1.56 2.43 0.553 1.46 2.02 
Symptom 4.55 2.25 0.158 4.80 2.15 0.029 5.31 2.17 
Affect 2.66 1.31 0.073 2.85 1.27 <0.001 3.22 1.42 
 
Social 4.49 1.83 0.173 4.68 1.80 0.173 4.87 1.86 
PHQ-9 sum score 14.32 4.59 0.165 14.85 4.44 0.002 16.67 4.93 
* by means of ANCOVA, adjusted for age, disease duration, Kellgren and Lawrence-score and number of 
comorbidities for comparing normal vs. overweight and overweight vs. obese 
 
Table 4 displays the comparison of PA between the three weight groups by means 
of ANCOVA (adjusted for age, disease duration and comorbidities). As can be 
seen, PA decreased significantly from patients with normal weight to overweight 
and to obese patients.  
 
Table 4. Physical activity according to IPAQ scoring, separated by BMI 
 
 ≤24.9  25-29.9  ≥30 
N 251 (25.7%) p* 402 (41.1 %) p* 325 (33.1%) 
IPAQ-scoring Mean SD  Mean  SD  Mean SD 
Vigorous activity (min/week) 121.3  (169.1) 0.001 101.2  (155.9) 0.007 70.1 (113.4) 
Moderate (min/week) 137.8 (158.2) 0.004 112.8 (147.2) 0.001 94.2  (117.9) 
Walking 275.8 (284.8) 0.002 249.9 (271.8) 0.009 242.5 (238.2) 
Sitting 2139.2 (879.5) 0.003 2088.1 (855.5) 0.004 2031.9 (977.9) 
Total 2674.1 (1959.5) 0.002 2552.0 (1921.5) 0.005 2438.7 (1799.2)
Activity group (%)  
Insufficiently active 126 40.1 0.003 202 50.2 0.008 228 70.1 
Sufficiently active 109 43.4 0.067 176 43,8 0.079 89 27.4 
Highly active 16 6.3 0.042 24 5.9 0.039 9 2.8 
* by means of ANCOVA, adjusted for age, disease duration, Kellgren and Lawrence-score and number of 
comorbidities for comparing normal vs. overweight and overweight vs. obese 
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The health service utilisation (HSU) patterns of the study sample are displayed in 
table 5. In unadjusted analysis, visits to GPs increased significantly with the BMI. 
Since visits to GPs may often be related to other reasons than OA, we adjusted 
the ANCOVA for comorbidities (as displayed in table 5). Interestingly, the 
significant difference between normal-weight and overweight patients faded. 
However, the difference between obese and normal-weight patients remained 
significant (p=0.002) even after adjusting for the number of comorbidities. Visits to 
orthopaedics as well as performed X-rays remained associated significantly with 
the BMI after adjustment. 
 
Table 5.  Health service utilization according to BMI 
 
 ≤24.9 p* 25-29.9 p* ≥30 
 Mean SD  Mean SD  Mean SD 
Contacts with GPs 5.56 9.73 0.059 4.46 5.73 0.051 5.43 7.81
Contacts with Orthopaedics 1.51 2.78 0.049 1.70 2.95 0.001 2.26 4.72
Use of complementary and alternative medicine 0.69 4.99 0.567 0.23 1.47 0.098 0.06 0.66
Use of  Physiotherapy 5.36 8.82 0.478 6.97 12.75 0.081 7.78 13.06
Performed X-rays 0.62 3.02 0.003 0.83 3.67 0.002 1.01 4.10
* by means of ANCOVA, adjusted for age, disease duration, Kellgren and Lawrence-score and number of 
comorbidities for comparing normal vs. overweight and overweight vs. obese  
 
Discussion 
The findings of our study suggest an increased prevalence of overweight and 
obesity among primary care patients with OA. Furthermore, the burden of OA 
increased with the BMI and thus confirmed our hypothesis that QoL of OA patients 
is inversely correlated with the BMI. QoL of patients with OA is mainly determined 
by pain and physical disability. As our results show, pain as well as physical 
disability increased with patients’ weight. In respect to QoL, patients with OA can 
be compared to primary care patients in general: as Sach et al. assessed health 
related quality of life (HRQL) with three different instruments, the EQ-5D, the EQ-
VAS and the SF-6D and also found obesity to be associated with lower HRQL.24
Bramlage et al. found a prevalence of 37.9% of overweight persons and 19.4% of 
obese persons among all primary care attendees in Germany.25 Rates of 
overweight/obesity increased steadily with the number of comorbid conditions and 
were highest in patients with diabetes (43.6/36.7%) and hypertension 
(46.1/31.3%), followed by patients with cardiovascular disorders. With 41.1% 
overweight and 33.1% obese patients, the prevalence rates we found in patients 
with OA are significantly higher. Similar results in a cross-sectional study were 
found by Wannamethee et al. who showed that the prevalence of CV risk factors 
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and morbidity, disability and medication use increased significantly with increasing 
overweight.  
Obese patients were more likely to be referred to a specialist and received 
significantly more X-rays than non-obese OA patients. Regarding encounters with 
GPs, the initially significant difference disappeared after adjusting for the number 
of comorbidities. It can be discussed if this adjustment is appropriate since many 
of the comorbidities were associated with obesity. However, the focus of this study 
was OA-related HSU. Nevertheless, the revealed HSU patterns are in line with 
other findings showing that increase in body weight is associated with increase in 
medical care costs compared to weight maintenance.26
The positive effects of PA on the QoL and well-being, but also on the course as 
well as on the symptoms of OA, has been shown in multiple studies.27 Especially 
for patients with OA in the knee, strengthening the musculus quadriceps femoris 
can reduce pain and slow down the progress of OA most probably mediated by 
increased stability to the joint.28,29 Even though a causality cannot be assessed 
due to the cross-sectional design of the study, our results, showing that obese OA 
patients have a significantly reduced level of physical activity, emphasise the need 
for lifestyle counselling.30
Obese patients in our study were significantly more limited in functional disability 
than non-obese patients. This finding may be due to two different reasons: first of 
all, the findings regarding perceived pain suggest that these patients simply suffer 
from more pain that limits functional ability. Secondly, muscle strength, especially 
the musculus quadriceps femoris has been shown to be of great importance for 
the stability of the knee and the incidence, progress and symptoms of OA. As 
Zoico et al. could show, a high BMI and high body fat were associated with greater 
probability of functional limitation.31 The skeletal muscle index (SMI) was the 
strongest predictor for functional disability of patients (without OA).  
Prior research has shown that the prevalence of depression and depressive mood 
among OA patients is increased compared to the normal population of the same 
age.20 Physical limitation (especially to the lower body), pain and social contacts 
were revealed as most important predictors for a clinically relevant depressive 
disorder (minor or major depression). Interestingly, being overweight was not 
associated with a higher PHQ-9 score (compared to normal weight), but obesity 
was. This is an important finding since prior research showed that there is some 
kind of bidirectional relationship between functional disability and depression: 
although functional disability can lead to depression, depression has a detrimental 
effect on physical mobility.32  
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The association between obesity and depression has been assessed in a number 
of studies, including longitudinal studies. Results suggest that obesity predicts 
later depression.33 Our data, showing that obese patients have significantly higher 
PHQ-9 scores, are in line with these findings.  
Some weaknesses of our study have to be acknowledged: our data are not able to 
assess causality of the association between QoL, physical activity and the BMI. 
But they confirm the relationship in a large sample of primary care patients and 
emphasise the influence of obesity on QoL, PA and HSU. Despite the study’s 
weaknesses, to our knowledge, it is the largest study assessing the association of 
BMI, QoL and HSU in primary care patients with OA so far. 
 
Conclusion 
It has been known for a long time that obesity is the strongest modifiable risk factor 
for OA and recent research has also shown that the association with the waist 
circumference is similar.34
Prior research has shown that GPs’ management of overweight and obesity is 
largely deficient, predominantly due to four interrelated factors: (1) doctors' poor 
recognition of patients' weight status, (2) doctors' inefficient efforts at intervention, 
(3) patients' poor acceptance of such interventions and (4) dissatisfaction with 
existing lifestyle modification strategies. Counselling patients to change their 
lifestyle is a huge challenge, but it has to be the first approach to OA, according to 
all guidelines. Recent studies suggested that more intense approaches such as 
telephone monitoring can increase the effect of PA counselling in primary care.10,35 
Evidence-based concepts such as the “5A-approach”, which originally has been 
developed for smoking cessation, need to be implemented in the counselling 
strategy for OA.36 Our study underlines the need to break the vicious circle of 
increase in body weight, decrease of physical activity, increase in OA related pain 
and depression. More research is needed to provide evidence-based lifestyle 
counselling programs for physicians, especially the GP, who in most cases, is the 
main care provider for patients with OA.  
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Abstract 
Objective: Pain represents one of the most important predictors of quality of life in 
patients with osteoarthritis (OA). Prior studies were conducted in hospital settings 
and /or failed to control such important factors as depression, obesity or physical 
activity. Therefore, the aim of the study was to determine factors associated with 
pain intensity in a large sample of OA patients in primary care. 
Design: A cross-sectional survey with a questionnaire containing sociodemogra-
phic data, the short form of the Arthritis Impact Measurement Scale (AIMS2-SF), 
and the Patient Health questionnaire (PHQ-9) to assess concomitant depression. 
A hierarchical stepwise multiple regression analysis with the AIMS2-SF dimension 
“symptom” reflecting patients’ pain intensity as the dependent variable was 
performed. 
Patients: 1,021 patients from 75 primary care practices.  
Results: In the regression model 4 factors remained explaining 47.9 % of the 
variation in the dependent variable (p<0.0001): severity of depression, reflected in 
the PHQ-9 score, influences pain intensity the most (beta = 0.459, p<0.001). 
Functional disability of the lower limb accounted for a beta of 0.427 (p=0.003). A 
low educational level was associated with increased pain scores (beta=-0.321; 
p=0.029) as was disease duration (beta=0.178; p=0.017). Social 
contacts/networks, addressed by the AIMS social scale, accounted for a beta of 
0.211 (p=0.040).  
Conclusion: A variety of physical and psychological factors was associated with 
pain intensity. Appropriate pain treatment of OA patients in primary care should 
consider as many of these factors as possible. Further research is needed to 
assess if a more comprehensive and proactive approach will result in less pain 
and in increased quality of life.  
22
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Introduction  
Osteoarthritis (OA) is highly prevalent in the general population and its prevalence 
is expected to increase further in the upcoming years. Increasing life expectancy 
and obesity as well as decreasing physical activity are the main reasons for this 
trend.1 OA not only leads to disability, it is also often associated with pain and 
decreased quality of life.2 The majority of OA patients is treated in primary care, 
but recent research indicated that this care needs to be improved.3  
Assessment of OA patients’ pain intensity in daily practice is associated with 
several problems. Firstly, the correlation between radiographic changes and 
reported pain is weak.4,5 Obviously, the degrees of pain and disability vary widely 
in subjects with the same degree of pathomorphological damage to the joint, and 
thus radiological damages are a poor predictor for patients’ pain. Secondly, prior 
studies revealed multiple factors that are associated with pain intensity: some of 
them found sociodemographic factors such as age, gender and marital status to 
be important variables.6,7 Others emphasised disease characteristics such as the 
duration of the disease, the body mass index (BMI) and accompanying 
comorbidities as important factors.8,9 Moreover, patients with OA seem – as many 
chronically ill – to be prone to depression and depressed mood.10 Therefore, some 
studies focused on the complex relation between chronic disease, depression or 
depressed mood and perceived pain in OA.11-14
In addition to these internal characteristics, external factors such as an intact 
social network, which provides social support, contribute substantially to the 
coping with pain.15 This has already been assessed in intervention studies 
showing that  involvement of the spouse in arthritis self-management programs 
increases the success of such programs.16
Obviously, many factors influence the perception of pain in arthritis17,18 and 
interestingly, more studies focused on patients with rheumatoid arthritis than on 
patients with OA, even though the prevalence of OA is much higher. If OA patients 
were assessed, sample sizes were small and important factors which could 
influence pain, such as obesity, physical activity, disease duration and radiological 
severity were not controlled.9,19-22 As a consequence of the current research, 
Dieppe et al. recently stated in The Lancet: “The associations and pathogenesis of 
pain are in as much need of investigation as joint damage”.18 And Craemer et al. 
suggested that studies aiming to explore pain among OA patients should define 
how pain is identified, differentiate community and hospital subjects and control for 
other factors potentially associated with pain: obesity, comorbidity, muscle 
weakness and physical fitness.11 Consequently, the aim of this study was to 
23
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assess a wide range of factors which could be associated with pain intensity in a 
large sample of OA patients in primary care and to reveal their contribution to pain 
intensity. The prevalence of knee and hip OA differs between genders, and 
women frequently achieve higher scores on instruments assessing pain.20,23 
Therefore, we hypothesised that factors associated with pain intensity differ 
according to gender.  
 
Methods 
The data used for this study are retrieved from the baseline assessment of the 
PraxArt project [ISRCTN87252339]. The project is financed by the German 
Ministry for Education and Research over a period of six years starting in 2003 
(grant number 01GK0301) and comprises data from a representative sample of 75 
general practitioners’ (GPs) practices in the areas of Baden-Wuerttemberg and 
Bavaria. The aim is to learn about patients’ needs, provided care and to develop 
tailored multifaceted interventions in order to increase quality of life.24
 
Patient inclusion criteria  
To be eligible for inclusion patients had to be 18 or older and diagnosed with 
arthritis to the hip or the knee according to the ACR criteria.25 In every practice, 15 
patients were contacted in consecutive order of appearance in the practice, and if 
the reason for the current encounter was related to OA, they were informed about 
the option to participate in the study.  
 
Data collection  
After giving their written informed consent, patients received a package of 
questionnaires which they were asked to return to the university either by returning 
it using an enclosed stamped envelope or by putting it in a sealed box at their GPs 
practice. Neither the GP nor the practice team had the possibility to get knowledge 
of the patients’ answers. Patients received written reminders from the university, 
but were also reminded by their GP to return the questionnaires. 
Each questionnaire was linked to the participants list with an identification number, 
so data provided by the patients could be checked by comparing them with their 
medical files. If differences occurred, the data from the medical file were used for 
further analysis. This procedure was applied to assess reliability of patients’ 
answers later on in the project. Since GPs were also asked to record patients who 
denied participation, it was possible to compare the non-responders to the 
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participants with regard to most sociodemographic variables, comorbidities and 
medication. 
 
Demographics 
Sociodemographic data regarding sex, age, educational level (defined as follows: 
1 ≤ elementary school; 2=high school; 3 ≥ college degree), working situation 
(1=unemployed or retired, 2=part-time job, 3= full-time job), partnership (1= living 
alone, 2= married/living with partner) were collected.  
 
Comorbidities 
Based on prevalence and clinical relevance in the observed age group, the 
following ten comorbid conditions were controlled: high blood pressure 
(HBP:RR>140/90 mmHg), diabetes, heart insufficiency (HI), coronary heart 
disease (CHD), elevated cholesterol level (defined as total Cholesterol > 200 
mg/dl), ulcer or stomach disease, asthma/chronic obstructive pulmonary disease 
(COPD), renal insufficiency, cancer and stroke.  
 
Depressive disorders  
Since depressive disorders were found to be associated with pain intensity26, we 
assessed severity of depression by means of the depression module of the 
German form of the Patient Health Questionnaire (PHQ-9).27 The PHQ-9 is a self-
administered questionnaire used to diagnose major depression and minor 
depression according to DSM-IV and to assess severity of depression.28,29 The 
PHQ-9 has proven to be a valid instrument for those assessments.30,31  
 
Quality of Life 
The most widespread instrument to assess QoL among OA patients is the AIMS, 
available also in a revised short form, the AIMS2-SF.32-34 It represents a reliable, 
valid and comprehensive tool and has recently been validated in German in a 
sample of OA patients.33,35 It covers the five dimensions physical limitation (divided 
in upper limb and lower limb), affect, social, work and symptom. The symptom 
scale addresses pain intensity in 4 items and has frequently been used to assess 
pain in intervention trials, including surgical interventions.20,36 The social scale is 
defined as reflecting patients’ social interactions and network. It contains 4 items 
asking about the frequency of personal contacts with friends and relatives 
(including phone contacts) but also if relatives and friends are sensitive to the 
individuals’ needs. The affect scale reflects patients’ mood without assessing 
5
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depression as an outstanding disease. The work scale is applicable only to 
patients who are not retired since it assesses restrictions in daily work caused by 
OA. Scale internal validity and reliability for all scales is excellent.35  
 
Physical activity 
Prior studies have shown that the strength of Musculus quadriceps femoris 
contributes to the course of the disease as well as to the perceived pain.37 Due to 
the large sample size it was not possible to assess individuals’ muscle strength, 
but as suggested by Creamer et al., we decided to examine physical activity by 
means of the International Physical Activity Questionnaire (IPAQ). The IPAQ was 
developed by an international panel of experts (EUPASS) and validated in nine 
European countries, including Germany. It has frequently been used to assess 
physical activity in different countries.38,39 The purpose of the International Physical 
Activity Questionnaire (IPAQ) is to provide a set of well-developed instruments that 
can be used internationally to obtain comparable estimates of physical activity. It 
was considered to be the most advanced international approach to assess type of 
activity, frequency, duration and intensity of physical activity at a population level. 
The physical activity (PA) status (insufficiently active, sufficiently active and highly 
active) was calculated according to the recently revised scoring protocol following 
the recommendations of the IPAQ Executive Committee for the 7-days short-
version, available at www.ipaq.ki.se. The PA categories are adjusted to 
recommendations of the CDC recommendations.40
 
Radiographic severity 
Severity of radiographic changes were classified according to Kellgren et al.41
 
Data Analysis  
The data were transferred into the SPSS program (version 12.0). First of all, 
descriptive analyses were undertaken for all variables, separated by gender. 
Continuous variables were reported using mean, standard deviation (SD) and t-
tests for group comparisons. For dichotomous variables, absolute numbers and 
percentages were displayed, and gender comparisons were made using the 
Mann-Whitney U test. Differences between genders regarding dimensions of 
quality of life (assessed by means of AIMS2-SF) were assessed by means of 
ANOVAs (ANCOVAs) adjusted for BMI, disease duration, age, number of 
comorbidities and depression (PHQ-9 score) and a post hoc Bonferroni correction 
was performed to avoid bias of multiple testing. Prior to the regression analysis a 
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correlation analysis, by means of calculating Pearson’s r was performed. The 
dependent variable of the regression was the symptom scale of the AIMS2-SF. 
Factors entered into the regression model were chosen according to the achieved 
significance in the correlation analysis (p ≤ 0.05). To assess predictors, different 
types of multiple linear regression models are available. We chose a hierarchical 
stepwise technique with sociodemographic variables entered in the first block and 
disease characteristics entered in the second block.  
 
Results 
Overall, 1,250 questionnaires were distributed to patients of which 1,021 (81.68%) 
were returned and analysed. As far as data were available in patient files, the non-
respondents were compared to the respondents. Regarding important socio-
demographic variables (age, gender) as well as the available disease 
characteristics (duration of disease, no. of comorbidities, health service utilisation 
and prescription of pain relievers), both groups did not differ significantly. Over 
90% of the enrolled patients were Caucasian. If missing data occurred, they mainly 
occurred within the same questionnaire, in total in 271 of the 1,021 questionnaires. 
In 123 cases the data could be completed from the patient file. A radiological 
scoring according to Kellgren was only available in 735 (72%) cases.  
Table 1 displays the characteristics of the study sample separated by gender.  
7
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Table 1.  Characteristics of the study sample separated by gender (n=1021)  
 
Gender 
Male (347/34.0%) Female (674/66.0%) 
 
mean SD/% mean SD/% 
Age 65.16 14.75 66.64 15.33 
Duration of OA (years) 14.80 16.18 13.13 11.09 
Body mass index (BMI)  28.39 4.26 28.12 5.16 
No. of comorbid conditions (0-10) 2.20 1.81 2.24 1.65 
Educational Level (1-3)**  2.61 1.11 2.38 0.83 
Married/Living in partnership** 278 80.1 (%) 376 55.8(%) 
retired 233  67.1(%) 482  71.5(%) 
Radiographic severity (Kellgren score)*  2.76 0.92 2.53 0.77 
IPAQ score (MET/week) 2356.2 (1982.5) 2108.3 (1879.6) 
Quality of life (AIMS2-SF dimensions) #:     
Lower body ** 2.39 1.71 2.98 2.08 
Upper body 1.38 2.33 1.54 2.22 
Symptom ** 4.49 2.17 5.12 2.18 
Affect ** 2.60 1.28 3.10 1.36 
Work * (126 women / 89 men) 3.08 2.67 2.34 2.23 
Comorbidities  Total % Total % 
High blood pressure** 181 52.1 384 56.9 
Elevated cholesterol 124 35.7 245 36.3 
Diabetes 57 16.4 120 17.8 
Heart Insufficiency 63 18.1 131 19.4 
CVD 62 17.8 70 10.3 
Ulcer/Gastritis 77 22.1 146 21.6 
Asthma/COPD 34 9.8 64 9.5 
Renal Insufficiency 23 6.6 33 4.9 
Cancer 21 6.1 16 2.4 
Stroke 16 4.6 30 4.4 
p <0.05; ** p < 0.01 in group comparison (t-test, Mann-Withney U test, respectively); # by means of 
ANCOVA adjusted adjusted for BMI; disease duration, age, number of comorbidities and (PHQ-9 score)  
 
As can be seen, 347 (34.0%) of the 1,021 included patients were male and 674 
(66.0%) were female. 233 (67.1%) men and 482 (71.5%) women had retired from 
work. Significantly more men than women were married or lived with a partner. A 
significant difference in the (formal) educational level was revealed in group 
comparison. BMI, age, number of comorbidities and disease duration did not differ 
significantly between genders. Regarding comorbidities, more than half of the 
included patients suffered from HBP, men significantly more frequently than 
women. Cardiovascular diseases were the most frequent comorbidity: heart 
insufficiency (18.1% of men and 19.4% of women) and CVD (17.8% of men and 
10.3% of women) were much more common than stroke (4.6% men vs. 4.4% in 
women).  
 
Table 2 displays the bivariate correlation analyses with the symptom scale. 
Significant correlations (p<0.01) occurred in the sociodemographic variables 
gender, education and marital status, but Pearson’s r for all correlations was quite 
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low (-0.111-0.210) indicating only weak correlations. Since most of the patients had 
already retired from work, the work scale of the AIMS2-SF was also excluded from further 
analyses. Notable high values for Pearsons’ r were revealed in the lower body scale, the 
upper body scale and the PHQ-9 sum score as well as in the affect scale.  
 
Table 2.  Correlations of patients’ demographic and clinical variables with the symptom scale of 
AIMS2-SF 
 
   Symptom scale Pearson r  Significance 
Gender** 0.210 0.021 
Age 0.012 0.372 
Educational level** -0.142 0.009 
Marital status* -0.111 0.045 
Disease duration** 0.189 0.004 
BMI** 0.182 0.009 
Kellgren score* 0.388 0.007 
IPAQ score (MET/week)* 0.125 0.044 
No. of comorbidities** 0.202 0.009 
PHQ-9 sum score** 0.439 0.010 
Lower body 0.551 0.009 
Upper body 0.437 0.008 
Affect 0.471 0.002 
Social 0.119 0.007 
AIMS2-SF scales 
Work 0.322 0.009 
level of significance: *p<0.05; **p<0.01;  
 
The BMI showed only a weak correlation, as did disease duration. Nearly all variables 
showed significant correlations, but the size of the correlation was notable only for 
the AIMS2-SF affect-scale (r=0.678; p<0.001), the symptom scale representing 
pain intensity (r=0.442; p<0.001) and the lower body limitation scale (r=4.36; 
p<0.001). 
Except age, which achieved no statistical significance in the bivariate correlation 
analysis, and the Kellgren score, which was not available for all patients, all factors 
mentioned in table 2 were entered in the final regression model. Table 3 displays 
the results of the hierarchical stepwise regression with the symptom scale of the 
AIMS2-SF as the dependent variable. The adjusted R² of 0.465 indicates that the 
remaining factors are able to explain nearly half of the variance in the dependent 
variable. Four factors finally remained: the affect scale of the AIMS2-SF, assessing 
patients’ mood, was the strongest predictor for pain with a beta of 0.459 (p<0.001), 
followed by the lower body scale of the AIMS, reflecting the physical limitation to 
the lower limb (beta=0.427; p=0.003). A higher educational level was associated 
with less pain intensity, as the negative algebraic sign indicates (beta=-0.321; 
p=0.034). A better social network (resulting in lower scores of the social scale) 
also predicted less perception of pain (beta=0.211; p=0.042). Interestingly, the 
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PHQ-9 score did not remain in the final model. It was excluded in the last step of 
the model (beta=0.129; p=0.223) after the variable “disease duration” (beta=0.118; 
p=0.111). The adjusted R² of 0.465 indicates that the remaining factors are able to 
explain nearly half of the variance in the dependent variable. 
 
Table 3. Predictors of pain assessed by stepwise multiple regression model 
 
Dependent: symptom 
Unadjusted R² = 0.479  
Adjusted R²= 0.465  
F= 18.233; p<0.0001 B SE 
Change 
in R² p 
Affect* 0.459 0.114 0.147 <0.001 
Lower body* 0.427 0.108 0.137 0.003 
Educational level -0.321 0.141 0.062 0.034 
Social* 0.211 0.1.07 0.081 0.042 
* AIMS2-SF scale 
 
Discussion 
Depressed mood, physical limitation to the lower limb, educational level, and social 
contacts are the most important factors associated with pain perception of patients 
suffering from osteoarthritis to the knee or hip.  
With respect to these factors, the finding that depression is associated with 
increased pain intensity in patients suffering from musculoskeletal disorders has 
been known for a long time.9,42,43 Tsai et al., for instance, performed a path 
analysis aiming to explain depression in OA patients: pain, disability and social 
support remained in the final model. Contrary to their initial hypothesised model 
and similar to our findings, gender and age did not remain in the final model. The 
revealed association between physical limitation and pain is most likely 
bidirectional, so our results emphasise again the strong impact of physical 
limitation on perceived pain.44,45 The patients in our sample suffered mainly from 
OA to the hip or knee. Therefore, we used the GERMAN-AIMS2-SF with a 
separated assessment of upper and lower limb, as suggested in the validation 
study previously conducted by this study group.35
The fact that the educational level remained as a predictor in the regression model 
is in accordance with our assumptions, and confirms previous findings 
emphasising the importance of education for coping strategies and managing daily 
live in chronic diseases.14 Furthermore, a low educational level has been found to 
be associated with both radiographic as well as symptomatic knee OA.46 However, 
it has to be considered that many factors such as different working situations or 
access to health care can mediate the association between education and 
perceived pain.11 The social scale of the AIMS2-SF addresses patients’ social 
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contacts and social support. Since several studies have pointed to the importance 
of the social network for coping with chronic diseases and especially with pain, our 
results confirm prior findings in a large sample of primary care patients.12,15,47 So, 
interventions aiming at social support by simple monthly telephone calls48 or 
spouse assistance have shown to improve patients’ QoL.  
As already mentioned, none of the previous studies assessed such a large variety 
of factors that might be involved in pain in OA patients, such as e.g. the BMI, 
physical activity, depression, localisation of OA. Furthermore, if assessing OA 
patients, they enrolled only a small number of patients.11 Due to this, comparisons 
between our results and previous studies are only possible to a limited extent. For 
instance, Thumboo and colleagues conducted a comparable survey among 126 
Chinese patients.7 Additional to Chinese ethnicity, work and education, age and 
disease duration were predictors for pain intensity: a result we could not confirm. 
However, they defined disease duration as the time period since the first physical 
limitation occurred whereas we defined it starting from when OA was first 
diagnosed. In addition, it can be assumed that the social network of most Chinese 
people as well as the accessibility to health care differs completely from the 
situation in Germany. Nevertheless, our results are not conflictive to previous 
findings: age, sex, marital and socioeconomic status, duration of disease, BMI, 
amount of chronic diseases, social support and psychosocial factors have been 
revealed as important influences on pain in prior studies.  
Some weaknesses of the study have to be noted. Firstly, we failed to control for 
individuals’ catastrophising, which has been found to be of great importance for 
the coping with pain. 49 Although it is known that catastrophising is also associated 
with factors we controlled, as, e.g., depression and mood, this limits our findings. 
Secondly, the radiological severity was not available for all patients. Nevertheless, 
the strength of this study is that a wide variety of factors which have been shown 
to be associated with pain singularly or in combination has been assessed within 
one study. Furthermore, results from hospital-based examinations cannot easily be 
transferred to the general population. With over 1,000 patients from 75 solo 
practices this study enrolled about five times more patients than prior studies 
assessing pain in OA patients.   
Pain is an important target in the treatment of OA.50 It has not only substantial 
impact on patients’ QoL, it is also associated with further complications such as 
the risk of falls among women.51,52 Currently, pain treatment – especially in primary 
care – focuses on pharmacological treatment, but NSAIDs and opioids are 
associated with multiple problems, especially in older patients with various 
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morbidities.53 Therefore, inadequate pain treatment cannot only cause avoidable 
impact of OA on patients QoL, it can also be a source of high secondary costs.54 A 
variety of physical and psychosocial factors was associated with pain intensity in 
the present sample. It is indispensable to aim at all targets in order to relieve 
patients’ perceived pain, to reduce the risk of side effects of pharmacological 
treatments and to increase QoL. We think that current care for OA patients should 
include awareness for psychosocial stress and depression. Current research 
shows that pain treatment in primary care often misses these targets and needs to 
be improved.3 The event-driven, reactive approach in pain treatment applied 
nowadays should be replaced by a more proactive approach acknowledging these 
factors. Our results should encourage assessing the effect of more complex 
approaches in randomised trials.  
32
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Abstract 
Background: Osteoarthritis (OA) has a high prevalence in primary care. Patient 
satisfaction is an important indicator for the quality of care provided to OA patients. 
Little is known about satisfaction of patients with this condition in a primary care 
setting in Germany. The aim of the study was to assess current satisfaction of 
patients and reveal possible disease and quality of life related predictors. 
Methods/Design: 75 German GPs approached 1,250 patients with OA 
consecutively. Sociodemographics, OA-specific quality of life (GERMAN-AIMS2-
SF), comorbidities and depression (using PHQ-9) were assessed. Patient 
satisfaction was measured by means of the EUROPEP instrument. A stepwise 
linear regression analysis with the EUROPEP score as dependent variable 
controlled for the amount of GP visits was performed to assess predictors of 
satisfaction. 
Results: 1,021 OA patients returned the questionnaire. The adjusted R² of the 
final model was 0.270 (p<0.001). Beside the duration of OA, no disease related 
factor was associated with patient satisfaction: Main predictors were the PHQ-9 
score (beta=-0.372; p<0.001), age (beta=-0.185; p<0.001), living alone (beta=-
0.209; p<0.001), number of comorbidities (beta=-0.152; p<0.001), duration of OA 
(beta=-0.105; p=0.008). 
Discussion: The finding that depression and social factors are more important for 
patient satisfaction with provided care than disease related aspects suggests that 
these factors need to be considered carefully in treatment. This represents a big 
challenge within an increasingly specialised healthcare system. The general 
practitioner as the regular and first-choice provider of health care seems to be the 
most appropriate instance who can accomplish that.  
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Background 
In recent years, sensitivity to the patients’ perspective on the provided care has 
increased. Physicians as well as policy makers have recognised that meeting the 
patients’ needs and priorities is an important indicator for the quality of care 
provided to patients. Since they also contain important information to improve the 
quality of care, several instruments have been developed to assess patients’ 
perspectives on provided care, mostly conceptualised as patient satisfaction. But 
health care systems across Europe vary widely in terms of practice organisation, 
role of the GP and accessibility of the health care system; in Germany, for 
example, most practices are single practices. To allow comparisons across the 
systems, it is important to have an instrument that can be used in different 
settings. The EUROPEP has been developed by the EQuiP task force on Patient 
Evaluations of General Practice Care to satisfy these needs.1 It is currently the 
most widespread instrument to assess patient satisfaction with care in general 
practice. So far, researchers focused mainly on assessing patient satisfaction and 
comparing data of different countries.1,2 Other studies aimed to reveal factors 
associated with the practice, e.g. practice size, number of GPs, or GPs’ working 
hours, which have shown to influence patient satisfaction.3,4 Regarding specific 
chronic diseases, only a few studies have assessed patient satisfaction and if, 
they focused on process parameters: Nau et al., for instance, found more frequent 
HbA1c monitoring as well as foot exams and counseling to be associated with 
higher satisfaction in diabetes patients.5
Osteoarthritis is a chronic condition with a high and still increasing prevalence in 
western countries and frequently associated with pain and disability.6,7 
Consequently, the WHO has declared the current decade as “bone and joint 
decade”.8 The main care provider for OA patients is the GP. The aim of our study 
was to assess the extent of patient satisfaction with care provided by their GP and 
to reveal predictors of satisfaction in patients with OA. We hypothesised that 
patient satisfaction is associated with OA-specific quality of life.  
 
Methods 
Study design 
The data reported in this study were retrieved from the PraxArt project, a project 
conducted in primary care in Germany. This project aims to improve the quality of 
care which results in improved quality of life of primary care patients suffering from 
OA. Therefore, a large cohort of primary care patients with OA was created and 
frequent follow-ups as well as intervention trials are performed within this cohort.9 
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The presented data are retrieved from the baseline assessment. Initially, about 
500 GPs in the areas of Baden-Wuerttemberg and Bavaria, who fulfilled the 
inclusion criteria, were invited by a formal letter of the Department of General 
Practice and Health Services Research of the University Heidelberg to participate 
in the study. A representative sample of 75 GPs was finally included. All GPs had 
a contract with all of Germany’s health insurancers, which assured that patients of 
all social levels had unlimited admission to the practice.  
 
Patient inclusion criteria  
To be eligible for inclusion patients had to be adult and diagnosed with arthritis to 
the hip or to the knee according to the ACR criteria.10,11 Patients were addressed 
by the participating GPs in consecutive order of appearance in the practice and 
informed about the option to participate in the project. After giving their written 
informed consent, they received the questionnaire and a return envelope with the 
postal address of the university to ensure that neither the GP nor the practice team 
had any possibility to get knowledge of the patients’ answers. Reminders were 
sent out twice, and additionally the GPs reminded the patients to return the 
questionnaires without knowing who had already returned it. 
 
Instruments 
To assess patient satisfaction with the GP and the medical practice, we used the 
internationally standardised and validated EUROPEP (European Task Force on 
Patient Evaluations of General Practice) questionnaire.1,12 After being tested in an 
international validation study, the EUROPEP became the most widespread 
instrument to assess patient satisfaction.1 The questionnaire contains 23 items 
relating to specific aspects of family practice during the past 12 months allowing 
patients themselves to evaluate the quality of care they have received. The 
patients respond to each item on a five point Likert scale (1 = “poor”, 5 = 
“excellent”). The questionnaire covers two dimensions of care: a general 
practitioner evaluation (communication, technical aspects and information giving; 
items 1-17) and a general practice evaluation (items 18-23).1 The EUROPEP 
usually achieves high response rates, so that missing values are rare. In the cross 
European validation study, the internal consistency achieved a value of 0.96 for 
items 1-16 and 0.87 for items 17-23. As in the other studies, we calculated the 
percentage of patients rating the item under consideration as “excellent” or “good”. 
Since we focused on satisfaction with the GP, the correlations as well as the 
regression analysis were performed with the sum score of the items 1-17.    
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Other measures  
A large number of further data were addressed within the PraxArt project.9 GPs 
created a list of all addressed patients which was linked with the medical file. Due 
to this list, an analysis of non-respondents regarding sociodemographics (sex, 
age, educational level ranging from 1 (no school degree) to 5 (university degree), 
working situation, family situation as well as duration of OA, comorbidities, 
prescriptions and health service utilisation was possible. In addition to the 
EUROPEP instrument, the patient questionnaires comprised a number of other 
instruments including the GERMAN-AIMS2-SF13 and the PHQ-9. The AIMS2-SF is 
one of the most widespread instruments to assess the OA-specific quality of life.13 
The PHQ-9 was used to address severity of depression; it is a sensitive and 
specific instrument to assess severity of depression, especially for screening 
purposes in a primary care setting.14,15
Patients were asked about comorbidities (high blood pressure, diabetes, heart 
insufficiency, coronary heart disease, elevated cholesterol level, ulcer or stomach 
disease, asthma/chronic obstructive pulmonary disease (COPD), kidney disease, 
cancer and stroke) as well as about health service utilisation (GP contacts, 
contacts with orthopaedics, use of complementary and alternative medicine and all 
OA-related treatments as injections, physiotherapy, etc. To assess accuracy and 
reliability of patients’ answers later on in the project, patients’ answers were 
checked by comparing them with the medical file as far as possible. If differences 
occurred, the data of the medical file were used.  
 
Data analysis   
Patients’ information on medication and health care utilisation were checked by 
three research assistants, visiting each medical practice. The study protocol was 
approved by the ethics committee of the University Hospital Heidelberg. 
 
Statistical analysis  
The data were transferred into the SPSS program (version 14.0). Mean and 
standard deviation are provided for the scores of the 23 items of the EUROPEP. 
Spearmans’ rho was calculated in order to assess correlation of the EUROPEP 
sum-score of items 1-17 (satisfaction with GPs) with sociodemographics, disease 
characteristics and disease-specific quality of life. A stepwise linear regression 
analysis was performed. The predefined significance for inclusion in the next step 
was 0.05. R² and adjusted R², displaying the amount to which the remaining 
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factors explain variation in the dependent variable were provided as well as the F-
statistic and p-values.  
 
Results 
In total, 1,311 patients were addressed by their GPs. 1,250 of them agreed to 
complete the questionnaire. Of those, at least 11 patients of each medical practice 
responded, leading to 1,021 (81.7%) returned questionnaires. Regarding available 
data, including sociodemographic variables, comorbidities and medication, no 
statistically significant differences could be revealed between the non-respondents 
and the respondents. The main reason given for not participating was a lack of 
time. Among the enrolled patients, 347 (34.0%) were male and 674 (66.0%) were 
female.  
Significantly (p<0.01) more men were married or lived with a partner (men: 278; 
80.1%; (women:376; 55.8%). Most patients (223; 67.1% of men and 482; 71.5% of 
women) had already retired. Due to this, the “work” scale of the AIMS2-SF was 
excluded from further analysis since this scale is only applicable to patients who 
are still in employment. Table 1 displays the characteristics of the study sample.  
 
Table 1.  Baseline characteristics of the study sample 
 
  n Mean (SD) / % 
Age (years) 868 67.39 (11.72) 
Duration OA (years) 958 13.69 (13.04) 
Female 674 66.0% 
Married/Living in partnership 654 64.0% 
Retired 705 69.0% 
Upper body 1021 1.41 (2.23 
Symptom 1021 4.62 (2.42 
Affect 1021 2.72 (1.51 
Social 1021 4.56 (1.95 
BMI 978 28.18 (4.70) 
No. of comorbidities 1021 2.22 (1.71) 
PHQ sum score 834 15.74 (4.69) 
Educational level  1021 2.52 (2.05) 
High blood pressure 565 55.3 % 
Elevated cholesterol 369 36.1 % 
Diabetes 177 17.3 % 
CVD 122 11.9 % 
Asthma/COPD 98 9.6 % 
 
Table 2 displays the scores of the EUROPEP items in sequential order. As in most 
other studies the total amount and percentages of patients voting “good” or “very 
good” on the specific item were displayed. We also report the response rate and 
the rate of patients who mentioned “not applicable” in the specific item. As can be 
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seen, the response rate was high, only in three items, about 30%, indicated that 
the answer was not applicable. 
 
Table 2.  Descriptive values of the EUROPEP items  
 
What is your opinion of the GP and/or general practice over the last 
12 months with respect to... 
Good / excellent 
response (%) 
No answer or 
not applicable 
(%) 
1 Making you feel you had time during consultation? 77.2 1.9 
2 Interest in your personal situation? 76.8 2.2 
3 Making it easy for you to tell him or her about your problem? 59.2 3.1 
4 Involving you in decisions about your medical care? 69.4 2.8 
5 Listening to you? 82.2 0.4 
6 Keeping your records and data confidential? 89.5 11.4 
7 Quick relief of your symptoms? 38.4 2.1 
8 Helping you feel well so that you can perform your normal daily 
activities? 
49.4 4.9 
9 Thoroughness? 58.1 2.6 
10 Physical examination of you? 86.5 12.1 
11 Offering you services for prevention of diseases (e.g. screening, 
immunisation)? 
32.7 9.8 
12 Explaining the purpose of tests and treatments? 56.4 4.8 
13 Telling you what you wanted to know about your symptoms and / 
or illness? 
33.3 4.5 
14 Helping you deal with emotional problems related with your 
health status? 
39.6 8.6 
15 Helping you understand the importance of following his or her 
advice? 
42.7 4.3 
16 Knowing what they had done or told you during former contacts? 54.8 5.4 
17 Preparing you for what to expect from specialist or hospital care? 38.6 31.2 
18 The helpfulness of the staff (other than the doctor)? 55.4 3.4 
19 Getting an appointment to suit you? 51.8 2.1 
20 Getting through to the medical practice on the telephone? 59.4 4.5 
21 Being able to speak to the general practitioner on the telephone? 31.6 34.2 
22 Time spent waiting in the waiting room? 22.4 3.9 
23 Providing quick services for urgent health problems? 55.6 35.2 
 
Table 3 displays the correlations of sociodemographics and disease 
characteristics with the sum score of the items 1-17 of the EUROPEP addressing 
satisfaction with the care provided by the GP. Interestingly, gender was not 
significantly related to the EUROPEP score. Significant correlations were revealed 
for the marital status, BMI, the amount of comorbidities, the PHQ-9 score as well 
as the number of received prescriptions. Regarding OA-specific QoL, all AIMS2-
SF scales showed significant (p<0.001) correlations to the EUROPEP. Since the 
“affect” scale of the AIMS2-SF, addressing patients’ mood, showed a high 
correlation to the PHQ-9 sum score, we did not enter this scale in the regression 
model due to the obvious redundancy.  
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Table 3.  Correlations of the EUROPEP (1-17) sum score and sociodemographic and disease 
characteristics 
 
 n Spearman’s rho p* 
Living in Partnership 999 -0.082 0.010 
Educational level 996 -0.051 0.106 
BMI 976 0.243 0.000 
Duration of OA 945 -0.199 0.001 
Sex (being female) 1021 0.098 0.087 
No. of comorbidities 1017 0.162 0.000 
PHQ-9 sum score 832 -0.272 0.000 
Prescriptions  1017 0.076 0.015 
Contacts with orthopaedics  1021 0.024 0.219 
Performed X-rays  736 0.038 0.118 
AIMS 2-SF dimensions  
Lower body 1021 0.229 0.000 
Upper body 1021 0.142 0.000 
Symptom 1017 0.203 0.000 
Affect 1017 0.303 0.000 
Social 1017 0.172 0.000 
 
Table 4 displays the results of the final regression model which was adjusted for 
age and sex. It explains 27.0% of variation in the EUROPEP 1-17 sum score as 
dependent. A high score in the PHQ-9, representing more depression symptoms 
was associated with a lower EUROPEP score (beta=-0.372; p<0.001). Not living in 
a partnership also predicted lower EUROPEP scores (beta=-0.209; p<0.001) as 
well as age (beta=-0.185; p<0.001). Interestingly, the number of comorbidities, 
which was positively correlated to the EUROPEP score turned into a negative 
predictor of patient satisfaction after adjusting for age and sex (beta=-0.152; 
p<0.001). Duration of OA was also a weak negative predictor of satisfaction 
(beta=-0.105; p=0.008). Interestingly, and controversially to our hypothesis, none 
of the AIMS2-SF dimensions remained as a predictor.  
 
Table 4. Stepwise Regression with the EUROPEP (1-17) sum score as dependent 
 
R²=0.279; adj. R²= 0.270, F=29.421; p<0.0001  Beta T p 
PHQ-9 sum score -0.372 -80.968 <0.001 
Age -0.185 -40.386 <0.001 
Partnership (living alone)  -0.209 -50.361 <0.001 
No. of comorbidities -0.152 -30.740 <0.001 
Duration of OA 0.105 -20.666 0.008 
 
Discussion 
Our hypothesis that satisfaction of OA patients is related to their disease-specific 
quality of life was not confirmed since none of the AIMS2-SF dimensions remained 
in the final regression model. Regarding OA characteristics only the duration of OA 
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remained as a predictor and was associated with decreased satisfaction. 
Increased depression symptoms, reflected in higher PHQ-9 scores, increased 
number of comorbidities and living alone were associated with less satisfaction 
with the GP as well as a longer duration of OA. To our knowledge this is the first 
study addressing patient satisfaction regarding a certain disease and aiming to 
reveal associations with disease characteristics.  
 
Study sample 
Representing nearly two-thirds of the included patients, women dominated the 
study sample. Since patients were consecutively addressed by the GPs, this 
finding is most likely due to the different prevalence rates of OA in gender: the 
WHO reports a prevalence of symptomatic OA of 18% in women and 9% in men16, 
matching the observed rate of 2:1. 
 
Overall scores  
Previous studies using the EUROPEP have revealed high patient satisfaction with 
the GP in different health care systems across Europe.17 Overall, the scores in our 
assessment reflected a positive evaluation of the GPs, especially in items 1 to 7.2 
But the EUROPEP also quite nicely reflects the impact of OA on the evaluation of 
the GP: some items, as for instance items 7 and 8 addressing relief of symptoms 
and empowerment of the individuals’ capability to handle daily living, were 
reasonably lower than in previous studies. This finding most likely reflects the 
clinical characteristics of OA, where pain relief is a major challenge. Similarly, the 
low values in item 9 “Thoroughness” and item 14 “Dealing with emotional 
problems” are most likely related to the increased prevalence of depression in 
OA.18,19 Furthermore, studies showed that GPs’ recommendations regarding the 
illness as well as its course are often vague.20 This finding is reflected in the 
scores of item 11 (“Offering you services for preventing disease?“) and item 13 
(“Telling you what you wanted to know about your symptoms and/or illness?”) 
which were significantly lower than in other studies assessing patient satisfaction 
in a more general study population.21
 
Correlation and regression analysis 
Since the results of previous studies suggest that women and older patients tend 
to report higher satisfaction with their GPs, we adjusted our regression analysis for 
both variables.2 This revealed an interesting finding: the number of comorbidities, 
which was positively correlated to the total score turned into a negative predictor in 
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the regression analysis. We assume that this is related to the association of age 
and number of comorbidities. This emphasises that non-adjusted results of such 
surveys need to be interpreted with caution. In the final model, the remaining 
variables account for an explanation of 27% of the variation in the EUROPEP (1-
17) score. First of all, it has to be noticed that our hypothesis that satisfaction may 
be related to the OA-specific QoL was not confirmed. Furthermore, there was no 
association between satisfaction and performed procedures as for instance 
performed X-rays or contacts to orthopaedics. This is in contrast to a prior study 
which focused on the influence of process parameters and showed increased 
satisfaction with performed procedures, home visits and parameters related to the 
medical practice organisation.5 OA patients obviously do not regard more of these 
contacts or procedures as increased quality of care.  
However, it should be acknowledged that many of these factors interfere with each 
other since chronification of symptoms as well as pain are related to psychosocial 
factors and depression.22,23  
 
Strengths 
The strengths of our survey are obvious: we enrolled a large number of patients 
that can be regarded as representative of OA patients in primary care. 
Furthermore, the survey was conducted in a naturalistic primary care setting.  
 
Limitations 
Some limitations have to be noted; first of all it is known that the EUROPEP is 
limited by some ceiling effects which were also revealed in this study. 
Furthermore, as already mentioned, all doctor’s practices were single-handed – as 
most medical practices in Germany are. This may result in a doctor-patient-
relationship that is different from situations where several GPs treat the same 
patient. This may limit transferability to health care systems other than the German 
system.  
 
Conclusion 
Altogether our study revealed three main findings: patient satisfaction is not 
dominated by disease-specific QoL, at least not in OA patients. Our results rather 
suggest that a good doctor-patient-relationship, sensitivity towards concomitant 
depression and the social background of the patient influences patient satisfaction 
to a higher degree than the frequency of treatments and contacts with specialists. 
Most importantly, the needs of older patients, suffering from various chronic 
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diseases and tending to lower mood or depression, are not appropriately 
addressed in the current system. Since nowadays the social network as an 
important source of support for chronically ill patients increasingly disintegrates in 
most industrialised countries 24-26, a “natural” source to handle this situation is 
fading away. It could be assumed that the established trend to an increasingly 
specialised and fragmented health care system will not meet the needs of these 
patients appropriately.27 The general practitioner as the regular and first-choice 
provider of health care seems to be the most appropriate professional to achieve 
this.  
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Abstract 
Objective: The Chronic Care Model (CCM) and the 5A-approach have achieved 
widespread acceptance and reflect the core elements of patient-centred care in 
chronic diseases, including osteoarthritis (OA). The aim was to assess to what 
extent current care for patients with osteoarthritis accords with the CCM in 
Germany. Furthermore we aimed to reveal possible predictors to assess whether 
certain patients are more likely to receive care complying with the CCM than 
others.  
Methods: A cross-sectional observational study addressing 1,250 patients from 75 
primary care practices in Germany. 1,021 (81.7%) of the administered 1,250 
questionnaires were returned. The Patient Assessment of Chronic Illness Care 
(PACIC-5A) was used to assess accordance to the CCM, and the 5A-approach. 
Impact of OA was assessed by means of the Arthritis Impact Measurement Scale 
(AIMS2-SF); the Patient Health Questionnaire (PHQ-9) was used to assess 
depression symptoms. Two stepwise multiple linear regression models with the 
PACIC sum score and the 5A score as dependents were performed to reveal 
predictors of a high accordance to the CCM and to the 5A-approach, respectively.   
Results: With a mean of 2.79 in men (SD 0.83) and 2.67 in women (SD 0.89; p for 
difference=0.89), the PACIC sum score was notably lower than in previous studies 
conducted in HMO settings in the US. The PACIC score was associated with a 
higher educational level (beta= 0.421; p=0.008) and younger age (beta=-0.319; 
p=0.016); the 5A score was predicted by educational level (beta=0.344; p=0.002), 
age (beta=- 0.386; p=0.004) and the PHQ-9 score (beta=- 0.288; p=0.005).  
Conclusions: Younger and better educated patients achieve higher scores on the 
PACIC score, indicating that their care accords to a higher degree with the CCM. 
Whether this reflects differences in physicians behaviour toward different patient 
groups or rather different demands of these patient groups cannot be concluded 
from the data presented. Further research is needed to confirm our results and 
assess possible implications for implementing the Chronic Care Model in primary 
care. 
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Objective 
Chronic diseases like diabetes, hypertension, arthritis and asthma are expected to 
increase tremendously in the upcoming years.1 They are associated with high 
economical costs, but also with a high burden on the individuals’ quality of life. 
Multiple interventional studies have been conducted to increase quality of life of 
patients with various chronic diseases. Based on the evidence of these 
interventions Wagner et al. have developed the Chronic Care Model (CCM) as a 
conceptual framework.2-4 Current care for the chronically ill is often event-driven 
despite solid evidence that a structured, planned and proactive approach to 
chronic diseases helps to reduce the burden of many chronic diseases.5 The CCM 
contains 6 key dimensions of care: organisation of health care, clinical information 
systems, delivery system design, decision support, self-management support and 
community resources. A recent review of the literature reiterates that successful 
improvement strategies concerning chronic diseases are consistent with the 
concept and components of the CCM.6 The CCM has achieved widespread 
acceptance, and recently an intense discussion has started among German 
physicians if and how the CCM or its components can be implemented in health 
care.7,8 At the annual meeting of the German Association of Family Medicine 
(DEGAM) in 2006 a statement has been launched reflecting the intention to 
implement the CCM or at least some elements thereof in primary care. 
Nevertheless, no data are available to date showing to what extent current primary 
care for the chronically ill is congruent to the CCM. To assess the congruency of 
provided health care to the CCM, Glasgow et al. developed the “Patient 
Assessment of Chronic Illness care” (PACIC).9 It is organised according to the key 
elements of the CCM and assesses the behaviour of professionals and practice 
teams from a patient’s perspective. The PACIC contains 20 items assessing 5 
scale constructs: patient activation, delivery system design/decision support, goal 
setting/tailoring, problem solving/contextual, follow-up/coordination. “Patient 
activation” assesses to what extent the patient was motivated and supported by 
the physician to initiate changes, “decision support” assesses if the patient was 
supported e.g. by booklets and how satisfied he was with the organisation of his 
care. “Tailoring” assesses to what extent general instructions and suggestions 
were adapted to his personal situation. “Problem solving” addresses how the 
physician dealt with problems which interfered with achieving predefined goals. 
Finally, “follow-up” addresses how frequently and consequently the whole process 
was followed-up. Recently, a German version of the PACIC 5A has been validated 
in a sample of osteoarthritis patients.10 Its psychometric properties have been 
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reported in detail elsewhere10: Cronbach’s alpha ranged from 0.78 to 0.90, the 
test-retest validity, estimated by the intra cluster correlation coefficient (ICC) was 
at least 0.77. 
The “5A” model represents an evidence-based approach to induce a behavioural 
change.11 Originally developed for smoking cessation it represents the 
recommended counselling approach for behavioural changes according to the 
recommendations of the US Preventive Services Task Force (USPSTF). The key 
elements are: assessment of present behaviour (Assess), patient counselling 
(Advise), collaborative agreement with the patient about realistic goals (Agree), 
assisting the patient during his lifestyle changes (Assist) and frequent follow-ups 
(Arrange).12 Glasgow et al. expanded the PACIC by including 6 items assessing to 
what extent physicians’ counselling reflects the 5A-approach. They validated the 
PACIC-5A in a sample of diabetes patients.12
The aim of this study was to assess the congruency between care in general 
practice in Germany and the CCM as well as between general practitioners’ (GPs) 
counselling style and the 5A-approach. Since we assumed that care and 
counselling may differ according to sociodemographic, or disease-related 
characteristics, we aimed to reveal possible predictors of the PACIC-5A score.  
 
Methods 
Recruitment of patients and data collection 
The PraxArt-project, performed by the University Hospital Heidelberg and financed 
by the German Ministry for Education and Research (BMBF), intends to improve 
quality of life of patients suffering from osteoarthritis.13 1,021 OA patients from 75 
primary care practices in Germany are currently enrolled in this project. The 75 
practices are located across the areas of Baden-Württemberg and are a 
representative sample of German primary care practices: e.g. most of them are 
single-handed. The anonymous questionnaires are linked within the project via a 
code-list to the medical file of the practices. Thus, detailed data about 
sociodemographic variables, duration of OA as well as information about 
comorbidities, medication, and health services utilisation were available and 
considered in the analyses. Since GPs prepared a list of all patients addressed 
these data were available for respondents as well as non-respondents. Inclusion 
criteria were to be aged over 18, meeting the criteria of OA to the hip or knee 
according to the American College of Rheumatology (ACR)14,15 and sufficient 
German language skills to understand and answer the questionnaire. In all 75 
practices GPs consecutively asked patients enrolled in the PraxArt-project to 
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answer the PACIC-5A. After giving their written informed consent they received the 
questionnaire and a return envelope to the university. Patients were informed that 
their GP had no possibility to get knowledge of their answers and were asked to 
complete the questionnaire on their own. Inclusion of patients did not begin unless 
there was a written and unrestricted positive vote of the ethics committee of the 
University of Heidelberg which was received in March 2005.  
Depression was measured using the depression module of the German version of 
the Patient Health Questionnaire (PHQ-9).16,17 The PHQ-9 is a completely self-
administered questionnaire that enables screening for depression and assessment 
of depression severity. The PHQ-9 score ranges from 0 to 27 with higher scores 
indicating a poorer health status. The impact of OA on patients’ health was 
assessed by the AIMS2-SF, which provides a comprehensive assessment of 
patients’ health status including the dimensions physical limitation, symptom 
(reflecting perceived pain), social (reflecting social contacts), affect (reflecting 
mood), and work (reflecting the ability to work). It has recently been validated in 
German using a sample of OA patients, and regarding reliability and validity 
proved to be comparable to the original version (18;19). The AIMS2-SF 
dimensions score between 0 and 10, with 0 representing the best and 10 
representing the worst health status. Based on clinical relevance in primary care, 
the following comorbid conditions were collected from the medical record: high 
blood pressure (defined as > 140/90 mm Hg), diabetes, chronic heart failure, 
coronary vessel disease (CVD), elevated cholesterol level (total cholesterol > 200 
mg/dl), ulcer or stomach disease, asthma/chronic obstructive pulmonary disease 
(COPD), renal insufficiency, (prior) cancer and (prior) stroke. Educational level was 
assessed on five (nearly equidistant) stages: (1) no school degree, (2) basic 
degree (<=7 years of education), (3) <=10 years of education, (4) college degree, 
(5) university degree.  
 
Statistical analysis 
Data were transferred into the SPSS program (version 14.0) after questionnaires 
were scanned. Scores were calculated according to the scoring instructions for the 
PACIC-5A questionnaire, resulting in values between 1 and 5 for each scale. 
Higher scores represent higher congruency to the CCM. Descriptive analysis 
included mean and standard deviation. The intracluster correlation coefficients 
(ICCs) for each PACIC-5A scale were calculated to estimate the variation within 
the clusters and to choose the appropriate regression model.20 After calculating 
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bivariate correlations, stepwise regression analyses were performed to reveal 
predictors of a high PACIC sum score and a high 5A score.  
 
Results 
1,021 (81.7%) of the administered 1,250 questionnaires were returned. An 
analysis of the non-respondents revealed no significant differences with respect to 
sociodemographic data, OA duration and comorbidities in comparison to patients 
who returned the questionnaires. Table 1 displays characteristics of the study 
sample. Women were overrepresented (66.0% of respondents): an effect most 
likely related to the prevalence of OA being nearly twice as high among women as 
among men. Mean duration of osteoarthritis was 14.9 (SD 14.3) years.   
 
Table 1.  Characteristics of the study sample separated by gender (n=1021)  
 
Gender 
Male (347/34.0%) Female (674/66.0%) 
 
mean SD Mean SD 
Age 65.16 14.75 66.64 15.33 
Body mass index (BMI; kg/m²)  28.39 4.26 28.12 5.16 
Educational Level (1-5) 2.61 1.11 2.38 0.83 
Duration of OA (years) 14.80 16.18 13.13 11.09 
Married/Living in partnership 278 80.1 (%) 376 55.8 (%) 
Quality of life (AIMS2-SF dimensions) 
Lower body  2.39 1.71 2.98 2.08 
Upper body 1.38 2.33 1.54 2.22 
Symptom  4.49 2.17 5.12 2.18 
Affect  2.60 1.28 3.10 1.36 
Work (126 women/89 men) 3.08 2.67 2.34 2.23 
PHQ-9 score  15.33 4.76 15.95 4.63 
Comorbidities  Total % Total % 
High blood pressure 181 52.1 384 56.9 
Elevated cholesterol 124 35.7 245 36.3 
Diabetes 57 16.4 120 17.8 
CVD 62 17.8 70 10.3 
Asthma/COPD 34 9.8 64 9.5 
 
Table 2 shows the descriptive statistics of the individual scales of the PACIC-5A 
scores separated by gender. The average overall score of the PACIC was 2.79 
(SD 0.83) in men and 2.67 (0.89) in women. There was adequate variability in the 
overall scale and all subscales as indicated by the standard deviation. Significant 
differences between men and women occurred in the “problem solving” scale of 
the PACIC and the “agree” scale of the 5A.  
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Table 2. Score distribution of the PACIC-5A  
 
 Gender  
PACIC-Scale Male Female p* 
 Mean SD 95% CI mean SD 95 % CI  
Activation 3.51 1.10 3.31-3.52 3.39 1.14 3.22-3.48 0.302 
Delivery 3.34 0.84 3.20-3.46 3.33 0.92 3.18-3.38 0.851 
Tailoring 2.41 0.88 2.26-2.54 2.31 0.95 2.17-2.40 0.294 
Follow-up 2.39 1.02 2.16-2.52 2.29 1.02 2.15-2.41 0.370 
Problem solving 2.94 1.15 2.71-3.13 2.62 1.21 2.44-2.81 0.009 
PACIC sum score 2.79 0.83 2.64-2.93 2.67 0.89 2.53-2.76 0.185 
5A Scale        
Assess 2.86 1.12 2.67-3.02 2.77 1.11 2.61-2.88 0.427 
Agree 3.31 1.03 3.09-3.42 3.09 1.06 2.95-3.19 0.050 
Advise 2.74 0.83 2.60-2.86 2.74 0.94 2.58-2.88 0.938 
Assist 2.42 0.92 2.24-2.57 2.25 0.99 2.12-2.37 0.089 
Arrange 2.17 0.98 1.92-2.28 2.10 1.01 1.97-2.22 0.492 
sum score 2.79 0.84 2.64-2.93 2.65 0.89 2.53-2.73 0.131 
* t-test 
 
Correlations of the PACIC sum score and the 5A score to patient characteristics, 
PHQ-9 and AIMS2-SF scores are displayed in table 3. Notable correlations were 
found for age, educational level and the PHQ-9 score. Interestingly, the 
correlations for the AIMS2-SF scales were all statistically significant but, with the 
exception of the affect scale, quite low. All factors achieving significance were 
entered in the regression model.  
 
Table 3. Correlations of patients variables with the PACIC and 5A sum score 
 
   PACIC sum score 5A sum score 
Gender** 0.099 0.109 
Age (years)* -0.322 -0.349 
Educational level** 0.401 0.3.78 
Marital status* 0.028 -0.099 
Disease duration (years)** 0.184 0.178 
BMI (kg/m²)** 0.213 0.199 
No. of comorbidities** 0.145 0.177 
PHQ-9 sum score** -0.347 -0.421 
Lower body** 0.128 0.139 
Upper body** 0.188 0.201 
Affect** 0.292 0.277 
Social** 0.144 0.156 
AIMS2-SF 
Scales 
Work** 0.201 0.173 
Level of statistical significance: *p<0.05; **p<0.01; (Spearman rho)  
 
To decide which regression model would be appropriate we first calculated the 
ICCs of the PACIC-5A to estimate the variation between the different practices. 
Interestingly, the ICC was below 0.01. Consequently, we decided to choose a 
linear regression model without considering the cluster effect. Table 4 displays the 
results of the regression analysis with the PACIC sum score as dependent 
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variable. As can be seen, only two factors remained in the final model which 
explained 29.5 % of the variation in the PACIC sum score. The educational level 
was the strongest predictor with a beta of 0.421 (p<0.008), reflecting that a higher 
educational level predicted higher scores on the PACIC score. The relationship to 
age was inversely: higher age predicted lower PACIC sum scores, reflected in a 
beta of -0.319 (p=0.016). The PHQ-9 score was eliminated in the last step of the 
regression model while slightly surpassing the demanded significance level 
(beta=0.107; p=0.057). 
 
Table 4.  Predictors of the PACIC-score assessed by stepwise regression  
 
Dependent: PACIC sum score 
Unadjusted R² = 0.302  
Adjusted R²= 0.295  
F= 21.233; p<0.0001 beta SE 
 
 
 
T 
 
 
p 
Educational level  0.421 0.118 3.620 0.008 
Age  -0.319 0.121 2.022 0.016 
 
Interestingly, the regression model revealed similar predictors for the 5A sum 
score as for the PACIC score: age as a negative predictor of high 5A scores, and 
educational level as a positive predictor (table 5). Additionally, the PHQ-9 score 
remained as significant predictor in the final model. Higher PHQ-9 scores were 
associated with lower 5A scores.  
 
Table 5.  Predictors of the 5A score assessed by stepwise regression  
 
Dependent: 5A sum score 
Unadjusted R² = 0.312 
Adjusted R²= 0.302  
F= 21.455; p<0.0001 beta SE 
 
 
 
T 
 
 
p 
Age - 0.386 0.145 3.450 0.004 
Educational level 0.344 0.129 1.988 0.002 
PHQ-9 score - 0.288 0.243 1.874 0.005 
 
Discussion 
The CCM has been promoted as a template of care for the chronically ill, aiming to 
substantially improve quality of life.4,21 Our study showed that certain patients rated 
those aspects of their care more favourably that were consistent with the CCM. 
Being younger, better educated and less depressed increased the chance to 
achieve higher scores on the PACIC-5A. Assuming that the PACIC-5A reflects the 
accordance of physicians’ behaviour with the CCM, these patients are more likely 
to receive care that contains the core elements of chronic care such as activation, 
support, goal setting, assistance and frequent follow-ups. 
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Tsai et al. showed in their meta-analysis that interventions containing at least one 
CCM element could improve clinical outcomes as well as patient-relevant 
outcomes.22 They included 112 studies, assessing diabetes, asthma, chronic heart 
failure and depression. Furthermore, a number of studies are available to date, 
that focused on implementing at least a few elements of the CCM. The results 
emphasise that the CCM is not only a theoretical framework that improves process 
parameters as well as patient-relevant outcomes, in a recently published study, 
Vargas et al. could also show that the CCM approach can reduce risk factors for a 
heart disease in diabetes patients.23 Regarding chronic obstructive pulmonary 
disease Adams et al. reported in a recent review that patients who received 
interventions with two or more CCM components had lower rates of 
hospitalisations and emergency/unscheduled visits and a shorter length of stay in 
a hospital compared with control groups.24 It has to be considered, though, that 
most of these data were retrieved in hospital settings or HMOs and cannot easily 
be transferred to primary care settings. So far, only one study is available showing 
that CCM elements can be implemented in small independent practices and result 
in improved care for diabetics.25
Our paper has three main findings. First of all, the comparison of the scores of our 
study sample with previously collected data suggests that current care for patients 
with OA reflects the key elements of the CCM only poorly. Glasgow et al., for 
instance, found notably higher values among diabetes patients than we did: their 
reported means in the “tailoring/goal-setting” scale (3.1 in men and 3.0 in women), 
in the “follow-up” scale (2.9 in men and 3.0 in women), and the “problem-solving” 
scale (3.4 for both gender) do not even fall within the 95% CIs of our outcomes.12 
The same result applies to the sum score (3.2 in men and 3.2 in women). The 
results regarding the 5A-approach are quite similar, with notably lower scores 
regarding all scales of the 5A part of the PACIC-5A. 
In our opinion, there are several reasons that account for the significantly lower 
scores in our study: first of all, Glasgow collected his data in an HMO and not, as 
we did, in a primary care setting with a large number of single handed practices. 
Furthermore, and related to the first reason, care according to the CCM is 
proactive, focused on activating, involving and accompanying the patient. This 
kind of care frequently requires the involvement of qualified practice nurses or 
physicians’ assistants. But these medical professions are currently not available in 
Germany.26 Another important reason may be the observed disease itself. It could 
be assumed that physicians’ engagement in diseases such as diabetes, heart 
insufficiency or depression is higher than in OA, which is regarded as less 
 
162 Chapter 9 
threatening to the patients’ health, or at least associated with a lower burden of 
disease.27
The second important finding is that the PACIC as well as the 5A scores are not 
correlated with severity of OA. None of the AIMS2-SF scales, reflecting different 
aspects of quality of life of OA patients, was significantly correlated with the PACIC 
or the 5A scales, and none of them remained in the regression model. This 
suggests that GPs counselling efforts are not dominated by the disease itself.   
The most important finding is related to the predictors of high PACIC and 5A 
scores. The finding that younger, better educated patients with lower PHQ-9 
scores are more likely to achieve high scores on the PACIC-5A could reflect 
differences in physician behaviour towards different patient groups as well as the 
fact that these patients are more actively seeking care that complies with the CCM. 
Still, this association cannot be concluded from our data and remains speculative. 
Nevertheless, this information is valuable since it may suggest that in 
implementing the CCM or its elements, it will be of great importance to assure that 
all patient groups are able to benefit to the same extent from this advance in 
chronic illness care. It is well known that most chronic diseases such as diabetes 
and high blood pressure are associated with social status28,29; a recent German 
health survey confirmed the association of chronic conditions and social status 
once more.30 It is quite obvious that these patients would benefit the most from 
advanced approaches like the CCM. Our data suggest that efforts in implementing 
CCM elements should consider to assure that these patients will eventually benefit 
from the CCM as well as other patients.  
Since Glasgow et al. could not reveal significant differences in the PACIC scores 
regarding gender, ethnicity, income and comorbidities, it will also be of great 
importance to consider the setting in which the data were collected9,12: Their 
patients were enrolled in an HMO; ours in a primary care setting. 
 
Strengths and weaknesses 
There are some weaknesses in our study which should be acknowledged: first of 
all, the assumed linkage between different PACIC scores and differences in 
received care has not been proven empirically. But preliminary data from a 
nationwide research project using the PACIC-5A in evaluating diabetes disease 
management programs confirm this assumption. Secondly, the data were derived 
from a cross-sectional observational study within a sample of OA patients and it 
remains unclear whether the findings can be transferred to other diseases and 
patient groups. Furthermore, the social situation of participants could not be 
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assessed properly since it is still problematic in Germany to ask for the annual 
income. Since uninsurance is no problem in Germany and the health care system 
can be freely accessed by everyone this weakness may be limited. The strength of 
this study is its reasonably large and representative sample of primary care 
practices and patients. In contrast to previous studies, which assessed the 
congruency to the CCM by a health professionals’ perspective (by means of the 
Assessment of Chronic Illness Care (ACIC) 31), we assessed it from a patients 
perspective.  
 
Conclusion  
Without a doubt, the framework of the CCM represents an important step towards 
an improved care for the chronically ill. Our findings suggest that currently this 
structured approach is only rarely implemented in the care for patients with OA in a 
primary care setting. The finding that younger and better educated patients are 
more likely to receive care which complies with the CCM suggests that the 
implementation of CCM or CCM elements in primary care will be challenging in 
order to assure that all patients benefit equally. Further research is needed to 
confirm our results and assess possible implications for implementing the Chronic 
Care Model in primary care. 
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Background 
In Germany medical care in the primary care setting is provided exclusively by a 
physician, the GP. In a normal medical practice several practice nurses support 
the physician in mainly administrative aspects such as arranging appointments for 
patients, answering telephone calls, preparing and providing the patient files and 
so on. However, technological and/or societal changes, especially those 
concerning the health care system, are stimulating considerations of expanding 
nursing roles in Germany. For example, due to the big problem of recruiting 
prospective candidates, especially in primary care, the number of GPs in Germany 
will drop tremendously in upcoming years. In some rural areas, especially in the 
eastern part of Germany, it is already very difficult to find young GPs willing to 
work there. Additionally, the workload is increasing due to administrative work. The 
newly introduced disease management programs (DMPs) have again boosted this 
trend. This aggravation of labour conditions has started a fatal circle: more and 
more German physicians are leaving the country, mostly to work in the U.K. or 
Scandinavian countries where they find better working conditions1,2. Thus, these 
developments force physicians and policymakers to consider new models of 
nurses' involvement. 
In other countries, different health care professionals are involved in patient's care. 
In the U.S., for example, from the 1960s onwards, physicians assistants were 
established, providing care together with nurses and nurse practitioners3,4. There 
is very little equivalence in education and roles across borders. Different roles of 
nurse practitioners (NP) and physician assistants (PA) exist in different countries. 
In the United States both of these roles generally require graduate education 
involving intensive study in diagnostic methods and therapeutics. However, 
several studies showed that involvement of medical assistants improves patient 
care or quality of life, even if the involvement contained simple procedures as for 
instance frequent contacts by telephone5,6. Therefore, the number of assistants 
increased constantly in the primary care setting in Canada as well as in the U.S. 
Contrary to the U.S. and Canada, little is known about the involvement of doctors' 
assistants in the care of patients in Germany. GPs are complaining about an 
increasing workload so that increased involvement of doctor’s assistants could 
reduce the workload and help them concentrate on patients. Especially, chronic 
diseases with frequent consultations and less change in therapy could be possible 
domains where an increased involvement of practice nurses decreases GPs' 
workload and increases patient satisfaction5. Chronic diseases often require 
knowledge on coping strategies as well as information on strategies to prevent 
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further deterioration. This is reflected in the Chronic Care Model (CCM), a 
conceptual framework for delivering care for chronically ill, which has received 
widespread acceptance. However, the implementation of the CCM requires a team 
approach, i.e. heightened involvement of practice nurses in patient care. 
It seems that the time is right to consider a new breed of healthcare professionals 
who could take on many of the tasks currently undertaken by doctors, and 
therefore enable the physicians to concentrate on their original duty: providing 
medical care. 
The aim of our study, therefore, was to assess the present involvement of practice 
nurses in patient care, to estimate possible areas of heightened involvement and 
to reveal existing barriers by exploring the perspectives of all groups involved in 
the treatment process: patients, GPs and practice nurses. 
 
Methods 
We chose a qualitative approach because little is known about involvement of 
practice nurses in the care of chronically ill patients. So far, there has been no 
German study on this topic. 
 
Sample 
The selected GPs, assistants and patients represented a stratified sample 
regarding gender, city and rural population living in Heidelberg and surrounding 
areas7. The GPs were to have a minimum of 5 years’ experience; the practice 
nurses were required to have a minimum of 10 years’ professional experience. 
The patients were selected at random from the GPs' computer files. They had 
osteoarthritis as primary chronic disease, and all of them had at least one 
additional chronic disease such as diabetes, heart insufficiency or hypertension. 
During their practice visit the GP asked whether they were willing to participate in 
an interview. All patients but one agreed to take part in the study. Written consent 
of all participants was obtained. The study was approved by the ethics committee 
of the University of Heidelberg; approval number 019/2004. 
 
Interviews 
The interviews were conducted during the summer of 2004. The GPs and 
assistants were interviewed in their respective practices; the patients were 
interviewed at home by a trained interviewer. After a detailed study of the literature 
regarding patients' perspectives on chronic diseases, we compiled open-question 
interview guidelines. In order to have the possibility to compare the views of GPs, 
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patients and practice nurses, we matched the interviews for the three groups on 
important issues but also asked specific questions concerning the investigated 
group only.  
 
The questions focused on the following aspects: 
• Actual areas of practice nurses' involvement 
• Main obstacles regarding more involvement 
• Possibilities to overcome the obstacles 
 
Following the regular process of care, these aspects were assessed in the 
following areas: 
• diagnostic procedures, examinations and treatment 
• advice giving/counselling 
• referrals 
 
During the interview the interviewer ensured that every aspect was explained 
sufficiently and in detail, so that no questions or misunderstandings remained. 
 
Data analysis 
The interviews were recorded digitally, transcribed literally and analysed by four 
different researchers with ATLAS.ti -Software8. In advance, a categorising system 
had been established based on the interview guidelines. In order to achieve 
maximum objectivity, all interviews were read by all researchers and categorised 
independently. The categorising system was consequently modified after 
agreement had been obtained among all four researchers. Numerous free 
categories were developed from the text, discussed and adjusted so that they 
were as similar as possible in all three interviewed groups, since the objective was 
to compare the different perspectives of the groups. 
 
Results 
Although the interview guidelines for all groups contained the same number of 
questions, the interviews differed in length depending on the group; the GPs' 
interviews being the longest, and the assistants' interviews being the shortest 
(table 1). The categorical systems with subcategories are displayed for each 
interviewed group in tables 2, 3, 4. The numbers in brackets display how many 
participants responded to the respective category. 
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Table 1.  Baseline characteristics of the study sample 
 
 Practice nurses  GPs  Patients  
N 20 20 20 
Mean age (range) 41.3 (29-56) 43.5 (33- 57)  56 (40-78) 
Years of working experience in general practice (SD) 13-35 (21.7) 8-19 (11.3)  
Longest duration of chronic disease (Mean/(SD))   17 (9.3) 
Number of chronic diseases (Mean/(SD))   2.9 (1.1) 
 
Involvement in diagnostic procedures, examinations and treatment 
GPs considered it adequate to delegate simple routine examinations, for instance, 
the measurement of blood pressure or the measurement of height and weight to 
the practice nurses. They assumed that patients would accept practice nurses to 
perform only these examinations. Taking a blood sample was appraised quite 
differently: some GPs regarded it as alleviation; some preferred to take the blood 
themselves. The main reason for these differences was not an assumed lack of 
knowledge or skills, but rather the GPs' preferences with respect to the 
proceedings in the practice. 
 
"I prefer to take the blood myself; I can already start talking to the 
patient.....Sometimes I get the most important information during this 
procedure" GP 7 
 
All GPs said that it is their duty to perform the examination, to inform the patient 
and explain diagnosis, prognosis and therapy. Most GPs were convinced that 
examinations, the following explanations and counselling represent one of the 
main challenges in primary care and that this can only be done by the physician. A 
lack of medical knowledge was also mentioned as an important obstacle against a 
broader involvement of the practice nurse in this area. The third most frequently 
named obstacle was that GPs are convinced that patients expect to be informed 
about diagnosis, prognosis and therapeutic options only by the physician. 
 
"To inform the patients that's only my job. That's also what the patient 
expects. They would never accept that the practice nurse tells them 
what's going on with them." GP 17 
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Table 2.  Categorical system with first subcategories (General Practitioners) 
 
Main categories  First subcategory 
Present situation (20*): 
 
• Involvement in medical proceedings (6 ) 
• No involvement in medical proceedings (14) 
Team approach in general (20): 
 
• Imaginable (18) 
• Not imaginable (2) 
Barriers / Problems (20):    
 
• Lacking (medical) knowledge/skills (19) 
• Workload (16) 
• Perceived lack of patients’ acceptance (14) 
• Fear of worsening physician-patient-relationship (12) 
• Lack of reimbursement (5) 
• Doubt about efficacy of increased involvement (5) 
• Lacking motivation by practice nurses (2)  
Possible tasks for practice nurses  in the 
context of  team approach (20): 
 
• Hand out patient information leaflets (12) 
• Lifestyle counselling/advice giving (11) 
• Arranging/Assisting  referrals (5) 
• Others (4) 
Possibilities to overcome  the obstacles (12):  
 
• Better education for practice nurses (11) 
• Reimbursement (5) 
• Offers of training for practice nurses (2) 
*  numbers in parentheses are the frequency of subjects who said something relating to the respective 
category  
 
Most patients found the practice nurse to be skilled enough to measure the blood 
pressure, blood sugar and also to take i.v. blood samples. Information about the 
disease itself, the prognosis and possible treatment options were very important to 
patients. In accordance with the assumption of the GPs, they expected to receive 
important information about their disease only from the physician. They assumed 
that the practice nurses do not have the knowledge to inform them about the 
causes and prognosis of the disease. Moreover, it was very important to the 
patients that they can always talk directly to the GP about their concerns without 
having to explain the requests to the practice nurse first. With respect to treatment, 
many patients seemed to assume that the practice nurse is familiar with possible 
treatments beyond the evidence based procedures. Many patients assumed that 
the practice nurses have an overview or knowledge about treatments that had 
been beneficial for other patients. The practice nurse was regarded as a source for 
additional treatments which are beyond regular treatment procedures.  
 
"Well, I do sometimes ask the practice nurse, if she knows something 
which may have helped other patients, some sort of cream or something, 
which maybe the doctor can't prescribe." P3 
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Practice nurses stated that they are not asked about the diagnosis or prognosis of 
diseases by the patient. They complained that their schooling focused more on 
administrative things than on medical knowledge. Due to this, they did not feel 
competent to say anything about the disease, its cause, possible influences on the 
progression, the treatment and prognosis. The knowledge they have on these 
aspects is mostly acquired by working experience and not by schooling. Patients 
rarely questioned the practice nurse regarding medication. Formal matters such as 
equivalence of medications with different names etc. were a matter of concern. 
The practice nurses did not consider themselves competent enough to talk about 
medication and often refered to the GPs' instructions. All of them desired to 
receive more medical information during their education, but nevertheless, they 
clearly stated that providing this information to the patient is up to the GP. Practice 
nurses' statements were in line with patients' statements: most of them confirmed 
that they were frequently asked about additional treatment options which are 
beyond the classical treatment as for instance possibilities to support a lifestyle 
change, supplements, etc. 
 
"Patients often ask me: do you know somebody who had positive 
experiences with this or that.....sometimes I wonder why they don't ask 
the doctor about that, but it seems that they feel ashamed to ask the 
doctor about this, especially the older ones." N 10 
 
"Sometimes I ask the patient if he mentioned the problems to the doctor 
during the consultation, but the patients often reply that the doctor is too 
busy and that they don't want to bother him with their complaints too 
much, because there's no real effective relief anyway." N 19 
 
Involvement in counselling 
As shown in the interviews, advice giving or some sort of counselling by the 
practice nurse was acceptable for the GPs mainly in the fields of "lifestyle-change", 
"nutrition" and "motivation for physical activity". Advice concerning medical issues 
such as pharmacological treatment or other specific treatments is regarded to be 
solely the GPs' responsibility. Moreover, as GPs indicated, the involvement of 
practice nurses is only possible in the context of group education for patients, 
whereas individual guidance is rejected for financial and time reasons. In the 
context of DMP's such educational groups for patients have been implemented in 
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many medical practices. However, some GPs were ambivalent concerning group 
education for patients. 
Some doubted their efficacy, others criticised that it is too time-consuming, or that 
some practice nurses are not motivated enough. 
 
"These diabetes education groups are quite all right, but what if even 
more DMPs will be implemented? Should the practice nurse educate 
patients all day long then?" GP6 
 
"...you can communicate that to younger practice nurses, but that 
doesn't work with older assistants, they just don't regard it to be their 
duty..." GP13 
 
Most of the GPs found it acceptable that practice nurses hand out patient 
information leaflets, or point out contacts such as self-help groups. However, some 
GPs indicate that this kind of patient care is already beyond their field of duty. 
 
"She can't assess what is good for the individual patient, and I don't think 
it's good if the task is handed down to the next level..." GP 10 
 
"We can't coordinate patients' sports activities." GP14 
 
All practice nurses found involvement in counselling, for example in the context of 
DMP, to be an appreciation of their work and a diversion from administrative tasks 
which constitute their daily routine. Some practice nurses objected that they are 
only insufficiently qualified for advice giving which highlights the importance of high 
quality education for practice nurses. Education programs in the context of DMPs 
seem to attend to this aspect insufficiently.  
Patients were mainly positive about educational groups and thought that the 
practice nurse is competent to offer such groups. In addition, most patients would 
like the practice nurses to hand out printed information and provide knowledge 
about self-help groups, community-based or other local offers. They regarded the 
practice nurse to be a more adequate source for this kind of information than the 
GP. 
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Table 3.  Categorical system with first subcategories (Patients) 
 
Main categories  First subcategory 
Team approach in general (20*): 
 
• Imaginable (19) 
• Not imaginable (1) 
Barriers / Problems (20): 
 
• Lacking (medical) knowledge (11) 
• Fear of worsening physician-patient-relationship (2) 
• Others (4)  
Possible tasks for practice nurses in the 
context of a team approach (13):  
 
• Organising education groups (10) 
• Giving information about referrals (specialists) (4) 
• Asking patient about his mood (2) 
• Talking to the patient sympathetically (1) 
* numbers in parentheses are the frequency of subjects who said something to the respective category  
 
Involvement in the referral process 
Concerning the referral process, the GPs delegate many steps in the process to 
the practice nurses, e.g. filling in the referral form or making an appointment in 
case of urgent referral. The practice nurses were responsible for the administrative 
part of the referral. Some GPs generated lists of specialists, which the practice 
nurses hand out to the patients. 
Practice nurses indicated that patients often ask them about recommendable 
physicians regarding criteria such as localisation, friendliness and short waiting 
times. Even if lists with specialists are handed out to patients, they often asked for 
personal recommendations. 
 
"Especially older patients appreciate it when we show them on the map 
how they can get there or which bus to take." N 5 
 
Patients did appreciate getting information about specialists they can consult. 
Particularly when the GP does not explicitly recommend a specialist, patients 
contacted practice nurses because they have a lot of information. 
 
"...it's not that easy to walk anymore, and I'm really glad when they tell 
me about an orthopaedist I can go to and reach easily." 
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Table 4.  Categorical system with first subcategories (Practice Nurses)  
 
Main categories  First subcategory 
Present situation  (20*): 
 
• Involvement in medical proceedings (3) 
• No involvement in medical proceedings (17) 
Team approach in general (20): 
 
• Imaginable (20) / Wish of being more involved (18) 
• Not imaginable (0) / No wish of being more involved (2) 
Barriers / Problems (20):    
 
• Lacking (medical) knowledge/skills (20) 
• Workload (17) 
• Perceived lacking patients’ acceptance (1) 
• Others (4)  
Possible tasks for practice nurses in the 
context of a team approach (15): 
 
• Giving information on local offers, self help groups, etc. (13)
• Calling the patient in regular intervals (i.e. case 
management) (7) 
• Motivating the patient to use self-help groups and social 
contacts (3) 
• Organising (self-help) groups (2) 
• Exchanging information about patient with GP (2) 
Possibilities to overcome the obstacles (19): 
 
• Improved medical education (14) 
• Changes in practice organisation (11) 
• More support by GP (3) 
• Training offers for practice nurses (2) 
* numbers in parentheses are the frequency of subjects, who commented on the respective category  
 
Discussion 
In German practices, there is only one kind of assistance for the GP: the practice 
nurse. As our findings showed, practice nurses are currently only rarely involved in 
diagnostics and treatment, and are mainly occupied with administrative tasks. The 
DMPs as performed in Germany can be regarded largely as management by 
protocol, meaning that they do not require extensive physicians' involvement. 
Therefore, since the implementation of DMPs, many practice nurses are more 
involved in giving patients' advice, which most of them do appreciate.  
Patients as well as most of the GPs are positive about this involvement. The 
growing role of disease management programs have led to considerations 
regarding nurses' broader involvement in the care of the chronically ill. For most of 
these patients the diagnostic phase is largely over, meaning that the more 
technically sophisticated and often more lucrative phase of care has passed - the 
"threat" to physicians is minimal. Furthermore, the great deal of time-consuming 
patient teaching involved in the care of chronically ill patients in maintenance care 
is believed to "come naturally" to nurses as a result of their education. Additionally, 
patient teaching can be done in a cheaper way by nurses, thus liberating 
physicians for "more complex" care. 
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Major barriers for further integration into care according to practice nurses are 
professional deficits stemming from a lack of medical contents in their education. 
Therefore, the continuous training of practice nurses is of great importance. 
However, with regard to further training, the study showed that there is still a lot of 
room for improvement quantitatively as well as qualitatively. Regarding physicians 
our results also indicated that the expansion of roles will only work if physicians do 
not feel threatened by the shift of territory and responsibility; when they believe 
that heightened involvement of nurses leads to advantages such as easier 
workload and happier patients, and are confident concerning nurses' competence. 
Moreover, the study showed that the role of the practice nurse in Germany is very 
different compared to the role nurse practitioners or physicians’ assistants have, 
for example, in the US or Canada where they are an essential part of care9. This is 
a prerequisite for the implementation of new treatment approaches as for instance 
the Chronic Care Model (CCM). The CCM is a recently developed conceptual 
framework for the care of chronically ill patients, which favours planned and 
proactive care10. Due to the complex approach of care in this model it cannot be 
performed by the physician alone, but requires a team approach11,12. Moreover, 
the wish of patients for more information will increase further13,14 and resources on 
the GPs' side will decrease1. Thus, in the near future, it seems inescapable to 
spread care, which is, as our findings showed, problematic since until now practice 
nurses in Germany are only marginally involved in patient care. 
Even by delegating simple tasks nurse-delivered interventions can improve 
patients QoL and reduce costs15,16. Practice nurses’ involvement can therefore 
range from regular telephone contacts, which reduce costs and heighten patients' 
satisfaction to more specialised fields of care17,18. Consistent with our results other 
studies show that practice nurses would appreciate an upgrading of their work 
within a more team oriented approach19. 
Our study has some weaknesses, e.g. the relatively advanced age of the patients 
as well as their low level of education. Older people tend to be happier with their 
GPs14,20, which could be one of the reasons why we did not get so many concrete 
suggestions for improvement from patients. A further weakness is that we did not 
mention ideas for improvement or interventions in the interview guide. Although 
this was discussed beforehand, we abandoned the idea in order to keep answers 
as open and honest as possible. 
Despite these limitations, to our knowledge, our study is the first to consider 
individual perspectives of patients, GPs' and practice nurses regarding 
involvement of practice nurses simultaneously. The interview guidelines were 
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developed interdisciplinary, i.e. in cooperation with a psychologist in order to 
ensure appropriateness for patients with chronic illnesses. Furthermore, four 
researchers assessed and categorised the qualitative data independently 
according to stringent guidelines, in order to achieve the highest possible 
objectivity7,21. 
 
Conclusion 
In conclusion, higher qualification of practice nurses could contribute to a reduction 
of GPs workload. This requires qualitatively improved education and further 
training for practice nurses22, which would lead to an appreciation of the profession 
in return. Our study showed that the majority of patients would accept the practice 
nurse as a competent part of the care team and that GPs' skepticism is often the 
main problem with regard to involvement of practice nurses. This however, will 
leave an important resource unused and will widen the gap between the German 
health care system and more team-oriented systems. 
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Abstract 
Objective: To assess whether providing information on arthritis self-management 
through general practitioners (GPs) increases the quality of life in patients with 
osteoarthritis and whether additional case management provided by practice 
nurses shows better results. 
Methods: We conducted a pragmatic, cluster-randomised, controlled, 3-arm trial 
that included 1,021 patients from 75 primary care practices in Germany. GPs were 
randomised to intervention group I, group II or a control group. GPs of both 
intervention groups participated in two peer group meetings. In intervention group 
II, additional case management was conducted via telephone by a practice nurse. 
The primary outcome was change in quality of life, assessed by the German 
version of the Arthritis Impact Measurement Scales Short Form (AIMS2-SF). 
Secondary outcomes were health service utilisation, prescriptions and physical 
activity. Data were controlled for depression using the Patient Health 
Questionnaire 9 as a potential confounder. 
Results: Of 1,125 administered questionnaires, 1,021 were analysed. Compared 
with the control group, no significant changes occurred in intervention group I with 
respect to the primary outcome. Performed radiographs decreased significantly 
(P=0.050), whereas prescriptions of acetaminophen increased significantly (P < 
0.001). In intervention group II, significant changes in the AIMS2-SF dimensions 
social (P < 0.001), symptom (P=0.048) and lower body (P=0.049) were identified. 
Radiographs (P=0.031) and orthopedic referrals (P=0.044) decreased whereas 
prescriptions of pain relievers increased significantly. 
Conclusion: Improving the quality of life in patients with arthritis using arthritis 
self-management seems challenging. Simply providing this information through 
GPs is not sufficient, but combining it with case management seems to be a 
promising approach. 
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Introduction 
Osteoarthritis (OA) is highly prevalent in the population and its prevalence is 
expected to increase in coming years.1 OA has a substantial impact on patients’ 
quality of life (QOL), as it is frequently associated with pain and disability. Because 
some of the factors that affect the course of OA such as body weight2 and physical 
activity3 are receptive to influence, programs such as arthritis self-management 
programs (ASMPs) or the Program for Rheumatic Independent Self Management4 
have been developed. Besides recommendations for physical activity and weight 
loss, these programs aim at increasing patients’ ability to handle the disease by 
increasing self-efficacy. However, their effects, at least in patients with OA, seem 
to be weak as a recent meta-analysis of self-management programs for certain 
chronic diseases has indicated.5 To date, these programs generally have taken 
place outside of medical care settings6, but a recently published study by 
Buszewicz et al. indicated that ASMPs may have no substantial impact on QOL of 
primary care patients.7
However, because the main care provider and primary contact person for most 
patients is the general practitioner (GP), it seems appropriate to evaluate 
interventions in a primary care setting.8 Programs such as ASMPs, which require 
participation in courses, are always subject to compliance problems. Because 
patients visit their GP for many reasons, and information on arthritis self-
management can be more easily and frequently provided during these visits than 
through courses, it would seem a worthwhile challenge to train GPs to provide this 
information. However, implementing interventions in a primary care setting creates 
several problems.9,10
In Germany as well as in many other European countries peer group meetings 
(quality circles) of physicians are a well-established concept, and several studies 
have proven their impact on different outcome parameters such as on 
prescriptions.11 Peer group meetings are characterised by a small number of 
participating physicians, usually less than 15, and by intense discussion among 
participants. Furthermore, recent studies have shown that case management is a 
promising approach to improving care for the chronically ill12, because it enables a 
structured follow-up which has been shown to be an important issue.13 Case 
management has been defined as “taking responsibility for following-up patients; 
determining whether patients were continuing the prescribed treatment as 
intended; assessing whether [...] symptoms were improving; and taking action 
when patients were not adhering to guideline-based treatment, or when they were 
not showing the expected improvement”.14 
184 Chapter 11 
The goal of our study was to evaluate whether providing information on arthritis 
self-management through GPs can increase patients’ QoL. Because prior research 
has indicated that case management is a promising approach to the treatment of 
chronic diseases, we assessed whether additional case management by the 
practice nurse shows better results than involving GPs only. 
 
Patients and methods 
The study was designed as a pragmatic, cluster-randomised, 3-arm intervention 
study, which is considered an appropriate approach when assessing 
implementations in a primary care setting.15 The study protocol was approved by 
the ethics committee of the University of Heidelberg prior to the start of the study. 
The study was conducted in accordance with medical professional code and the 
Helsinki Declaration (1996) as well as the German Federal Data Security Law. 
 
Recruitment of GPs 
As displayed in the flowchart (figure 1) created according to the Consolidated 
Standards of Reporting Trials (CONSORT) group (http://www.consortstatement. 
org), 503 GPs in the areas of Baden-Wuerttemberg and Bavaria were invited to an 
information meeting regarding the study with a formal letter from the Department of 
General Practice and Health Services Research of the University of Heidelberg. 
 
Patient inclusion criteria 
To be eligible for inclusion patients had to be aged ≥ 18 and diagnosed with OA in 
the knee or the hip according to the American College of Rheumatology 
criteria.16,17 Patients were contacted in consecutive order of appearance in the 
medical practice: if the main reason for the current encounter was related to OA. 
After giving their written informed consent patients received the questionnaire and 
a stamped envelope with the postal address of the university to enable them to 
return the questionnaires directly. The questionnaires for post-intervention 
evaluation were sent to the patients by mail. Written reminders were used and 
GPs were also asked to remind patients to return the questionnaires. Patients 
were explicitly informed that neither the GP nor the practice team had any way of 
gaining knowledge of their answers. 
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Figure 1. Study flow chart 
 
GPs=general practitioners 
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Primary and secondary outcomes and assessment instruments 
The primary outcome was QoL, assessed by the Arthritis Impact Measurement 
Scales Short Form (AIMS2-SF), an internationally validated instrument for the 
assessment of QOL in patients with arthritis. Secondary outcomes were physical 
activity, assessed using the short form of the International Physical Activity 
Questionnaire (IPAQ); health service utilisation (encounters with GPs, 
orthopaedics, or nonmedical practitioners of alternative medicine; number of 
physiotherapy sessions, radiographs, surgical interventions, injections to the joint) 
and prescriptions. Specialist care for patients with OA in Germany is provided by 
nonsurgical orthopedics, and not by rheumatologists as in many other health care 
systems. 
Referral rates to these orthopaedics are very high as are the number of 
radiographs.18 We hypothesised that referral rates and number of radiographs 
would decrease. 
To assess physical activity, we used the short form of the IPAQ.19 The IPAQ was 
developed by an international panel of experts and validated in nine European 
countries, including Germany. Energy expenditure related to physical activity 
(metabolic equivalents, minutes/week) was calculated according to the IPAQ 
recommendations (available at http://www.ipaq.ki.se). It is known that depression 
aggravates the pain associated with OA and contributes considerably to the 
disability.20 Furthermore, prior analyses have demonstrated that depression is 
particularly frequent among patients with OA.21 Because depression could have a 
negative influence on the effect of the intervention it was assessed by means of 
the Patient Health Questionnaire (PHQ-9)22 to enable it to be controlled as a 
potential confounder. We also assessed the following chronic conditions as 
comorbidities: high blood pressure (>140/90 mm Hg), diabetes, chronic heart 
failure, coronary vessel disease, elevated cholesterol level (total cholesterol >200 
mg/dl), ulcer or stomach disease, asthma/chronic obstructive pulmonary disease, 
renal insufficiency, (prior) cancer and (prior) stroke. The baseline assessment was 
conducted in April 2005, before any intervention was performed. The group 
meetings with the GPs took place from the end of April until the end of June. The 
post-intervention assessment was completed in December 2005, 6 months after 
the last group meeting, and 9 months after the baseline assessment. 
 
Sample size 
Sample size calculations for cluster-randomised trials differ from sample size 
calculations for common randomised controlled trials and require, due to the 
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cluster effect, larger numbers of patients to achieve the same power as trials 
randomised on the individual level.23 Based on the main outcome parameter 
(QOL) and the main outcome-assessment instrument (German version of the 
AIMS2-SF)24 we performed a power calculation with the Cluster Randomisation 
Sample Size Calculator, version 1.02 (University of Aberdeen, Aberdeen, UK): 
assuming a minimum detectable difference between groups of 10% (as being 
clinically relevant), an intracluster correlation coefficient (ICC) of 0.03 (based on 
results from comparable studies in primary care25), a power of 90% and a 
significance level of 0.05. Assuming a dropout rate of 10% we had to include 25 
medical practice; each including 14 patients at most. Because the characteristics 
of the clusters were already recognised when planning the study we aimed at 
minimising some important factors that had the potential to decrease significance 
or bias the cluster design: 1) we stratified the selected medical practices according 
to the variables rural/urban, and 2) instead of including a large number of patients 
per medical practice, we enrolled a large number of medical practices and allowed 
only 15 patients per medical practice to decrease variation in cluster size. 
 
Intervention 
The intervention was developed using a stepwise approach according to the 
recommendations of Campbell et al.26; including qualitative pre-studies to reveal 
the needs of doctors and patients as well as possible obstacles to 
implementation.27 We also conducted a pilot study to test the assessment 
instruments, and to reveal possible barriers to their implementation.28 After each 
step assessment tools and the intervention were reconsidered and refined in a 
consensus process including GPs and self-help groups. The intervention was 
multifaceted, because prior research demonstrated that strictly educational 
interventions with GPs were less effective. GPs in intervention group I participated 
in two interactive peer group meetings of 8 hours each. These meetings focused 
on three main issues: the evidence-based treatment of OA in a primary care 
setting; arthritis self-management programs for patients and the provision of 
motivational skills for working with patients, according to the 5-As approach (ask, 
advise, agree, assist, and arrange).29 In addition to the meetings GPs received a 
written summary of evidence-based treatments for OA in a primary care setting. 
This summary contained the recommendations of the European League Against 
Rheumatism (EULAR) group for the treatment of OA and information provided by 
the German Medical Association.30–32 Furthermore, GPs received written material 
for patients: a leaflet providing information about the cause, and the treatment 
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options as well as coping strategies. The leaflets also contained contact addresses 
for the two largest self-help groups, the German League against Rheumatism 
(Deutsche Rheuma-Liga) and the German Osteoarthritis Help Foundation 
(Deutsche Arthrose- Hilfe), for the patients. GPs also received booklets and audio 
CDs with a detailed exercise program, similar to some ASMPs, and were asked to 
provide these materials to every included patient. GPs in intervention group II 
participated in the same meetings so that all GPs received the same information. 
 
Implementing case management 
In an add-on approach practice nurses from intervention group II also participated 
in a course. During this course, the nurses were trained in case management. 
They learned about OA, how to call patients and monitor treatment using a 
structured OA-specific telephone questionnaire. The questionnaire assessed 3 
dimensions of treatment in 11 items: pain, effects and side-effects of prescribed 
drugs and adherence to the GPs’ recommendations regarding physical activity. 
Patients’ answers were grouped into 3 predefined categories based on urgency of 
the given information: immediate GP referral, information forwarded to the GP after 
the telephone call and information forwarded at the end of the day. The categories 
were additionally displayed by green, yellow and red flags on the questionnaire. 
For example, if a patient reported acute stomach pain this information was marked 
with a red flag, and the patient was immediately referred to the GP. This stepwise 
procedure assured that the information was forwarded to the GP according to its 
urgency. Telephone monitoring started after the baseline assessment in May 2005 
and ended in mid November, before the follow-up assessment. The telephone 
calls were conducted at least every 4 weeks. 
  
Data collection and analysis 
Each patient’s set of questionnaires was linked to the GP’s list via an identification 
number so that data given by the patients could be crosschecked with the patients’ 
file. Information on patients’ medication and health care utilisation was checked by 
1 of 3 research assistants visiting each medical practice. This was done to 
estimate the reliability of patients’ answers for a subsequent part of the project. If 
differences occurred, data from the medical file were used. Prescriptions were 
assessed via the Anatomical Therapeutic Chemical classification system code, 
and recalculated and displayed in defined daily doses (DDD) according to the 
recommendations of the World Health Organization (WHO; available at 
www.whocc.no/atcddd/). The DDD is the assumed average maintenance dose per 
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day for a drug used for its main indication in adults. Non-respondents were 
identified by comparing the questionnaires received with the GP’s list of patients 
who were invited to participate. Sociodemographic data (sex, age, ethnicity, 
education level, work situation, family situation) were collected. Education level 
was defined as follows: 1 = elementary school or less, 2 = high school and 3 = 
tertiary degree or higher. 
 
Statistical analysis 
A flowchart, in accordance with the CONSORT statement for cluster-randomised 
trials, was created to give an overview of the involvement of practices and patients 
throughout the trial. Analyses followed a pre-specified plan, taking into account the 
cluster design. Descriptive statistics for baseline characteristics were displayed. 
Baseline data were compared using Student’s t-test, or chi-square test for 
categorical data. In the case of missing data, the last observation carried forward 
method was used. If analyses of cluster-randomised controlled trials are performed 
on the patient level, the hierarchical structure has to be taken into account. To do 
so, we used the MLwiN package (Centre for Multilevel Modelling, University of 
Bristol, Bristol, UK). Following the recommendations of Campbell et al.33 we 
initially calculated the ICC for each specific variable based on the baseline data of 
all patients. This ICC was used in the analyses later on. Change in the means of 
both intervention groups was compared with the change in the means of the 
control group using analysis of covariance (ANCOVA). All analyses were 
performed based on intent-to-treat, regardless of whether patients really received 
the intended treatment, and post hoc correction for multiple testing (Bonferroni) 
was implemented.  
 
Results 
Of the 503 invited GPs, 120 gave their written consent to participate in the study 
and attended an information session. Two medical practices did not meet the 
inclusion criteria, and 3 GPs refused to participate due to time limitations. Of the 
remaining 115 practices 75 were randomly selected, stratified into rural or urban, 
and randomly assigned to either the control group or 1 of the 2 intervention groups 
(figure 1). Analysis of variation of cluster sizes revealed that the number of patients 
varied between 11 and 15 at baseline. No practice dropped out during the study 
(the chart displays the loss of patients). Of the 1,311 patients invited to participate 
by the GPs, 1,125 agreed to complete the set of questionnaires and 1,021 sets 
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were returned to the university at baseline; in 795 (77.9%) cases, questionnaires 
were returned post-intervention. 
Missing data occurred mainly within the same questionnaire, and in most cases 
the data could be completed from the patient file. An initial comparison of the 
1,021 respondents and the nonrespondents revealed no significant differences 
with respect to sociodemographic variables (age, sex), disease characteristics 
(duration of disease), or number of comorbidities and prescribed medication. A 
total of 674 (66.0%) of the included patients were women with a mean ± SD age of 
66.6 ± 15.3 years, whereas men had a mean ± SD age of 65.2 ± 14.8 years. 
The baseline characteristics of the study sample, separated for the control group 
and the two intervention groups, are displayed in table 1. Group comparison 
revealed no significant differences between the control group versus intervention 
group I and intervention group II. 
 
Table 1.  Characteristics of the study sample (n = 1,021) at baseline* 
 
 
 Control group  Intervention group I  Intervention group II 
Characteristic  (n = 25)  (n = 25)  (n = 25)  
General practitioners     
Number  25  25  25  
Working experience, mean ± SD years  23.1  ±18.2  22.2 ± 19.1  21.9 ± 18.7  
Location (rural/urban)  14/11  13/12  14/11  
Patients     
Number  332  345  344  
Female sex  229 (68.9)  214 (62.0)  231 (67.2)  
Age, mean  S±D years  66.11 ± 15.02  65.59 ± 14.68  66.27 ± 15.19  
Education level, mean ± SD  2.59 ± 1.07  2.45 ± 1.13  2.48 ± 1.02  
Living in partnership  225 (66.3)  203 (58.8)  226 (65.7)  
Retired  219 (65.7)  241 (69.9)  255 (74.1)  
Kellgren score, mean  ± SD  2.56 ± 0.87  2.71 ± 0.92  2.59 ± 0.79  
Duration of OA, mean  ±SD years  13.3 ± 14.1  13.9  ±13.0  13.4 ± 14.2  
PHQ-9 score, mean  ±SD  15.2 ± 4.8  15.1 ± 4.9  15.4 ± 5.2  
Comorbidities     
High blood pressure  187 (56.3)  195 (56.5)  182 (53.8)  
Chronic heart failure  58 (17.5)  70 (20.3)  61 (17.7)  
Coronary vessel disease  45 (13.6)  38 (11.0)  41 (11.9)  
Diabetes  63 (19.0)  58 (16.8)  55 (16.0)  
Cholesterol  126 (38.0)  136 (39.4)  140 (40.7)  
COPD/asthma  37 (11.1)  36 (10.4)  35 (10.2)  
* Values are the number (percentage) unless otherwise indicated. OA = osteoarthritis; PHQ-9 = Patient 
Health Questionnaire; COPD = chronic obstructive pulmonary disease. 
 
The primary and secondary outcome measures at baseline are displayed in table 
2. QoL was reflected in 5 different AIMS2-SF dimensions, but because most of the 
participants were already retired we excluded the work scale from further analysis, 
because this dimension is only applicable if the patient is not retired. Regarding 
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prescriptions, total numbers and percentages of patients receiving at least 1 DDD 
of the specific drug are mentioned. Group comparisons revealed no statistically 
significant differences in the outcome measures. 
 
Table 2.  Primary and secondary outcome measures at baseline* 
 
 Control group  Intervention group I  Intervention group II 
 (n=332)  (n=345)  (n=344)  
Primary outcome     
Quality of life (AIMS2-SF scores)     
Lower body  2.65 ± 1.85  2.67  ±1.88  3.01 ± 2.11  
Upper body  1.33 ± 2.09  1.47  ±2.25  1.68 ± 2.44  
Symptom  4.81 ± 2.18  4.87±  2.13  5.02 ± 2.29  
Affect  2.88 ± 1.33  2.89  ±1.35  3.04  ±1.39  
Social  4.69 ± 1.80  4.52 ± 1.88  4.79  ±1.80  
Secondary outcomes     
Health service utilisation     
GP contacts  4.82 ± 6.00  4.56 ± 6.13  5.01 ± 5.78  
Referrals to orthopedics  1.76  ±3.52  1.58 ± 3.43  1.76 ± 3.52  
Radiographs  0.79 ± 2.78  0.82 ± 3.12  0.80 ± 3.01  
Nonmedical practitioner  0.36  ±3.28  0.11 ± 3.01  0.50  ±4.20  
Physiotherapy  5.81  ±11.10  4.70 ± 9.10  5.22 ±10.03  
Acupuncture  0.97 ± 3.80  0.83 ± 3.45  0.77 ± 3.99  
Physical activity/BMI     
IPAQ total score (MET, minutes/week) 2,356.2 ± 1,982.5 2,209.7 ± 1,979.2  2,401.1 ± 1,992.3  
BMI, kg/m2  28.39 ± 5.09  28.02 ± 4.45  28.12 ± 4.57  
Prescriptions, no. (%)†     
Acetaminophen  22 (6.6)  31 (8.9)  25 (7.3)  
Opioids  23 (6.9)  20 (5.8)  25 (7.3)  
NSAID  139 (41.9)  138 (40.0)  149 (43.3)  
Homeopathics  27 (8.1)  21 (6.1)  23 (6.7)  
* Values are the mean ± SD unless otherwise indicated. 
AIMS2-SF = Arthritis Impact Measurement Scales Short Form; GP = general practitioner;  
BMI = body mass index; IPAQ = International Physical Activity Questionnaire; MET = metabolic equivalent; 
NSAID = nonsteroidal antiinflammatory drug. † Numbers of patients receiving a defined daily dose. 
 
The results of the intervention are displayed in table 3 as differences in mean 
scores between pre- and post-intervention for each group. The provided P values 
resulted from comparison of changes in means between the control group and the 
respective intervention group. The analyses using ANCOVA were controlled for 
the covariates age, disease duration, ICC and PHQ-9 score. As can be seen, 
changes in means did not differ between intervention group I and the control group 
with respect to the primary outcome. Significant results in intervention group I only 
occurred in the secondary outcome parameters: radiographs (P=0.050) and 
percentage of prescriptions of acetaminophen (P < 0.001). In intervention group II, 
significant increases in QoL were revealed in the symptom scale (P=0.048), 
reflecting patients’ perceived pain; the lower limb scale (P=0.049), assessing 
patients’ functional ability in the lower limbs; and the social scale (P < 0.001).  
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As in intervention group I, significant changes also occurred with respect to health 
service utilisation: orthopaedic referrals (P=0.044) and radiographs (P=0.031) 
decreased significantly. Prescriptions of acetaminophen (P < 0.001), nonsteroidal 
antiinflammatory drugs (P=0.019), and opioids (P < 0.001) changed significantly. 
Referrals to nonmedical practitioners and physiotherapists showed no notable 
changes. Interestingly, the IPAQ score increased in all 3 groups, but differences 
between groups were not significant. 
 
Discussion 
Multifaceted educational interventions with GPs provided through quality circles 
had no impact on patients’ QoL or physical activity. However, the interventions 
seemed to reduce certain aspects of health service utilisation such as radiographs, 
and to change prescription patterns. Additional case management by practice 
nurses involving a frequent, structured follow-up with immediate feedback to GPs 
was able to increase certain dimensions of QoL such as pain and social contacts 
in patients with OA. 
Although it is of great importance; providing arthritis self-management in primary 
care seems to be a big challenge. Buszewizc et al. provided ASMPs directly to a 
large sample of primary care patients and achieved no significant changes in pain 
and physical functioning after 4 and 12 months.7 Contrary to that study our 
intervention primarily focused on the GP, but the results of our intervention group I 
suggest that an approach that mainly uses educational interventions through GPs, 
even if the interventions are accompanied by written material and patient 
information leaflets, has no effect on patients’ QoL. We were not able to evaluate 
how much of the information provided to the GPs finally reached the patient, but 
our results fit quite well with previous findings regarding the impact of educational 
interventions. Bloom reported that the impact of educational interventions on 
patients through GPs is low34. Regarding the effect of case management, some 
impressive effects have already occurred in other contexts. Simple routine 
telephone calls were found to positively influence physical functioning and pain in 
patients with OA35 and QoL of patients with diabetes36. Our intervention was more 
complex than a simple telephone call, and our results indicate that case 
management including a structured, disease-specific monitoring tool can have the 
same or even superior effects. Positive effects from case management have also 
been shown for depression12, but previous studies have revealed inconsistent 
results for other diseases. It seems that the complexity of case management is 
correlated with the results37. However, Moher et al.38 noticed that just setting up a 
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patient register improved the planned follow-up of patients. Nevertheless, it 
remains unclear to what extent the effect in intervention group II, especially 
regarding the social scale, is due to the telephone calls, or due to frequent follow-
ups. 
Regarding health service utilisation, in both intervention groups the number of 
radiographs were reduced significantly, and in intervention group II so were 
referrals to orthopaedics. This finding indicates that educational interventions may 
be appropriate to achieve effects on the GP level, in the form of referral rates. But 
it should be acknowledged that referral rates to nonsurgical orthopaedics, as well 
as the number of radiographs, are extremely high in Germany18. This may have 
helped to achieve a significant reduction in referrals. It should also be mentioned 
that there have been studies in which outcomes such as guideline adherence were 
improved using a largely educational intervention through GPs39. 
With respect to the effects on prescription, it has to be acknowledged that the 
prescriptions of acetaminophen, the first-line treatment of OA according to most 
guidelines, and the proportion of patients receiving opioids were low at baseline. 
Therefore, significant changes were easy to achieve. Nevertheless, our findings 
confirm that peer group meetings can be useful instruments in changing 
prescription patterns11. Interestingly, Moher et al. recently demonstrated that a 
structured follow-up of patients with coronary heart disease is more effective if 
performed by practice nurses than by GPs38. Regarding adherence to 
prescriptions, a recent study demonstrated that frequent telephone calls can 
increase patients’ compliance significantly and even reduce mortality40. 
An interesting finding was that physical activity increased in all three groups with 
no significant changes between the groups. We assume that this occurred 
because the baseline assessment took place in early spring, and the post-
assessment took place 9 months later at a time when the weather is warmer and 
more compatible with outdoor activities. The possible effect of counseling provided 
by GPs seems to be weak, as a recent meta-analysis has indicated41. However, 
Elley et al.42 who implemented counseling for physical activity by telephone calls 
demonstrated that this intervention increased physical activity in patients; a finding 
that was confirmed by Castro and King43. 
Some limitations of the revealed effect should be acknowledged. First, the number 
of patients required to achieve the initially assumed power of 90% was not 
reached, but it should be noted that the number would have been adequate for a 
power of 80%. Regarding the validity of the data, some data such as consulting 
nonmedical practitioners could not be infallibly recorded on the medical file. 
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Moreover, information about prescriptions and referrals was only available if 
initiated by the GP. Besides the large sample size of primary care patients, the 
study has additional strengths: 1) we used a disease-specific assessment 
instrument for QOL that may be more sensitive to patient-relevant changes; 2) to 
our knowledge, this is the first study to assess case management in patients with 
OA and 3) we controlled our data for severity of depression, the prevalence of 
which is known to be increased in patients with OA21. Depression has a 
detrimental effect on certain important dimensions of QoL such as pain and 
physical ability. Regarding the generalisability of our results, the 75 GPs most 
likely reflect a representative sample in terms of localisation, working experience, 
practice size and nursing support.  
Providing arthritis management seems challenging, and educational interventions 
on the GP level, even if multifaceted, do not appear to achieve significant effects 
on QoL. Additional case management by practice nurses increases the effect and 
improves certain dimensions of patients’ QoL significantly. Our results encourage 
further research using similar approaches in other chronic diseases. 
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Introduction 
Although the figures regarding the prevalence of radiological or symptomatic 
osteoarthritis (OA) vary, there is no doubt that OA is highly prevalent and that 
primary care has an outstanding role in the diagnosing process and treatment of 
OA. In contrast to that, astonishingly little research on OA patients in primary care 
is available. In the first section of this thesis we presented several studies on the 
quality of life of OA patients, their needs and perspectives. We also presented the 
German validation of one the most widespread instrument to assess QoL, the 
Arthritis Impact Measurement Scale (AIMS), and showed that GPs assessment of 
patients’ QoL is dominated by pathological changes.  
In the second section we highlighted the implications of depression for the QoL of 
OA patients and the impact on their health service utilisation (HSU). Furthermore, 
the impact of obesity on QoL and the determinants of pain, one of the strongest 
predictors of QoL, were assessed.  
In the third and final section quality and outcomes of current primary care were 
examined, and ideas for larger involvement of the practice nurse were explored. 
And finally we tested the impact of case-management provided by practice nurses 
in a large cluster-randomised trial. 
 
Discussion of the main findings 
 
Quality of life 
Prior research had shown that pain and disability were the major burdens of OA1-4, 
and that patients with OA desire more information5. This was also reflected in the 
results of our qualitative study, presented in chapter one. Our results helped to 
specify the content of information for patients: patients are mainly interested in the 
impact of OA on their individual situation regarding pain and mobility rather than 
on information about the pathology of the disease. Interestingly, a similar result 
was revealed by Grime et al. regarding patient information leaflets for OA6. 
Considering this, it might not surprise that many patients felt their main fear, the 
individual course of the disease, to be insufficiently addressed. A similar lack in 
communication could be revealed regarding pain treatment and advice for lifestyle 
changes: GPs should emphasise the meaning of physical activity with individual 
advice. They should also emphasise that pain medication should be used to 
enable daily physical activity and not be used as a “rescue” treatment.  
In research QoL has become an important parameter and outcome measure; for 
instance in evaluations of treatments. A wide range of instruments has been 
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developed to assess patients’ QoL. Studies have shown that disease specific 
instruments are often more appropriate than generic ones. Regarding OA, there 
are three instruments which are of importance: The Western Ontario and Mc 
Master Universities Index (WOMAC)7, the Lequesne - Index 8 and the AIMS2, of 
which a revised short and long version are available.9;10 As in many chronic 
diseases, the impact of OA on QoL interferes with many individual factors as e.g. 
psychological and social ones.11-14 The advantage of the AIMS is that it is more 
comprehensive then the WOMAC and the Lequesne-Index and can be used 
without further instruments as e.g. the SF-36, even if a complex overview of all 
dimensions of QoL is of interest. We validated both versions of the AIMS2 in two 
different groups of patients. The psychometric properties of both versions were 
convincing, and in conclusion we showed with our study that both versions of the 
AIMS2 are reliable and valid instruments. The acceptance in a primary care setting 
was high, as reflected in the high response rate and the low amount of missing 
values, so that these two instruments are now available for the assessment of QoL 
in research as well as practice in primary care. 
Our qualitative study, presented in chapter one, showed that physicians have a 
very pathomorphological approach to OA and focus on “visible” affections of OA 
on the joints. Based on these qualitative finding, and with the validated AIMS2, it 
seemed interesting to reveal the determinants of physicians’ perceived QoL of 
patients with OA. Therefore, we compared a global physician assessment of 
patients’ QoL with the AIMS2-SF, the WOMAC and X-rays. In conclusion, and in 
accordance with our qualitative results, the study suggested that physicians’ 
assessment of patients’ QoL is mainly dominated by physical factors, namely pain 
and severity of X-ray findings. Socioeconomic and psychosocial factors, which are 
known to have a substantial impact on QoL, were underestimated or missed. This 
finding is in accordance with previous findings showing, for instance, that 
depression or depressive symptoms are often missed.15 Moreover, the 
overestimation of X-ray findings, which are known to be less correlated to QoL, 
may cause over-treatment, while important and promising targets to increase 
patients’ QoL are missed 16;17. 
 
The main predictors for QoL of OA patients are pain and functional disability. Many 
studies have shown the substantial impact of pain on quality of life18;19 and on 
health service utilisation (HSU)20, especially among OA patients. Even the 
association between depression and pain has been investigated for a long time; 
research in large primary care patient groups was not yet available.21-24 Our results 
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showed that severity of depression reflected in the Patient Health Questionnaire 
(PHQ)-9 score is the strongest predictor for pain intensity in OA patients. These 
results are in line with previous findings from smaller samples, or samples from 
hospital settings.18;19 Some prior studies also indicated that psychosocial aspects 
are important for pain perception; a result which could be confirmed in our large 
sample of primary care patients. Furthermore, we could show the close 
association between the educational level and pain perception as well as the 
contribution of the social network to the burden of OA.26 As mentioned above, 
functional disability is also of great influence on the QoL of OA patients. Our 
studies emphasised the strong association of depression and functional disability 
and confirmed prior findings, assessing less covariates and/or focusing on smaller 
patient groups.1;3;25
Taking into account that psychosocial aspects are often not recognised 
appropriately, our results emphasise again the importance of awareness for 
depression and psychosocial factors, especially in patients with chronic 
diseases.15 The GP is the physician who is more familiar with the social 
background than any other physician, and so he is predestined to consider this 
important factor in pain treatment.   
 
Comorbidities and health service utilisation 
We found that, as in many other chronic diseases, an increased prevalence of 
depression among OA patients27-31 (chapter 5). But depression did not only have a 
substantial impact on individuals’ QoL, it resulted also in increased use of the 
health care system32. This finding had been found in patients with depression 
before, but not that it also results in increased use of medical professions which 
are involved in the care of OA patients. On the other hand, contacts with providers 
of Complementary Alternative Medicine (CAM) offered e.g. by “healers” were not 
significantly increased. In conclusion, and continuing our findings presented in the 
first section, the challenge in daily care obviously is to be aware of concomitant 
depression in OA patients and to treat the whole patient, not only the affected joint. 
Our results suggest that this will not only increase patients’ QoL but also reduce 
inappropriate consultations and procedures.   
Body weight, the body mass index (BMI) respectively, is the strongest modifiable 
risk factor for OA. This was the finding of many large studies, including the 
Framingham population.33;34 But even if OA is already symptomatic, reducing body 
weight leads to less pain and less functional disability as a recent review pointed 
out.6 So far and similar to depression, only few data existed about the association 
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of obesity with quality of life, health service utilisation and physical activity within 
the same sample of OA patients. Our results, which assessed the impact of 
obesity on QoL are in accordance with prior studies and showed that obese and 
overweight persons achieved significantly higher scores on the AIMS2-SF lower 
body scale, the symptom, the affect and the work scale, indicating an increased 
burden by OA.35 Prevalence of depression, highlighted already several times in 
this discussion, increased significantly over the three weight-groups and confirmed 
the result of prior research, indicating an association of body weight and 
depression36. Also in accordance with findings within other diseases, with 
increasing BMI, the number of comorbidities -especially cardiovascular ones – also 
increased as the physical activity decreased significantly. As many studies – 
focusing on diabetes or cardiovascular diseases, our results emphasised the need 
for appropriate approaches in primary care to break the vicious circle of 
overweight, depression, decreasing physical inactivity and decreasing QoL from 
the perspective of OA patients.  
 
Improving the quality of care 
 
The research presented in chapter 10 and 11 focused on the delivery of care. In 
chapter 10, we analysed to what extent current care for OA patients was 
consistent with the Chronic Care Model (CCM), which claims to reflect the core 
elements of patient-centred care in chronic diseases37;38. In comparison to data 
available from Health Maintenance Organisation (HMO) settings in the United 
States (US), our data indicated that the core elements of chronic care were less 
present in German primary care, a finding which has recently also been found in 
German diabetes patients39-41. Furthermore, the data showed that younger and 
better educated patients achieved higher scores on the PACIC score, indicating 
that their care accords to a higher degree with the CCM. Whether this reflects 
differences in physician behaviour toward different patient groups or rather 
different demands of these patient groups cannot be concluded from the 
presented data. Further research is needed to confirm our results and to reveal 
possible limitations of the CCM since it may be only appropriate for certain patient 
groups.  
 
Regarding OA patients, satisfaction with healthcare delivery has been assessed 
regarding certain types of treatment such as pain treatment or surgical 
interventions42;43. Our hypothesis was that, similar to the results regarding these 
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treatments, disease specific quality of life will have a substantial impact on patient 
evaluation of care provided. But interestingly, beside the duration of OA, no 
disease related factor was associated with patient evaluations of care. Our results 
indicate that psychosocial factors are more important to explain the care provided 
than disease-related aspects. This finding emphasises the awareness of these 
factors from a completely different point of view.   
Many approaches to enhance care for chronically ills, as for instance the CCM 
model, require a team approach and the involvement of, for instance, practice 
nurses44-46. And indeed, there is good evidence that involvement of nurses in 
primary care can improve specific aspects of healthcare47;48. Since positive effects 
of nurse involvement have neither been shown in large samples of primary care 
patients with OA, nor in the German health care system it was our aim to assess 
such an approach in a large cluster-randomised controlled trial (RCT). The 
German health care system is physician-centred and it was completely unclear if 
and to what extent practice nurses could be involved in the care for chronically ill 
patients. In detail it was unclear what practice nurses themselves, but also general 
practitioners (GPs) and patients think about such a team approach. Our qualitative 
study (chapter 11) showed that practice nurses were only marginally involved in 
the treatment of patients, especially in OA. One important obstacle, mentioned by 
GPs, practice nurses and patients, was the lack of nurses’ medical knowledge. 
There was a consensus that current education for practice nurses obviously 
provides only a rudimentary professional medical background. Beside that point, 
most patients were optimistic regarding the involvement of nurses. Only few 
patients feared a worsening of the patient-doctor relationship. In conclusion, our 
study showed that the German health care system is far away from providing 
resources for a real team approach as provided in many other health care systems 
where established professions such as physician assistants exist48. The changes 
that need to be made are mostly on a political level and out of the reach of 
individual physicians. 
The implications of that finding for our RCT were quite obvious: The involvement 
had to be reduced to a simple but structured monitoring of the patients with a 
specially developed tool, the “Arthrosis Monitoring List” (ArtMoL). Bloom et al. 
pointed out in a review of interventions which are appropriate to result in significant 
changes that the effect of simple educational interventions is low49. Our results 
confirmed that result, since in the group which just received education no 
significant changes in QoL could be recognised. In the group which performed an 
additional case management, which consisted of frequent telephone calls based 
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on the ArthMoL, we could achieve significant changes in some areas of the 
disease specific QoL. Telephone calls, even if not accompanied by a structured 
monitoring tool, have shown to be an effective procedure in completely different 
settings: they increased physical activity, reduced pain and even mortality50-52. Our 
results suggest that they are very effective if combined with a structured tool such 
as the ArtMoL. Based on our results, structured telephone tools are currently used 
in further projects as for instance in patients with heart insufficiency or 
depression53;54. So, hopefully further results to confirm our findings will come forth, 
thus enabling advances in the tool and consequently in the care for chronically ills.  
 
Methodological considerations 
 
Limitations of the qualitative research  
Our qualitative studies had the limitations that are inevitably associated with this 
type of research: the statements reflect individual opinions, and self reported 
behaviour may not adequately reflect the real behaviour or does not reflect reality. 
For instance, if GPs report they have no problem in distinguishing articular from 
periarticular pain this does not mean that they are correct in doing so. Another 
limitation is that the results are appropriate for the German health care system and 
cannot easily be transferred to other health care systems.  
 
Limitations of the quantitative research  
The analysis based on the PraxArt- population of OA patients in primary care had 
a number of limitations. First of all, some of the data such as, e.g, the data about 
contacts with providers of complementary alternative medicine, or the over-the-
counter- (OTC) medication were based solely on patients' replies. Contrary to 
most other data they could not be checked by means of the patient file. Regarding 
the RCT, the required number of patients to achieve the initially desired statistical 
power of 90% was not reached, but it should be noted that it was adequate for a 
power of 80%. Furthermore, it has to be noted that we tested the intervention 
against a control group with no intervention at all (except usual primary care). To 
assess the efficacy of case management, that it is “pure effectiveness”, it should 
have been tested against a “placebo-intervention” (e.g. simple telephone calls 
involving only conversation but no medical content). Furthermore, it remains 
unclear if a more complex approach - as required for care according to the CCM - 
can be implemented in primary care in Germany. The evaluation of complex 
interventions, such as the Chronic Care Model, remains a scientific challenge. 
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Strengths of the study 
On the other hand, the studies presented in the thesis had a number of strengths: 
we had a large sample size of primary care patients and we used a disease-
specific and validated measure on QoL. Furthermore, to our knowledge this thesis 
presented the first study to assess case management in OA patients. As initially 
assumed and displayed in chapter 5, depression is an important comorbidity and 
of great influence on QoL but also for health service utilisation. Depression has 
also a detrimental effect on physical ability. Consequently, we controlled our 
analysis of the RCT for this covariate. Regarding the generalisability of our results, 
the 75 GPs most likely reflect a representative sample in terms of localisation, 
working experience, practice size and nursing support.  
 
Implications for practice and future research 
 
Our results confirmed in large primary care setting what has been found in hospital 
settings before: Psychosocial factors contribute tremendously to the quality of life 
of OA patients and are also important predictors for the use of the health care. And 
interestingly, even the GP who is more familiar with the psychosocial background 
of the patient as any other physician had a very pathomorhoplogical and 
mechanical idea of the QoL of OA patients (at least in Germany). As a 
consequence, psychosocial aspects were often not assessed, underestimated and 
not targeted in the treatment. GPs tried to distinguish between “somatic” and 
“psychological” problems instead of understanding them as closely related and 
influencing them reciprocal. These findings imply for daily practice, that physicians 
should always focus on the individual’s perspectives and QoL rather than on 
providing pathophysiological explanations which are not appropriate to decrease 
patients’ fears. Individuals’ QoL and not only actual pain and functioning have to 
be the targeted. Further research is needed to assess how GPs’ awareness for 
these factors could be increased, and also what type of treatments or counselling 
by the GP could effectively influence these factors. Possible approaches could 
assess, for instance, the use of structured screening tools for pain and depression 
as the PHQ-9, the AIMS2-SF or just a simple visual analogue scale (VAS). 
Furthermore, methods are needed to influence risk factors for OA, for instance, 
effective counselling to increase physical exercise. But without a doubt, 
appropriate consultation time is also an important condition to assess patients’ 
QoL and influence their behaviour. Politicians should be aware that the current 
trend to increase administrative workload and to pay physicians for the amount of 
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contacts rather than the time spent with the patients contradicts the needs of 
chronically ill patients. 
 
Proactive and structured care requires the involvement of practice nurses. GPs 
should abandon their fears and be more open minded towards team approaches. 
It seems inconsistent that to complain about an increasing workload on the one 
hand and at the same time to defeat the distribution of the work on more 
shoulders. As our large cluster-RCT suggested - similar to some studies before - 
involvement of non-physician practitioners increases the quality of care and also 
patients QoL. And in the long run it may also decrease the workload for the 
physician, although current research evidence is not conclusive on this. Obviously, 
such involvement of nurses requires professional development of the nurses 
themselves – e.g. special training programmes to qualify for working in primary 
care settings. But as prior studies indicated, politicians should also abandon the 
idea that this will decrease costs. How more complex approaches, such as the 
involvement of practice nurses, could be implemented in the physician-centred 
German health care system has to be the subject of future research.  
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212 Summary 
Chapter 1 
Chapter 1 reports the results of a qualitative approach on the views of patients, 
general practitioners and practice nurses on the current situation of care for OA 
patients in general practice in Germany. The main findings were that diagnosing 
OA represents no challenge for GPs. But in assessing pain and physical disability 
the GPs often found it difficult to distinguish between complaints resulting from the 
affection of the joints and complaints related to a concomitant depression. Patients 
felt to be well-informed about the degenerative nature of the disease and possible 
side effects of medications, but they lacked information on individual 
consequences of the disease. Therefore, the most important concerns of many 
patients were pain and fear of disability which they felt to be addressed by GPs 
only marginally. Regarding pain treatment, physicians and patients had an 
ambivalent attitude towards non-steroidal anti-inflammatory drugs (NSAIDs) and 
opiates. Therefore, pain treatment was not performed according to prevailing 
guidelines. GPs felt frustrated about the impact of counselling regarding lifestyle 
changes, but on the other hand admitted to have no systematic approach to it. 
Patients stated to be aware of the impact of lifestyle on OA but lacked detailed 
information, e.g., on how to exercise. Several suggestions were made concerning 
improvement. 
 
Chapter 2  
To assess quality of life, valid and reliable instruments are required. In chapter 2 
the process of translation and validation of the most widespread instrument to 
assess QoL of OA patients, the Arthritis Impact Measurement Scale 2 (AIMS 2) 
and its short form the AIMS 2-SF, are given. Both instruments were translated into 
German and culturally adapted. Each of the questionnaires was then administered 
to 220 primary care patients with OA of the knee or hip. 209 (long version), 
questionnaires were returned and analysed. Test-retest reliability was tested in 50 
(long version), respectively 35 (short form) randomly selected patients. The 
“physical” scale of the original AIMS2-SF was divided into an “upper body 
limitations” and a “lower body limitations” scale. In both versions the assessment 
of internal consistency reliability revealed satisfactory values; Cronbach's alpha 
was 0.77 or higher for all scales of the long version and 0.83 or higher for all 
scales, except for the “social interaction” scale (0.66 of the short version). The test-
retest-reliability, estimated in an intraclass-correlation-coefficient (ICC), exceeded 
0.90, except the “social activities” scale (0.87) in the long version. In the short 
version the ICC exceeded 0.85, except the “affect” scale (0.72). Since only 
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patients with OA to the lower limb were enrolled, substantial floor effects occurred 
in the “arm function” (28.2 %) and the “hand and finger function” scale (29.2) in the 
long version and in the “upper limb scale” (33.8 %) of the short form. The principal 
factor analysis confirmed the postulated three-factor structure with a physical, 
physiological and social dimension for both versions. External validity was 
assessed by calculating correlations to the Western Ontario and Mc Master 
Osteoarthritis Questionnaire (WOMAC): a visual analogue scale for pain (pain-
VAS) and radiological severity of joint affection (assessed by means of the 
Kellgren and Lawrence score). Spearman’s “R” achieved satisfactory values for 
the corresponding WOMAC scales and the pain-VAS. Correlations with the 
radiological grading were low. In conclusion, our validation studies showed that 
both versions of the AIMS2 are reliable and valid instruments to assess the quality 
of life in primary care patients suffering from OA. While addressing different 
impacts of OA the physical scale should be divided in an “upper body” and “lower 
body” scale. The revealed floor and ceiling effects are in accordance with the 
disease characteristics of the study sample and do not limit the significance of the 
questionnaire. 
 
Chapter 3 
The aim of chapter 3 was to assess determinants of physicians’ estimation of 
patients’ QoL. Therefore, we included 220 primary care patients with OA of the 
knee or the hip treated by their general practitioner for at least one year. All GPs 
were asked to assess patients’ QoL based on the patients’ history, actual 
examination and existing X-rays by means of a visual analogue scale (VAS scale), 
resulting in values ranging from 0 to 10. Patients were asked to complete the 
McMaster Universities Osteoarthritis Index (WOMAC) and the Arthritis Impact 
Measurement Scale2 Short Form (AIMS2-SF) questionnaire. The results showed 
significant correlations between the GP assessment and the AIMS2-SF scales 
“physical” and “symptom” as well as to the “pain” scale of the WOMAC. A 
multivariate ordinal regression analysis revealed only the AIMS2-SF “symptom” 
scale and the X-ray grading according to Kellgren and Lawrence as significant 
influences of the GPs’ assessment of QoL. In conclusion, the results of our study 
suggested that physicians’ assessment of patients’ QoL is mainly dominated by 
physical factors, namely pain and severity of X-ray findings. The results also 
suggest that socioeconomic and psychosocial factors, which are known to have 
substantial impact on QoL, are underestimated or missed.  
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Chapter 4 
The aim of chapter 4 was to assess predictors of depression in a large sample of 
primary care patients with osteoarthritis. Patients were approached consecutively 
in 75 general practices. Of 1,250 distributed questionnaires, 1,021 were returned 
and analysed. Besides sociodemographic data, medication and comorbidities, 
depression and arthritis were assessed using the Patient Health Questionnaire 
(PHQ-9) and the Arthritis Impact Measurement Scale (AIMS2-SF). A stepwise 
multiple linear regression analysis with the PHQ-9-score as the dependent variable 
was performed. According to the PHQ-9, 19.8 % of men and 19.2% of women 
achieved a score of 15 or higher, indicating at least a moderately severe 
depression. Interestingly, significant gender differences could not be revealed. The 
strongest predictor for depression severity was perceived pain and few social 
contacts. Further predictors were physical limitation of the lower body as well as of 
the upper body, age and the body mass index. The findings suggest an increased 
prevalence of depression among OA patients and emphasise the need for 
recognition and appropriate treatment. Most of the revealed predictors are 
influenceable and should be potential targets in a comprehensive treatment of OA 
in order to interrupt the vicious circle of pain, physical limitation and depression. 
 
Chapter 5 
The aim of the paper in chapter 5 was to assess the impact of concomitant 
depression on quality of life and health service utilisation in patients with 
osteoarthritis. Data from 1,021 outpatients from 75 general practices enrolled in 
the PraxArt project were analysed. Measures included sociodemographic data, a 
short form of the Patient Health Questionnaire (PHQ-9) to assess depression. 
Data about health service utilisation (contacts with GPs, orthopaedics and to 
providers of complementary alternative medicine) were retrieved by straight 
forward questions as well as by means of patients’ medical. The results showed 
that patients with a depressive disorder showed significantly more frequent 
contacts with GPs (p<0.01), orthopaedics (p<0.01) but not with providers of 
complementary alternative medicine offered, e.g., by healers. The findings 
provided a more differentiated view on health service utilisation patterns. It could 
be concluded that depressed patients tend to visit providers where they can 
remain passive.  
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Chapter 6 
The aim of the study presented in chapter 6 was to assess the association of 
obesity with quality of life, health service utilisation and physical activity in a large 
sample of primary care patients with osteoarthritis (OA). In 978 patients from the 
PraxArt project, height and weight were measured and the body mass index (BMI) 
was calculated. The AIMS2-SF was used to assess quality of life (QoL). Data on 
health service utilisation (HSU) were retrieved by means of patients’ medical files. 
Concomitant depression was assessed by means of the Patient Health 
Questionnaire (PHQ-9). Patients were grouped into normal weight, overweight and 
obese according to the definition of the WHO and compared by means of analysis 
of covariance (ANCOVA). Obese and overweight persons achieved significantly 
higher scores on the AIMS2-SF lower body scale, the symptom, the affect and the 
work scale, indicating an increased burden of OA. The PHQ-9 score increased 
significantly over the three weight-groups, indicating a positive association of BMI 
and depression. With increasing BMI, the number of comorbidities increased and 
physical activity decreased significantly. After controlling for covariates, contacts 
with orthopaedics and performed X-rays remained significantly higher in obese 
patients but not contacts with general practitioners.  
 
Chapter 7 
Pain represents one of the most important predictors of quality of life in patients 
with osteoarthritis. But most studies assessing pain failed to control important 
covariates such as depression, obesity or physical activity. Therefore, we aimed to 
determine factors associated with pain intensity in a large sample of OA patients in 
primary care. In a regression model with the “symptom” dimension of the AIMS2-
SF as dependent four factors remained explaining 47.9 % of the variation: severity 
of depression reflected in the PHQ-9 score influences pain intensity the most (beta 
= 0.459, p<0.001). Functional disability of the lower limb accounted for a beta of 
0.427 (p=0.003). A low educational level was associated with increased pain 
scores (beta=-0.321; p=0.029) as was disease duration (beta=0.178; p= 0.017). 
The social contacts/network, addressed by the AIMS social scale accounted for a 
beta of 0.211 (p=0.040). Our study showed that a variety of physical and 
psychological factors was associated with pain intensity.  
 
Chapter 8 
Patient satisfaction is an important indicator for the quality of care provided to OA 
patients. Previous studies focused on patient satisfaction regarding certain 
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treatments such as, e.g., surgical interventions or pain treatment. The aim of the 
study presented in chapter 8 was to assess current satisfaction of OA patients and 
to assess if disease related factors are important for satisfaction. Within the 
sample of 1,021 OA patients, QoL was assessed by means of the AIMS2-SF and 
patient satisfaction was measured by means of the EUROPEP instrument. A 
stepwise linear regression analysis with the EUROPEP score as dependent 
variable controlled for the amount of GP visits was performed to assess predictors 
of satisfaction. Contrary to our assumptions, only the duration of OA (beta=-0.105; 
p=0.008) and no other disease related factor was associated with patient 
satisfaction. The main predictors were the depression score (beta=-0.372; 
p<0.001), age (beta=-0.185; p<0.001), living alone (beta=-0.209; p<0.001), 
number of comorbidities (beta=-0.152; p<0.001).  
 
Chapter 9 
The aim of chapter 9 was to assess to what extent current care for patients with 
osteoarthritis accords with the Chronic Care Model in Germany. In addition, we 
tried to reveal possible predictors of a high congruency and to assess the question 
whether certain patients are more likely to receive care complying with the CCM.   
The Patient Assessment of Chronic Illness Care (PACIC-5A) was used to assess 
accordance to the CCM, QoL was assessed by means of the Arthritis Impact 
Measurement Scale (AIMS2-SF). The PACIC sum score was notably lower than in 
previous studies conducted in HMO settings in the US. The stepwise multiple 
linear regression models, with the PACIC sum score and the 5A score as 
dependents, revealed that the PACIC score was associated with a higher 
educational level (beta= 0.421; p=0.008) and younger age (beta=-0.319; p=0.016). 
The 5A score was predicted by educational level (beta=0.344; p=0.002), age 
(beta=- 0.386; p=0.004) and the PHQ-9 score (beta=- 0.288; p=0.005). In 
conclusion, our results showed that younger and better educated patients achieve 
higher scores on the PACIC score. Why these patients received care that complies 
to the CCM more remains unclear.  
 
Chapter 10 
In chapter 10 we aimed to reveal possibilities to involve the practice nurse in the 
care of osteoarthritis patients. We performed qualitative, semi-structured 
interviews with 20 GPs, 20 practice nurses and 20 patients in the Heidelberg area. 
The interviews were digitally recorded, transcribed and content-analysed with 
Atlas.ti. Our results showed that practice nurses are only marginally involved in the 
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treatment of patients with OA. GPs as well as patients are very sceptical about 
their increased involvement in care. Patients were sceptical about nurses’ 
professional background and feared a worsening of the patient-doctor relationship. 
GPs also complained about the nurses’ deficient education concerning medical 
knowledge. They feared a lack of time as well as lacking reimbursement for the 
efforts of an increased involvement. Practice nurses were mostly willing to be more 
involved; regarding it as an appreciation of their role. The most important barriers 
we revealed were lack of time, overload with administrative work and a lack of 
professional knowledge.  
 
Chapter 11 
In the paper presented in chapter 11, we aimed to assess whether providing 
information on arthritis self-management through GPs increases the quality of life 
of patients with osteoarthritis and whether additional case management provided 
by practice nurses shows better results. In a pragmatic, cluster-randomised 
controlled, three-armed trial, 1,021 patients from 75 primary care practices in 
Germany were included. GPs were randomised to intervention group I or II or to a 
control group. GPs of both intervention groups participated in two peer group 
meetings. In intervention group II additional case management via telephone was 
conducted by a practice nurse. The primary outcome was change in quality of life 
(QoL), assessed by means of the GERMAN-AIMS2-SF. Secondary outcomes 
were health service utilisation, prescriptions and physical activity. Data were 
controlled for depression (using PHQ-9) as a potential confounder. 1,021 of 1,125 
administered questionnaires were analysed. Compared to the control group, no 
significant changes occurred in intervention group I with respect to the primary 
outcome. Performed X-rays dropped significantly (p=0.050), while prescriptions of 
paracetamol increased significantly (p<0.001). In intervention group II, significant 
changes in the AIMS2-SF dimensions “social” (p<0.001), “symptom” (p=0.048) and 
“lower body” (p=0.049) were identified. X-rays (p=0.031) and contacts with 
orthopaedics (p=0.044) decreased while prescriptions of pain relievers increased 
significantly. To conclude, improving the QoL of arthritis patients using arthritis 
self-management seems to be challenging. Simply providing information through 
GPs is not sufficient, but combining it with case management seems to be a 
promising approach. 
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Hoofdstuk 1 
Hoofdstuk 1 doet verslag van de resultaten van een kwalitatieve benadering van 
de oordelen van patiënten, huisartsen en praktijkassistentes over de huidige zorg 
voor artrosepatiënten in huisartspraktijken in Duitsland. De voornaamste 
bevindingen waren dat het diagnosticeren van artrose geen uitdaging voor de 
huisartsen is. Maar bij het beoordelen van de pijn en fysieke handicaps vonden de 
huisartsen het vaak moeilijk onderscheid te maken tussen klachten voortkomend 
uit een aandoening van de gewrichten en klachten gerelateerd aan een daarmee 
samenhangende depressie. Patienten vonden dat ze goed geïnformeerd waren 
over de degeneratieve aard van de ziekte en mogelijke bijwerkingen van de 
medicijnen, maar ze misten informatie over individuele consequenties van de 
ziekte. Daarom waren de belangrijkste zorgen van veel patiënten pijn en angst 
voor handicaps, wat naar hun mening door huisartsen maar globaal besproken 
werd. Betreffende pijnbestrijding hadden huisartsen en patiënten een ambivalente 
houding ten opzichte van non-steroidal anti-inflammatory medicatie (NSAIDs) en 
opiaten. Pijnbestrijding werd daarom niet uitgevoerd overeenkomstig de 
heersende richtlijnen. Huisartsen voelden zich gefrustreerd over de invloed van 
het geven van adviezen over verandering van leefstijl, maar van de andere kant 
gaven ze toe er geen systematische benadering voor te hebben. Patiënten 
verklaarden zich bewust te zijn van de invloed van hun leefstijl op artrose maar 
misten gedetailleerde informatie, bijv. over het doen van oefeningen. Diverse 
suggesties zijn gedaan voor verbetering.  
 
Hoofdstuk 2  
Om de kwaliteit van leven te toetsen zijn valide en betrouwbare instrumenten 
nodig. Het proces van vertaling en validatie van het meest verspreide instrument 
om de kwaliteit van leven van artrose patiënten te toetsen, de Arthritis Impact 
Measurement Scale 2 (AIMS 2) en de korte versie, de AIMS 2-SF worden in 
hoofdstuk 2 gepresenteerd. Beide instrumenten werden vertaald naar het Duits en 
aangepast aan de duitse cultuur. Elk van de vragenlijsten werd gestuurd aan 220 
patiënten in de eerste lijn met artrose van de knie of heup. 209 (lange versie) 
vragenlijsten werden teruggestuurd en geanalyseerd. De test-retest 
betrouwbaarheid werd getest bij 50 (lange versie), respectievelijk 35 (korte versie), 
willekeurig geselecteerde patiënten. De “fysieke” schaal van de oorspronkelijke 
AIMS2-SF werd verdeeld in een schaal voor de beperkingen van het 
bovenlichaam en een voor de beperkingen van het onderlichaam. In beide versies 
leverden de toetsing van de interne betrouwbaarheid voldoende waarden op; 
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Cronbach's alpha was 0.77 of hoger voor alle schalen van de lange versie en 0.83 
of hoger voor alle schalen, behalve voor “sociale wisselwerking” schaal (0.66 bij de 
korte versie). De test-retest betrouwbaarheid, uitgedrukt in een intraclass-
correlation-coefficient (ICC), kwam boven de 0.90, behalve de “sociale activiteiten” 
schaal (0.87) in de lange versie. In de korte versie kwam de ICC boven 0.85, 
behalve bij de “gevoelens/emoties” schaal (0.72). Omdat alleen patiënten met 
artrose bij de lagere ledematen (arm/been) waren geïncludeerd, traden 
substantiële bodemeffecten op in de “armfunctie” (28.2%) en de “hand- en 
vingerfunctie” schaal (29.2) in de lange versie en in de “bovenste ledematen 
schaal” (33.8%) van de korte versie. De principal factor analyse bevestigde het 
uitgangspunt van een drie factoren structuur met fysieke, fysiologische en sociale 
dimensies voor beide versies. Externe validiteit werd beoordeeld door berekening 
van correlaties met de Western Ontario en Mc Master Osteoarthritis Questionnaire 
(WOMAC), een visueel analoge schaal voor pijn (pijn-VAS) en radiologische 
zichtbare ernst van botbeschadiging (getoetst door middel van de Kellgren en 
Lawrence score). Spearman’s “R” bereikte voldoende waarden voor de daarmee 
samenhangende WOMAC schalen en de pijn-VAS. Samenhang met de 
radiologische beoordeling was laag. We concluderen dat onze validiteitsstudies 
lieten zien dat beide versies van de AIMS2 betrouwbare en valide instrumenten 
zijn om de kwaliteit van leven te toetsen van patiënten in de 1e lijn die lijden aan 
artrose. Bij het richten op verschillende vormen van artrose zou de fysieke schaal 
verdeeld moeten worden in een schaal voor het bovenlichaam en voor het 
onderlichaam. De gevonden bodem- en plafondeffecten zijn in overeenstemming 
met kenmerken van de ziekte bij de steekproef van de studie en beperken de 
betekenis van de vragenlijst niet.  
 
Hoofdstuk 3 
Het doel van hoofdstuk 3 was determinanten te toetsen van de inschatting van de 
huisartsen van de kwaliteit van leven van de patiënten. Derhalve includeerden we 
220 patiënten in de eerste lijn met artritis aan de knie of heup die minstens een 
jaar onder behandeling waren bij hun huisarts. Aan alle huisartsen werd gevraagd 
om de kwaliteit van leven van de patiënten te toetsen, gebaseerd op de 
geschiedenis van de patiënt, huidig onderzoek en bestaande röntgenfoto’s d.m.v. 
een visueel analoge schaal (VAS-schaal), resulterend in waarden tussen 0 en 10. 
Patiënten werd gevraagd twee vragenlijsten in te vullen: de McMaster Universities 
Osteoarthritis Index (WOMAC) en de Arthritis Impact Measurement Scale2 Short 
Form (AIMS2-SF) vragenlijst. De resultaten lieten een significante samenhang 
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zien tussen zowel de beoordeling door de huisarts, de AIMS2-SF schalen “fysiek” 
en “symptomen” als de “pijn” schaal van de WOMAC. Een multivariate ordinal 
regressie analyse toonde aan dat alleen de AIMS2-SF schaal “symptomen” en de 
röntgenfoto beoordeeld volgens Kellgren en Lawrence een significante invloed 
hadden op de beoordeling van de kwaliteit van leven door de huisartsen. 
Concluderend: de resultaten van onze studie laten zien dat de beoordeling van de 
kwaliteit van leven van patiënten door de huisartsen voornamelijk wordt bepaald 
door fysieke factoren, namelijk pijn en ernst van de röntgenfoto’s. De resultaten 
laten ook zien dat sociaal-economische en psychosociale factoren, waarvan 
bekend is dat ze een substantiële invloed hebben op de kwaliteit van leven, 
onderschat of gemist worden.  
 
Hoofdstuk 4 
Het doel van hoofdstuk 4 was om voorspellers van depressies te vinden in een 
grote steekproef van patiënten in de eerste lijn met artrose. Patiënten werden 
opeenvolgend benaderd in 75 huisartspraktijken. Van 1250 uitgedeelde 
vragenlijsten werden er 1021 teruggestuurd en geanalyseerd. Naast 
sociodemografische data, medicatie en comorbiditeit werden depressie en artritis 
getoetst door gebruik van de Patient Health Questionnaire (PHQ-9) en de Arthritis 
Impact Measurement Scale (AIMS2-SF). Een stapsgewijze multiple lineaire 
regressie analyse met de PHQ-9-scores als afhankelijke variabelen werd 
uitgevoerd. Volgens de PHQ-9 bereikten 19.8% van de mannen en 19.2% van de 
vrouwen een score van 15 of hoger wat in ieder geval wijst op een matige tot 
ernstige depressie. Het is interessant dat er geen significante verschillen tussen 
mannen en vrouwen konden worden aangetoond. De sterkste voorspeller voor de 
mate van depressie was de ervaren pijn en weinig sociale contacten. Andere 
voorspellers waren lichamelijke beperkingen van zowel het bovenlichaam als het 
onderlichaam, leeftijd en de BMI. De bevindingen suggereren dat depressie bij 
artrose patiënten vaker voorkomt en benadrukt de noodzaak voor herkenning en 
geschikte behandeling. De meeste aangetoonde voorspellers zijn te beïnvloeden 
en zouden potentiële doelen kunnen zijn in een uitgebreide behandeling van 
artrose om de vicieuze cirkel van pijn, lichamelijke beperkingen en depressie te 
doorbreken. 
 
Hoofdstuk 5 
In dit hoofdstuk is gekeken naar de invloed van een bijkomende depressie op de 
kwaliteit van leven en gebruik van de gezondheidszorg door patiënten met artrose. 
 Samenvatting 223 
Data van 1021 patiënten van 75 huisartspraktijken, voortkomend uit het PraxArt 
project werden geanalyseerd. Metingen bevatten sociodemografische data en een 
korte versie van de Patient Health Questionnaire (PHQ-9) om een depressie te 
meten. Data over gebruik van de gezondheidszorg (contacten met huisartsen, 
orthopedisten en andere aanvullende of alternatieve hulpverleners) werden 
verkregen door zowel het stellen van vragen als de medische gegevens van de 
patiënt. De resultaten lieten zien dat patiënten met een depressie significant vaker 
contact hadden met huisartsen (p<0.01) of orthopedisten (p<0.01) maar niet met 
aanvullende of alternatieve hulpverleners. De bevindingen verschaften 
verschillende inzichten in patronen met betrekking tot het gebruik van de 
gezondheidszorg. Er kan geconcludeerd worden dat depressieve patiënten de 
neiging hebben hulpverleners te bezoeken waar ze passief kunnen blijven.  
 
Hoofdstuk 6 
Het doel van de studie, gepresenteerd in dit hoofdstuk was de samenhang te 
toetsen van zwaarlijvigheid met kwaliteit van leven, gebruik van de 
gezondheidszorg en lichamelijke activiteiten bij een grote steekproef van patiënten 
in de eerste lijn met artrose. Bij 978 patiënten van het PraxArt project werden 
lengte en gewicht gemeten en werd de BMI berekend. De AIMS2-SF werd 
gebruikt om de kwaliteit van leven te toetsen. Data over gebruik van de 
gezondheidszorg werden verkregen via de medische dossiers van patiënten. 
Bijkomende depressie werd getoetst middels de Patient Health Questionnaire 
(PHQ-9). Patiënten werden gegroepeerd in normaal gewicht, overgewicht en 
zwaarlijvigheid conform de definitie van de WHO en vergeleken middels analyse 
van de covariantie (ANCOVA). Zwaarlijvige personen en personen met 
overgewicht bereikten significant hogere scores op de AIMS2-SF onderlichaam 
schaal, het symptoom, het effect en de werk schaal. Dit impliceert een verhoogde 
last bij artrose. De PHQ-9 score was significant hoger bij de drie gewichtsgroepen, 
wat een positief verband aantoonde met BMI en depressie. Bij een verhoogde BMI 
nam het aantal comorbiditeiten toe en lichamelijke activiteiten namen significant 
af. Na correctie voor covariaten, bleven contacten met orthopedisten en 
uitgevoerde röntgenfoto’s significant hoger bij overgewichtpatiënten, maar 
contacten met huisartsen niet.  
 
Hoofdstuk 7 
Pijn vertegenwoordigt een van de belangrijkste voorspellers van kwaliteit van 
leven bij patiënten met artrose. Maar bij de meeste studies die pijn toetsten 
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werden belangrijke covariaten zoals depressie, overgewicht of lichamelijke 
activiteiten niet meegenomen. Daarom wilden we factoren vaststellen die 
samenhingen met pijnintensiteit in een grote steekproef van artrosepatiënten in de 
eerste lijn. In een regressiemodel met de “symptoom” dimensie van de AIMS2-SF 
als afhankelijke variabele bleven 4 factoren over die 47.9% van de variatie 
verklaarden: Mate van depressie weergegeven in de PHQ-9 score beïnvloedden 
pijnintensiteit het meest (bèta=0.459, p<0.001). Functionele handicap van de 
onderste ledematen telde voor een bèta van 0.427 (p=0.003). Een laag 
opleidingsniveau hing samen met toenemende pijnscores (bèta=-0.321; p=0.029) 
net als duur van de ziekte (bèta=0.178; p= 0.017). De sociale contacten/netwerk 
gemeten door de AIMS sociale schaal gaf een bèta aan van 0.211 (p=0.040). 
Onze studie liet zien dat een variatie van lichamelijke en psychosociale factoren 
samenhing met pijnintensiteit.  
 
Hoofdstuk 8 
Patiënttevredenheid is een belangrijke indicator voor de kwaliteit van zorg 
gegeven aan artrosepatiënten. Eerdere studies richtten zich op 
patiënttevredenheid betreffende zekere behandelingen als chirurgische ingrepen 
of pijnbestrijding. Het doel van de studie in hoofdstuk 8 was de huidige 
tevredenheid van artrosepatiënten te bepalen en na te gaan of ziektegerelateerde 
factoren belangrijk zijn voor tevredenheid. Bij de steekproef van 1021 
artrosepatiënten werd de kwaliteit van leven gemeten door de AIMS2-SF en werd 
de patiënttevredenheid gemeten met behulp van het EUROPEP instrument. Een 
stapsgewijze lineaire regressie analyse met de EUROPEP score als afhankelijke 
variabele, gecorrigeerd voor het aantal huisartsbezoeken werd uitgevoerd om 
voorspellers van tevredenheid te toetsen. In tegenstelling tot onze verwachtingen 
hing alleen de duur van de artrose (bèta=-0.105; p=0.008) en geen andere 
ziektegerelateerde factor samen met patiënttevredenheid. De voornaamste 
voorspellers waren de depressiescore (bèta=-0.372; p<0.001), leeftijd (bèta=-
0.185; p<0.001), alleen leven (bèta=-0.209; p<0.001), aantal comorbiditeiten 
(bèta=-0.152; p<0.001).  
 
Hoofdstuk 9 
In hoofdstuk 9 werd getoetst in welke mate de huidige zorg voor artrosepatiënten 
overeenkomt met het Chronic Care Model (CCM) in Duitsland. Bovendien 
probeerden we mogelijke voorspellers te tonen met een hoge overeenstemming 
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en op die manier de vraag te bepalen of bepaalde patiënten zorg zouden 
ontvangen volgens het CCM.  
De Patient Assessment of Chronic Illness Care (PACIC-5A) werd gebruikt om te 
meten volgens het CCM, kwaliteit van leven werd gemeten door middel van de 
Arthritis Impact Measurement Scale (AIMS2-SF). De PACIC somscore was 
aanzienlijk lager dan in eerdere studies uitgevoerd in HMO settings in de USA. De 
stapsgewijze multiple lineaire regressie modellen met de PACIC somscores en de 
5A scores als afhankelijken onthulden dat de PACIC scores samenhingen met een 
hoger opleidingsniveau (bèta=0.421; p=0.008) en lagere leeftijd (bèta=-0.319; 
p=0.016). De 5A score werd voorspeld door het opleidingsniveau (bèta=0.344; 
p=0.002), leeftijd (bèta=-0.386; p=0.004) en de PHQ-9 score (bèta=-0.288; 
p=0.005). Onze resultaten laten zien dat jongere en beter opgeleide patiënten 
hogere scores bereiken op de PACIC score. Waarom deze patiënten zorg 
ontvangen die meer overeenkomt met de CCM blijft onduidelijk.  
 
Hoofdstuk 10 
In hoofdstuk 10 probeerden we mogelijkheden te laten zien om de 
praktijkverpleegkundige meer te betrekken bij de zorg voor artrosepatiënten. We 
hielden kwalitatieve, semi-gestructureerde interviews met 20 huisartsen, 20 
praktijkverpleegkundigen en 20 patiënten in de omgeving van Heidelberg. De 
interviews werden digitaal opgenomen, uitgewerkt en inhoudelijk geanalyseerd 
met Atlas.ti. Onze resultaten laten zien dat praktijkverpleegkundigen alleen 
marginaal betrokken zijn bij de behandeling van artrosepatiënten. Zowel 
huisartsen als patiënten zijn erg sceptisch over het verhogen van de 
betrokkenheid bij de zorg. Patiënten waren sceptisch over de professionele 
achtergrond van de verpleegkundigen en vreesden voor een verslechtering van de 
patiënt-arts relatie. Huisartsen klaagden ook over onvoldoende opleiding van 
verpleegkundigen betreffende medische kennis. Zij vreesden een tijdgebrek en 
weinig rendement bij de pogingen tot meer betrokkenheid. 
Praktijkverpleegkundigen wensten meer betrokkenheid en zagen dit als een 
waardering van hun rol. De belangrijkste belemmeringen waren een gebrek aan 
tijd, teveel administratief werk en een gebrek aan professionele kennis.  
 
Hoofdstuk 11 
In dit hoofdstuk probeerden we te toetsen of het verschaffen van meer informatie 
door huisartsen over (‘zelfbehandeling’ van) artritis de kwaliteit van leven van 
artrosepatiënten verbetert en of aanvullende zorg door de praktijkverpleegkundige 
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betere resultaten geeft. In een pragmatische, cluster-gerandomizeerde 
gecontroleerde, drie-armige studie werden 1021 patiënten uit 75 huisartspraktijken 
in Duitsland geïncludeerd. Huisartsen werden willekeurig toegewezen aan 
interventiegroep I of II of aan de controlegroep. Huisartsen uit beide 
interventiegroepen namen deel aan 2 groepsbijeenkomsten. In interventiegroep II 
werd via de telefoon begeleiding geboden aan patiënten (case management) door 
de praktijkverpleegkundige. De primaire uitkomsten waren verandering in de 
kwaliteit van leven, gemeten door de Duitse AIMS2-SF. Secondaire uitkomsten 
waren gebruik van de gezondheidszorg, voorschriften en lichamelijke activiteiten. 
Data werden gecorrigeerd voor depressie (middels PHQ-9) als een potentiële 
confounder. 1021 of 1125 geregistreerde vragenlijsten werden geanalyseerd. 
Vergeleken met de controlegroep werden er geen significante veranderingen 
gevonden in interventiegroep I met betrekking tot de primaire uitkomsten. 
Uitgevoerde röntgenfoto’s daalden significant (p=0.050), terwijl voorschriften van 
paracetamol significant toenamen (p<0.001). In interventie groep II werden 
significante veranderingen gevonden in de AIMS2-SF dimensies “sociaal” 
(p<0.001), “symptoom” (p=0.048) en “onderlichaam” (p=0.049). Röntgenfoto’s 
(p=0.031) en contacten met orthopedisten (p=0.044) verminderden, terwijl 
voorschriften en pijnstillers significant toenamen. De conclusie is dat het 
verbeteren van de kwaliteit van leven van artritispatiënten door ‘zelfbehandeling’ 
een uitdaging lijkt. Alleen het verschaffen van informatie via de huisartsen is niet 
voldoende maar dit combineren met case management lijkt een veelbelovende 
aanpak. 
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